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• # O *CrO » P O pec t Û Q
The r,istnric-?J. development, uses, phermacol ony, ci’'o;r,istry 
and n^etabolis-1 of phenothiazine and the phenothiazine tranquillisers 
are raviewad along with the analytical techniques which have been 
used for their detection arri deternir^ation.
The netabolism and excretion hy the horse of proKiazine 
chlorproma.zinGj acepromazine end propionylpronazine, tranquillisers 
commonly used in equine practice, h.ava been examine''I qualitatively and 
quantitatively* hathods of collection, storage and analysis 
of horse urine have been developed; and tiro use of mass spectroscopy 
in combination with gas liquid chromatography fzr the detection of 
phenothiazine derivatives in biological fluids .has boon 0x2mined, 
Qualitative results hove shown that '-'any biotrzns formations 
of such derivatives take place in the horse, 3fj metabolites of 
promazine were detected in a'.ldition to the parerit drug, 2u of 
chlornroaazine and 11 and 6 respectively f ran acsprc.'azlna and nropior 
ylpronazina, Hydroxylation followed by conjugation, predr.ninar.tly
with, glucuronic acid and to a smaller extent with sulpturic acid, 
is tea major rc'Ut.-j of tabolis’:i of pro';iazina and chlorpio :azina« 
Acepromazine and propionylpromazine, on the other hand, ar^ not 
conjugated to a great extent. Instead t^ey lose the side chain 
ketone grouping attached to the nucleus at the 2-oositban and er= 
excreted in t e sul-rhoxida for::,
Quantitative results mzve sh::un that excretion is irregular an 1' 
prolonged, in ac-e c-aas laeting "or a we-k after a"'■ ini 21 r a ei ^0 ^
The of ioee detested as urimsry "etaholitas 1 as iou,
being approximately 19;i for chlorpromazine, lOp for promazine 
and 3/ for acepromazine. Conjugated metabolites were excreted 
predominantly as sulphide derivatives, uhsreas the unconjugated 
fraction were predominantly in the sulphoxide form,
The applicability of the techniques used for the detection 
of phenothiazine derivatives, after administration in small doses 
just sufficent to produce an effect, has also been examined.
r . T M E r C L ' ^ T U n :
Threo different nu'nhnrino systelinve b='.-en used by different 
authors at different times to designate the positions on the 
phenothiazine rinn system, The first (l) is that advocated by tiie 
International Union of Pure and Aaplird Chemistry, the Chemical
H
3 
2
9 10
6
7
(I) (II) (III)
Society and Chemical Abstracts* The second s y s t ( H )  appears in
Beilstein’s "nondbuch dsr organischen Chomie", 2ith edition, and
system (ill) may be found in 'laycr-Oacohson's "Lehrbuch dor organised
Chemio" and T ,m * Tic'''tar’s "Lex ikon dsr Kohle.nstnfi^vorbindcrtg'^n" *
The system of no'i end a tu ze used in the present s t u ' y is that
accented hy the International Union of Pure and Annli.ed Che.nistry (l)
In addition, thrnughout the text the ter;i '’phenothiazine"rzfrrs to 
H
ICH " phenott’.iazioe (A), the hypothetical iso>0"i.T '
(a) being referred to as S'jch uhen necessary
HISTORICAL BACKGROUND, PHARMACOLOGICAL PROPERTIES AND
CLINICAL USES OF THE PHENOTHIAZINE TRANQUILLISERS
H I 5 T 3 1 I C A L  R - ' K P'-.y: y C P L G P i C ‘-'L P R O P E R T I E S  P:OJ
C L I P T O S L  UOEO or TOE PPrOOTHI AZIO f; TR"*;0UILL TOOTS
A * Oev^Iop-pnt oO Pîi'ünot'r zinA *
P h e n ü t h ziHG j The chcr'iicG.1 nucl^ Mjs of thG nodern 
* phanothiazlno ' branpuillisGrR, i-'as first prepared hy Bernthsen 
(1833) durinn studies into the structures of the t'-jo dyes 
Leuth’s Violetj (V^-sinino-j'-iuino^ S^ ypMen:. thiazine hydrochloride- 
Lauth, 1876), and r^ethylone blue, (3, 7-hJs (dinebhyla.''ino)- 
phenazbthioniua chloride h Caro, 1876) &
H NH2
8
7
Phenothiazine
N
2 3
Lauth's Violet
Cl
Methylene Blue
In initial experinents ha achieved the synthesis by fusion 
of sulphur and diphenylano at 25G-260°C, and went on to prove 
its structure in a series of sophisticated studies (Cornthein, lots) 
The sane -le thod of synthesis is en^loyad to tlie present day, 
altfvoijnh e, feu ref ins’.ants have been edded, part ic,.ii.ar,
iodine ( ■'cher~.ann, 1911a j KnoevanepaT, 1916) or alun in ion 
chloride ( "chrr-ann 1911b) has been u-ed es a catalyst, a.e;: =
usini a cereoo erc<i.
\1 *
Although seldo.n used as the starting material for 
phenothiazine dyes, its role as the nucleus of such compounds 
has proved of great interest to researchers in the dyestuffs 
industry (Vonkatarnaran, 1952) « It has also been used 
industrially as an antioxidant for petrochemicals, showing a 
high degree of inhibition (Murphy, Rainer and Smith, 1950;
Smith, 1951).
The compound was of little commercial interest until its 
insecticidal properties were discovered by Campbell, Sullivan,
Smith and Haller (1934), who demonstrated its lethal action on 
the larvae of culicine mosquitoes. The extensive investigations 
which followed showed that phenothiazine has toxic effects on 
a large range of economically important insects (Zukel, 1944).
This worker attributed its insecticidal properties to cytochrome 
oxidase inhibition by an unspecified conjugate of leucothionol 
(3, 7 “ dihydroxy phenothiazine). However, reports of photo­
sensitization of human skin by phenothiazine dust, or sprays^ 
restricted its widespread use in this field (Harwood, 1953).
The anthelmintic properties of phenothiazine were first 
discovered by Harwood, Derstad and Swanson (1938),who investigated 
its effects on ascarids and nodular worms in swine* It has 
since been tested on nematode parasites in most domestic animals 
and man (Davey and Innes,.1942), A particular advantage of 
phenothiazine^ which had not been observed with other anthelmintics^ 
was its ability to control worm levels by reducing egg production,
when administered in repeated -inses fcno a e^ll tn have a lethal 
effect on the parasite (F'inrilay, 1953).
It is thougîd: to enter t!ie parasite through the cuticle 
(Lazarus and Rogers. 1950, i.^ Sl), and many theories have been 
put forward 3?3carclirg the active fore (Collier, 196Ü; De Eds 
and Til on as , 1941), Phono thi azina sulphoxi.de, (Phenothiazine- 
5-oxid-')j has bean reporter! to possess anthalnintic activity, 
whereas the sulphona, (plienothia zine-5, 5-dioxide ), was inactive 
(Rogers, Cy ier. ian- Crain and '-iar'iick, 1955). Similarly, 
phenothiazone, (5]i~;'jhenot’iiazina-3-ans) , and thinnol, (3-hydroxy- 
3H-phnnnthiazino-.7-one), showed no activity (Gordon and Lipson, 
1940: Taylor and Sanderson, 1960: Rogers et al., 1955). On
this basis Craig and Tate (.1961) suggested that the sul dicxi I'e, 
for"<ncI n, at the site of action, is the activa spnciea.
This is in ke.aping with the findings of Cl-ra (196?), who resort; 
that suj phoxidatinn nf phenothiazine ncc.'rs in tlie ru.'i=’n of 
sheen and cattle. This was later confic-ed hy Harpur, Gwal-ra 
and Dans ter't (l95C). The s'jt’j'^ ct has h‘>~n discussed in detail, 
by D-vay and Innes (1962) and Craig and T: te (1961).
Although at first considered to'-.ic, re nor t- of
h a e n o 1 y t i. c an a e -1 i a a fter p li enot h i cs z i n a a r! a i n ^ s t r -■ t i. o n pu t a n 
end to its use as an nnthel d.ntic in h un ans ( E india y, "93''':
Haïr 100 d, 1-53), Hrwevar, t h - en.-pound i.a still extensively c-s = d 
in veterinary neJ'cinn (Griffiths, 195h)» 11 a an t‘-. ■ l •Innic uses
have b 1 n - X t n - 1 vnlv r^vie e by 9av"v and I^rea 'l-ég' f- a a
(1967), Findlay (1990), H.’r'oood (1953), Griffiths (1954), and 
Craig end Tats (196]).
iTany other T.odical uses of piarnothiaz.ino have been reported 
over the lest 30 years. It acts as a urinary antiseptic (De 
EdSj Stockton and Tho^ 'ias, 1939; Do Eds and Thomas, 1962), a 
tuborculostatic nnant (Erecdlander, 1946), and its deriv-tives 
have been used as antiemetins (Friend and Curuins, 19S3), 
antihistamines (Halpern, 1966; Halpern an;! Duorot, 1966), and 
in the troat''''Grit of Parkinson’s disease (Ourger, 1951), During 
the last tiuo decades interest in substituted phenothiazinos, 
especia]. 1 y t o  10*«suhstituted derivati.vos, has increased enornous 1 y 
due to their unique tranquillisinn properties,
B, D'^velonnent of the ’ P'ronothiazins ’ Trannuillisers«
Since certain phe not fie zinc c'erivative^, (c,g, ^^thyiane 
blue), had earlier shown anti^alarial activity (outturn and 
Ehrlich, 1892), and since phenothiazine Itself had boon found 
useful as an .r.ntudr-intlc, G i In an ana! Shirley (1966) synthesised 
a number of substituted phenothiazinas in a search for more 
effective agents. Included amongst th-^se i-fere a series of 
10-dialkyl-^minoalkyl derivatives. However, they i.-ere found to 
be lacking in such activity and the investigation was closed.
At the same timo a similar lO-sucs ti tu to ■’ s-ries was 
synthesised independently in France, an.d , in addition "-q ecti- 
malarial and ant'veli'intic screening, was tested for antihiste^inic 
activity. This rasuitce in the disco''ery of ci^si^ersble 
anti'is te -inic activity t’zc crmrn-jn's, I ^ -(2-dimat’*"-'l"mi “o-" th''’
- 13 -
phenothiazine, (RP3015), and 10 «(2-dimethylamino « 1 - propyl)- 
phenothiazine, (Promethazine) (Halpern, 1946; Halpern and Ducrot, 
1946). They were also found to be less toxic than any previously 
reported antihistamines (Halpern and Cruchaud, 1947), and to 
have sedative and local anaesthetic properties (Halpern, Perrin 
and Dews, 1947).
The discovery of biological activity in lO-substituted 
phenothiazines led immediately to the synthesis of a large range 
of such compounds, many of which were found to be pharmacologically 
active (Charpentier, 1947; Charpentier and Ducrot, 1951; 
Charpentier, Gailliot and Gaudechon, 1951; Charpentier, Gailliot, 
Dacob, Gaudechon and Buisson, 1952).
Amongst the first derivatives studied were lü-(2-diothyl- 
eminoethyl)phenothiazine, (Oiethazine), and 10-(2«diethylamino 
-l~propyl)-phenothiazine, (Ethopropazine), which in audition 
to exhibiting antihistamlnic properties (Bovet, Fournel and 
Charpentier, 1947; Schaepdryver, 1950) were also effective in 
the treatment of Parkinson’s disease (Bovet, Durel and Longo,
1950; Burger, 1951). 10-(3-dimethylamino -1- propyl)-
phenothiazine, (Promazine), was also investigated, but although 
effective as a local anaesthetic, it showed little antihistamlnic 
activity (Halpern, Perrin and Dews, 1947). Its value as an 
ataractic was not realised until much later, (Begany, Seifter 
and Pless, 1956).
The action of such compounds on the central nervous system
J.'-f —
was later reported by Laborit and co-workers, who demonstrated 
their potentiating action in general anaesthesia. In initial 
studies promethazine or diethazine was used in combination with 
the anaesthetic, but later investigations showed that 2-chloro- 
10«(3-dimethylamino -1- propyl)"phenothiazine, (Chlorpromazine), 
was the derivative of choice (Laborit, Huguenard and Alluauma, 
1952; Laborit and Huguenard, 1954), The latter compound, 
synthesised by Charpentier et al, (1952), was also found to possess 
a wide range of pharmacological properties (Courvoisier et al,, 
1952). The most important of these was its ability to calm 
mentally disturbed patients (Delay, Deniker and Hart, 1952), 
and it has since been extensively used in the psychiatric field.
This discovery prompted further synthesis and research 
into the pharmacological properties of such derivatives which 
resulted in the large series of 10-substituted phenothiazines 
known collectively as the phenothiazine tranquillisers. They 
have since been extensively used in psychiatric wards in the 
management and treatment of psychoses and neuroses, sedation 
being achieved without the loss of consciousness, or the 
drowsiness,usually associated with barbiturates and other hypnotics 
A representative series of tranquillisers is shown in Table 1.
The group has a complex pharmacology, acting on both the 
central and autonomic nervous systems. On the former they have
- 15
sedative effects and diminish conditioned avoidance behaviour*
They possess antiemetic and antipruritic activity, and have a 
degree of potency as analgesics* Endocrine ci’ianges and seizure 
discharge can also be effected, along with changes in skeletal 
muscle tone, and temperature regulation.
a n d ,
They have antihistamlnic and antiserotonin activity/on the 
autonomic system^ ]aj3o^ act as adrenergic and cholinergic blocking 
agents* They potentiate the action of various narcotic drugs, 
and have a degree of potency as local anaesthetics. They also 
have a large number of undesirable side effects including extra- 
pyramidal reactions (e.g, parkinsonian tremors), hypersensitivity 
reactions (e.g. photosensitivity), agranulocytosis, jaundice, 
and dermatitis.
Although as a group they possess many similar pharmacological 
properties, the degree of activity and of adverse side effects 
varies considerably from compound to compound, and from species 
to species. The pharmacology of these drugs in humans has been 
reviewed in detail by Courvoisier et al. (1952) and Domino (1952).
D. Structure-Activity Relationships,
I W j.wi, ■ W IN w  «  i I —  III I I * . ^  p m m i '# » « l#i ,4%;# ■ m
The activity of such derivatives has been loosely related 
to structure, the determining factors being the substituents at 
the 2- and 1Ü- positions. Substitution at the 2-position renders 
the molecule asymmetrical, and has been found to increase its 
activity (Goodman and Gilman, 1965). Thus in the ’promazine*
series (Table 1) subsiiiution of a mathoxy, acetyl, or 
trifliioroaethyl group, nr of a chlorine atom, results in 
increased potency to depress the central nervous system, (c.f* 
promazine, nethoxypronazine, acepromazine, chlorpromazine, 
triflupromazine) • In addition, compounds with a trifluoromethyl
group tend to produce reactions of an cxtrspyramidal nature,
(triflupronazine, trifluoperazine, fluphsnazine)«
The activity of compounds with a three carbon polymethylene 
chain between the t'uc nitrogen atoms seems to increase according 
to the 2-substituent in the order unsubstituted = methoxy ecetyl< 
chloro <C trifluoro-'iothyl (Carey and Sanford, 1963), On the 
other hand the activity of compounds with a two carbon polymethyleni 
chain tends to decrease with substitution at the 2-position, (ccfc 
promotnazine, chlorpromethazine, propionazins ) <,
The potency of such con:pounds can also be broadly divided 
into th'’'ee groups depending on the nature of the side chain at 
the 10-positionf The least active derivatives possess an 
aliphatic side chain terminating in a dialkylamino group,
(promazine, chlorpromazine. acepromazine, triflupromazine),
Uith these compounds tranquillisation is usually accompani eel 
by a degree nf sedation, The nature of the aliphatic chain 
also determines to some extent the specific activity of the 
compound. Thus those with a tiiree carh'Oo chain have greater 
central depressant and anti^^mntic activity, ('Promazine' series), 
whereas a two carbon chain tends tn produce ^nbihistam-iriic activity
and anti-Parkinsonism affecta, (pro.'-a thazi na, pyrathiazinc ; diethazt 
ethopropazine)*
The second group has approximately the same central 
depressant activity as the first, in this case the terminal side 
cliain amino group being repJ.acod by a. substituted piperidin? ring* 
Such compounds incluc’e mnpaz.ine and thioridazine.
The ro-iaininj group, with much greater central activity, 
incorporates a substituted piperazine ring in place of the terminal 
nitrogen atom and includes the ’parazinc’ series, the 'ph'nazine' 
series and thionropazate (Table. l)« In this caso tranquillisation 
is achieved u.'ithout appreciable sedation, Ti'oy have a large 
' egree of antie’netic activity, and ax tr spy ran idol reactions are 
common.
Structure-activity relationships between the phenothiazine 
tranquillisers have been revieviod and discussed by Friend (l950)o
E. cjrtn^.
Many suggestions have been put forward a.s to the classification 
of phenothiazine derivatives in the broader field of tranquillisinn 
and sedative drugs. There is difficulty in classification since, 
on the one hand, small changes in structure within a chemically 
related gr :up can give rise to vast differences in pharmacological 
activity^ (chlorpromazine end nron.efnazino ), '-jharees, on the otlisr 
hand, cz-mpounds co'plately unrelated chemically can produce the 
sane therapeutic action, (chlozorc-azine and reserpine),
Sergar (1957) suggested a classification based both on t-eir
Table 1 CLASSIFICATION OF THE
TRANQUILLISERS
STRUCTURE.
ON THE
PHENOTHIAZINE 
BASIS “of CHEMICAL
(See next page)
General formula
* Denotes Major Use
A = Tranquilliser 
B = Antihistamine 
C = Antiemetic 
D = Antipruritic 
E = Anti-Parkinsonism
*
LU
(/)
3
< Û CÛ Cû CÛ LU LU U Cû cû
LU
S
<
û< l i : IIII
c —  g
ï I î'i
<D
C
II
N C q
.8 ‘n
il o
(D
C .5
i-i
ilf  o o V)Èè Ou£ 0>:E
^  <D
8 o o ? U
d)
c
'c
L.
O
5
o
u
D
0)
O
N
O
>.a.
ix—  QJUtOsi§vôu LUŸ ? 8 X XI I I uI XI
</)
LU
-I
Q.
S
<
X
LU
<D 
Ç 
N
gg
2 N
W
0) 0) 
fi
O O
N
l
<D
E
OL'C
d>
0 0
ill
s.iE
M Q  n
a.
!H|
"îr ^ 3
0
4-
o
N
O
Q-
O
i_
CL
O
0 
C
N
D 
-C
IIo 0
s-i
o
0 
c
N  N
0
C
N
O
_c
"0
O
E o
Q. 
O
0
C
1
2 c.
o. Q-
0
O-c
I
N
D
CL
0
0
Ç
N
-8
g
N
E
o
a
X
0
c
8
Ü
0
:S
g
N
O
ÎË
O
L_
V
ùl
CL
li
Z'0
fi
0
:S
Z
Xu
à
X
u
1
a
3
2
/ 0
Z c
‘n
E
u (g
I
%
X
u
0
X
u
z
LUo
O
ù:
H
O
ù.
3
§
O
CÛ
3
U)
I
X
_c
0
E
b
0
cI
0
Q.
&
S  §•
lî
I■z10
■I
y.y
' Xu
Xu ü
X
Zou
10
i
Z
X
U Xu
Q.
Xu
g
CM
X
y.
I
0
O
c
Ê
_o
X
_c
0
E
0
O
C
£
_o
X
_c
0
b
i
_9-
X
5
X
zz
0
a
X
_c
X
-D
0
ÜL
X
CL
O
X
"O
X
_Q.
X
_c
0
:E
X
~o
X
a
20 -
Chemical structure and action on the nervous system. The 
phenothiazines and the Rauwolfia alkaloids were classed as 
tranquillisers with effects on both central and autonomic 
systems, whereas the propanediols and diphenylmethane derivatives 
were classified as only affecting the central nervous system.
Several authors have suggested classification of 
tranquillisers or, the basis of their specific use in psychiatry- 
(Schiele and Benson, 1958; Ross and Cole, 1960). In this 
system they were grouped as having either major or minor 
activity. The major group were those used to control patients 
with more severe mental disorders, which may produce extra- 
pyramidal reactions, but do not induce physical dependence.
The minor group were those used in the treatment of slight 
neuroses and psychoses, and of psychosomatic disorders. Again 
this grouping is very general, and the two classes overlap 
considerably.
A similar classification was put forward by a study group 
of the World Health Organisation. (W.H.Ü., 1958), dividing 
tranquillisers and sedatives into three groups. The first 
group, the major tranquillisers, comprised those used in more 
severs psychiatric disorders and included the stronger 
phenothiazine tranquillisers such as chlorpromazine and 
perphenazine, the Rauwolfia alkaloids, butyrophenones such as 
haloperidol, and thioxanthene derivatives such as chlorprothixene
The minor.tranquillisers were those used in the treatment
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of anxiety, psychosomatic disorders, nervous tension, and the 
milder neuroses and psychoses. Included were the weaker 
phenothiazine tranquillisers such as promazine and promethazine, 
diphenylmethane derivatives such as hydroxyzine and azacyclonol, 
and chlordiazepoxide, A third group, based on their much 
more marked sedative properties included the dithiocarbamates , 
such as meprobamate, and phenaglycodol.
There can be no absolute classification of tranquillising 
and sedative agents on the basis of specific tharapeutic activity 
due to the wide range of pharmacological properties exhibited 
by those drugs. However the methods of classification described 
give some insight into the position of phenothiazine tranquillisers 
in the broader spectrum of tranquillising and sedative agents.
The problems of such classification have been discussed in 
detail by Domino (1962),
r* Tranquillisers in Veterinary Medicine.
Apart from their use in general medicine and psychiatry, 
these compounds have proved extremely useful in the veterinary 
field in the restraint, management and treatment of temperamental 
animals, and as premedication for general anaesthesia. Although 
there have been many rsoorts of undesirable side effects from 
these drugs in animals, the toxicity is appreciably less than 
in man. (Oubost and Parcel, 1953; Dobkin, Gilbert and 
Lamoureux, 1954).
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They have o sedative affect in all species, the degree 
dopehding on the specific drug, dose and species, and also on 
the individual ani'r'.l. Typically the eninal develops a relaxed 
posture and shows no sign of anxiety. It does not appear to 
be aware of its surroundings, but can be aroused if stimulated.
This depression is usually most marked over the first six hours 
after administration, but residual signs are often detected up 
to 48 hourso With smaller doses the animal tends to become 
sleepy, and from f.E.G. studies, this state seG-;s to resor'ble natural 
sleep rathar than the drowsiness produced by barbiturates^
(I'lesthues and fritsch, 1965), 'Jhen higher doses are am ployed 
muscular weakness occurs an'" the animal tends to he unsteady when 
standing, or may lie down, Occasionally, i-iith certain drugs, 
especially when administered to horses, an abnor“al excite".er,t 
reaction takes place (Pg. 25),
Other visible signs associated with tranquilliser therapy 
are enophthelmue, miosis, ptosis and protrusion of the third 
eyelid. In male animals the penis is relaxed and orotrudcs 
from the sheath. The drugs also -roduce hypothor^u.a and can 
cause hypotension and irregular respiration and ouisa rates.
Although all the above reactions have been noted after, 
administration of tranquillisers to animals, effects and 
visible signs vary for individual compounds and from spcci-s 
to species.
The most imocrtant clinical applications of tt^ as?
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compounds are basically the same in all species, and will bo 
discussed with emphasis on their use in equine practice (pg, 24)
In particular, chlorpromazine, promazine and acepromazine 
have been widely used in the veterinary field. Chlorpromazine 
has a marked sedative action and adrenolytic activity. It is 
a powerful antiemetic and a potent vagolytic agent. It is 
commonly used in veterinary medicine as premedication for general 
anaesthesia and chlorpromazine therapy has been extensively 
described in the treatment of domestic animals (Troughton, Gould 
and Anderson, 1955; Brodey and Thorald-Christensen, 1956;
Estrada, 1956; Weaver, 1956; Martin and Beck, 1956; Clifford, 
1957; Graves, 1957).
Promazine is closely related to chlorpromazine and has 
somewhat similar actions, although sedation is not so marked and 
is of shorter duration. Its clinical and surgical uses have 
been reported in detail in small animelS; (Gradess, 1956;
Clifford, 1957; Knowles, 1957; Krawitz, 1957), swine- (Welson,
1958), cattle (Schulz, 1958) and horses. (Owen and Neal, 1957; 
Shambaugh, 1958; Dawson, Lickfeldt and Brengle, 1959; Gorman, 
1959; Raker and English, 1959; Raker and Sayers, 1959).
Acepromazine, one of the more recently discovered 
tranquillisers (Schmitt et al*^1957) has properties similar to 
promazine, but has the advantage of requiring very small doses. 
Although references to it in British Veterinary literature are 
few (Cooper, 1961; Van Laun, Nettleton and 3app, 1961; Baillie, 
1967), it has been extensively used abroad as a tranquilliser
and preanaesthetic agent in domestic animals. In particular, its 
usefulness has been widely reported in Scandinavia (Hansen, 1958; 
Korsbach, 1958; Nordstrom, Orstradius and Lanek, 1950; Dstradius 
and Lanek, I960; Sonnichsen, I960 )o
The other phenothiazine derivatives used in veterinary medicine 
have properties similar to the three compounds mentioned, but 
their application in this field has been more limited,
G, Tranquillisers in Equine Practice.
These drugs have proved exceptionally useful in equine practice^ 
both due to the size and temperament of members of this species.
They are used as sedatives in the examination and treatment of 
nervous, aggressive, or excitable animals, especially when surgery 
under local anaesthesia is involved. This sedative effect is 
also used to reduce the apprehension of such animals during 
loading or transport, or when placed in strange surroundings.
They have proved invaluable as premedicants for general 
anaesthesia,reducing excitement during induction and recovery, 
and potentiating the action of the anaesthetic. Such compounds 
have also been used in the treatment of shock (bJesthues and 
Fritsch, 1955), tetanus (owen, 1955; Troughton, Gould and 
Anderson, 1955; Shambaugh, 1958; Dawson, Lickfeldt and Brengle,
1959). %nd colic (Troughton, Gould and Anderson, 1955).
Variable effects are produced after their administration to
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the horse, which can be classified broadly into three groups.
The first type is the normal tranquillisation experienced in 
most species. In the horse this takes the form of l o w e r i n g  of 
the head; immobility, and a sleepy appearance^ with drooping eyelids, 
ears or mouth. Occasionally nasal discharge, salivation, 
shivering and sweating are observed. In the case of male animals, 
as in all species, the penis becomes relaxed and protrudes from 
the sheath, 'The animal appears to show no interest in its 
surroundings, and is not readily aroused.
In the second case there seems to be complete lack cf 
response to the drug. After administration the animal stands 
quietly, but does not have the sedated appearance noted in the 
first type of reaction. This effect, for reasons unknown, 
seems to be due to the inability of the drug to function normally 
(Carey and Sanford, 1963), Such findings have been reported by 
several workers (Martin and Beck, 1956; Owen and Neal, 1957;
Dawson, Lickfeldt and Brengle, 1959; Gorman, 1959; Cosgrove, 
Collins, Ravenagh and Cosgrove, I960),
Occasionally, especially with thoroughbred horses, a third 
type of reaction occurs, being a complete reversal of the normal 
action of the drug. It has most commonly been observed after 
administration of chlorpromazine, although it has been noted from 
time to time with promazine, acepromazine, propionylpromazine, 
trimeprazine, or perphenazine (owen and Neal, 1957; Williams 
and Young, 1958; Nordstrom, Orstradius and Lanek, 1958; Gorman,
1959; Dones, 1963; Uosthues and Fritsch, 1965). At first the 
animal stands quietly, but after a feu minutes becomes excited, 
uneasy and unsteady. It will sink back on its haunches, and 
may rear, neigh, and paw the ground, besides plunging around with 
lincoorriinated Movements. This condition recurs at periods of 
several hours alternating with periods of sedation and has been 
found to be associated with an increase in pulse rate (Gorman,
1959; Hall, 1960; Oones, 1963; Westhues and Fritsch, 1965).
This type of uncoordinated excitement has also been noted in dogs 
and pigs (Wssthues and Fritsch, 1965). Bones ; (1963) succeeded in 
reversing the reaction in a horse by means of an intravenous 
injection of methylamphetamine.
Several theories have been put forward as to the cause of this 
third reaction. One suggestion is that the effect is caused by hypo­
tension giving rise to vertigo (Owen and Neal, 1957). However, 
investigations of this theory, after administration of chlorpromazine, 
have shown no fall in blood pressure (hall, 1960; Carey and Sanford,
1963). Ball, on the other hand, found a slight increase in 
blood pressure, and a large increase in pulse rate when the condition 
was evident. Bente (1957) suggested that the effect is due to the 
alternating dominance of opposing depressant and excitant reactions 
of the autonomic nervous system, whereas Owen and Neal (1957) 
suggested that it is a panic reaction in the animal due to a sensation 
of muscular weakness. These theories, however, have not been 
substantiated.
Side effects of phenothiazines have also bean investigated
in the horse. Hypotension does not appear to occur to any appreciable 
extent. Martin and Beck (1955) noted a slight fall in blood 
pressure after intramuscular administration of chlorpromazine 
{ 2mg/kg). On the other hand Carey and Sanford (1963) detected 
no change, and Hall (i960) reported a slight hypertension with 
this drug (0*5 mg/kg). Rapid intravenous injection of promethazine 
has been found to produce a distinct fall in blood pressure 
(Hall, 1960)^ A very slight hypotension unnoticed after adminis­
tration of chlorpromazine (2-»4mg/Kg), although with larger 
doses a greater drop was observed (Martin and Beck, 1956; Owen 
and Weal, 1957). A fall of 3F° was reported by Alexander (i960) 
two hours after administration of chlorpromazine (1*5 mg/kg,) 
returning to normal after seven hours. After intravenous 
administration of promazine ( 1 . 5  mg/Kg) Carey and Sanford 
(1963) reported a fall in rectal temperature of 5F° within two 
hours*
Under normal conditions of sedation, the effect on pulse 
rate is slight, an increase usually being produced. A slight 
tachycardia has been reported after administration of chlorpromazine 
(Martin and Beck, 1956; Hall, 1960; Bones, 1963), this being 
greatly accentuated during the excitement reaction (Gorman, 1959;
Hall, 1960; Bones, 1963; liiesthues and Fritsch, 1965). A 
noticeable increase in pulse rate has also been reported 
following administration of large doses of acepromazine. (Sonnichsen, 
1960).
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Effects on pulse rate after administration of promazine 
are variable* Carey and Sanford (1953) found that the rate was 
virtually unaltered after doses of 0*5-1 mg/kg* Raker and 
English (1959) administered repeated intravenous doses (/v-lmg/Kg) 
to two horses every three days for two weeks* After each dose 
they found the pulse rate had dropped by 10 minutes after injection, 
but had risen to a maximum by 45 minutes, gradually returning to 
normal within, three hours. The decrease was of the order of 
10"20ÿ and the subsequent increase from 30-50^* However, with 
other horses they found only sliglit increases.
The duration of action of these drugs has also been found 
to vary with dose, route of administration and the specific animal 
involved. Owen and Neal (1957) administered chlorpromazine 
intravenously (img/Kg), and intramuscularly (2mg/Kg), to a series 
of horses. They found after intravenous injection that 5 to 15 
minutes elapsed before the full effects of the drug were noticeable^ 
and residual effects lasted from 5 to 8 hours. For intramuscular 
injection the corresponding times were 45 to 60 minutes and 12 
to 18 hours, and in some cases very slight effects were noted up 
to 48 hours, Martin and Beck (1556) reported that intramuscular 
doses of chlorpromazine greater than 2.5 mg/Kg produced greatest 
effects between 1 and 6 hours of injection and in some cases 
effects were still noticeable up to 48 hours.
After intravenous injection (^  1 mg/Kg)^ promazine was found 
to produce noticeable effects within 5 minutes, the action
diminishing gradually ovsr 2 hours (Raker and English, 1959)*
After a dose of 1*25 mg/Kg, Schulz (1958) reported the same time 
of onset, the effect lasting for 4 hours* Repeated daily doses 
did not appear to have any effect on the onset or duration of 
action* Gorman (1959) administered 50-500 mg,doses of promazine 
intramuscularly and noted an effect within five minutes which
became most marked within the first hour. In some cases residual
effects were noticed up to 24 hours. After parenteral administration 
of acepromazine predictable sedation has been produced withmlS 
minutes and residual effects have been noticed up to 8 hours (Van 
Laun, Nettleton and Oapp, 1951)*
From these facts the following observations can be made
regarding the onset and duration of action of phenothiazine 
tranquillisers in the horse. After doses producing the same 
clinical effect their duration of action decreases in the order 
chlorpromazine > promazine > acepromazine. Effects of intravenous 
administration are noticeable within the first 5 to 15 minutes 
after injection, whereas, after intramuscular administration 45 
minutes to 1 hour elapses before there is any noticeable response. 
Effects are most marked up to 8 hours depending on the dose and 
route of administration, and residual effects can be noticed up 
to 48 hours. Repeated daily doses do not seem to have any 
cumulative effect on duration of action.
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II, CHEMICAL AND BIOCHEMICAL TRANSFORMATIONS 
OF PHENOTHIAZINE AND ITS DERIVATIVES.
A, Chemistry of Phenothiazine.
Phenothiazine, when pure, is a light yellow crystalline 
solid (M.P. 180-181^C), soluble in most organic solvents, but 
almost insoluble in water, being wetted only with difficulty.
It is a reactive compound giving rise to a vast range of 
derivatives, many of which have proved useful commercially,
(Chapter l). Its reactivity is most evident in its ease of 
oxidation, particularly in the presence of moisture. This 
accounts for the grayish or greenish blue colour of commercial 
preparations.
The compound and its derivatives act as weak bases, and 
have low ionisation potentials. The latter property is thought 
to be related to their physiological activity (Kearns & Calvin,
1961; Lyons and Mackie, 1963), They are strong electron donors 
and form weak complexes with molecules of high electron affinity 
by means of an intermolecular charge-transfer process. Many 
of these complexes are coloured, and their formation has been 
used as a method of colorimetric assay (Cupples, 1942; Payfer 
and Marshall, 1945; Stewart, 1947),
(l) Preparation of Derivatives - Nuclear Substitution.
Phenothiazine undergoes many direct nuclear substitution 
reactions, the most common being nitration, acylation, halogénation, 
metalation and mercuration. Nitration is usually accompanied 
by oxidation of ths sulphur atom, the degree of nitration
depending on the conditions used. By heating phenothiazine with 
fuming nitric acid at O^C, Bernthsen (1885) obtained two isomers, 
only one being identified (3,7-dinitro phenothiazine sulphoxide). 
Using milder conditions only the mono-derivative was obtained 
(3-nitro phenothiazine sulphoxide), and at higher temperatures 
trinitro sulphoxides (Kohrmann and Nossenko, 1913), and tetranitro 
sulphoxides have been obtained (Barnett and Smiles, 1910),
Reduction of such compounds to their corresponding phenothiazine 
amines, followed by treatment with ferric chloride, gives rise to 
various members of the thiazine group of dyes (Bernthsen, 1885),
The nucleus is also readily acylated using the Friedel-Crafts 
reaction, but alkylation has not been reported by this method.
The usual product is the 3,7-diacyl derivative (Massie, 1954), 
but N-acyl derivatives tend to orientate substitution to the 2- 
and 8- positions (Michels and Amstutz, 1950),
Direct halogénation has only been reported using chlorine, 
producing small amounts of 3,7-dichloro phenothiazine, a tetrachloro 
phenothiazine, and its sulphone (Ungar and Hoffman, 1896), Other 
halogens have been found to produce the corresponding pheno- 
thiazonium derivatives (Pummarer and Gassner, 1913), Ungar and 
Hoffman also reported a chlorination reaction using an ethereal 
solution of hydrogen chloride and nitrogen tetroxide,which produced 
1,3-dichloro phenothiazine plus a mono- and a tetra-substituted 
derivative. This method also produced small yields using
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hydrohro'^iic acid, hut no reaction was noted with hydriodic acid,
(Pace and Smiles, 1910), Haloganated derivatives are bast prepared 
by ring closure methods using helogeneted diphsnylat.iines (Smith, 
1950), or by replacement of a metal nuclear substituent (Oilman 
et al.p 1954), The latter method,using either litliium or mercury, 
has been used as an into m e  rüa to step in the preparation of e 
variety of substituted ph.enot^'iazi nos,, (Gilman at al.pl944, 1954; 
finzB, 1932).
( 2 ) Ring C't osuro fothods.
In addition to direct substitution of the phenet'-'iazine 
ring, nuclo'-r subs to tu tori phenothiozines can also be prepared 
by ring closure c;?toons, using storting n^t^rials already substituted 
witli the required grouping* The most cr/i-inn technique folic's 
Bernthsen's original synthesis of phinothiaine by fu-ing an 
appropriately substituted diphenylamine iwj to sulphur. Para- 
substituted diphenylamines form n-subrd'i tu ted pivonothia zinas, 
ortho-diphenyla-^ ines giv? the 1-subs ti tu ted derive ti ve, but --'eta 
compounds give rise to either 2- or 4» substituted phenot'miaz'’n-'s, 
which ere very difficull: to differentiate chemically* Using 
this methorl alkyl phenott'iazines have her ■ prepared from the 
corresponding alkyl di ptienyla'ines (Gil "an an! Shirley, lT4i), a^d 
hydroxy ihenothiazines fro '. hydrrxy diphenyl "'lines (Houston,
Ksster end Oc Eds, 1549). Alkoxy phenothiazines (Saltzly,
Harfenist and dzbb, 1945) a h.^ln- nrood phencthiazinas ( S ' i t ' ,
1959) have also beam preoeza in this - a n e : . ’l-srrstitut zd
diphenylamines do not appear to undergo this thionation reaction 
(Massie, 1954).
Ring closure can also be effected using substituted 
diphenylanine-ortho-sulphinic acids, Krishna and Dain (1931) 
prepared 3«nitro phenothiazine by dissolving 4-nitro diphenylamine 
-2-sulphinic acid in sulphuric acid, and subsequently diluting 
this solution. Other substituted phenothiazines have been 
prepared by this reaction using acetic acid. (Warren and Smiles, 
1932).
Nuclear substituted phenothiazines have also been prepared 
by condensation of o-amino or o-amido thiophenols with various 
nitrobenzenes* Kehrmann and Steinberg (l91l) condensed o-amino 
thiophenol hydrochloride with picryl chloride to give 1,3-dinitro 
phenothiazine. Many substituted derivatives have been prepared 
using the same reaction (Baltzly et al., 1946). Such reactions 
have been shown to proceed through a rearrangement common to
2-nitro«2'«aminodiphenyl sulphides, which in the presence of 
alkali rearrange to 2-nitro~2' mercapto diphenylamines (Evans and 
Smiles, 1935a, 1935b; Wight and Smiles, 1935),
(3) N-substitution.
The interest in nuclear substituted phenothiazines of industrial 
importance was largely confined to the first half of this century. 
Recently interest has tended more to the synthesis of N-substituted
derivatives, especially N-alkylaminoalkyl phenothiazines, due to 
their widespread therapeutic properties (Chapter- l).
The nitrogen atom can bo alkylated using either alcohols, 
sulphates or halides. However, only the 10-methyl and the 10- 
ethyl derivatives can be prepared using alcohols. The reaction 
involves heating phenothiazine, dry hydrogen chloride, and the 
appropriate alcohol in a sealed tube (Bernstein and Rothstein,
1944), Likewise only methyl sulphate has been found useful as 
an N-alkylating agent (Gilman and Nelson, 1953),
More important are the condensation reactions, involving 
alkyl or aryl halides, which normally require a basic medium.
In initial studies Gilman and Shirley (1944) prepared a series 
of long chained 10-alkyl phenothiazines, and a series of 10- 
aryl phenothiazines, by condensing phenothiazine and the corresponding 
halide in the presence of sodium carbonate, with copper powder 
as catalyst. However, further attempts at condensation using 
alkylaminoalkyl halides were unsuccessful,
10-alkylaminoalkyl phenothiazines were subsequently prepared 
by Charpentier (1947, 1952) by condensing phenothiazine and the 
corresponding halide in the presence of sodamide. Using the 
same condensing medium Dahlbom (1949) prepared piperidyl alkyl 
phenothiazines by reaction with the appropriate halide. This 
method has also been used for the preparation of morpholinyl alkyl 
phenothiazines and N-pyrrolidyl alkyl phenothiazines (Reid, Wright, 
Kolloff and Hunter, 1948), Other methods used for the preparation
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of aminoalkyl phenothiazines liEive jnclucled reaction with 
Grignard complexes (Berg and Ashley, 1953), or reaction of 
alkylamino halides with 10-lit.Hio phenothiazine (Gilman and Shirley;, 
1944)c
(4) 2.L^  dhenoth.i azlne ,
The most important property of phonothiazino, from a 
biological point of view, is its case of oxidation, Thn products 
are shown in Figure 1. It readily forms the sulphoxide (B) and 
the sulphone (c) on reaction with such oxidising agents as 
potassium permanganate or hydrogen peroxide (Massie, 1954),
Sulphoxide formation has also been reported on irradiation of an 
alcoholic solution of phenothiazino (Brown, 1955), The compound 
can also be oxidised to various hydroxyls tad and quinonoid s true turos 
(Kshrmann, 1905; Do Eds and Eddy, 1933a), The nucleus can be 
hydroxyXated at one position para to the nitrogen atg-n to give the 
col.ourloss compound leucophenothiazone (D), which, in aqueous 
solution,is readily oxidised by the atmosphere to the intensely 
coloured compound, phenothi'azone (E), Hydroxylation at both 
positions para to the nitrogen atom produces another colourless 
compound leucothionol (F), which is also realily oxidised by sir 
and moisture to a deep red compound, thionol (l).
These two systems, leucophenothiszane-phenot^iazone and 
leucothionol-thionoL have bean shown to be based on redox r e a c t i o n - ,  
proceeding, in acid solution, V rough r. s t r i " - ! 0 f r s s  radicol 
internediete (Da Eds an:’ Eddy, 1933b; Granlck, ''ichrelis
Fig.l PHENOTHIAZINE AND ITS OXIDATION PRODUCTS
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anr! Sci'.ubRrh, 19-Ul; Gr-nic'.'- ond G i ch?g.lis, 1947), In 
stronnly aricJ solut.i--ns the i.ntori-uedtote is stabilised by 
resonance, but as thn pM increases the stability of the free 
radical decreases, until the nxidation see;'S to take place in 
a single step, (Figure ?.) o
A relationship betuecn the various oxidation products has 
been described, and explained by a postulated rearrangement of 
the su In box ids to the ryclroxyl Fi ted forn, (Grain and Tate, 1961), 
‘details of the rearrange",ont are given in Figure 3, The first 
stable oxidation prodL!ct of phenotiriarino is phenothiazine 
PulohoxiuB (d), (Gil an and Shirley, 1944). This product is in 
tautc'iiaric cnuilibriui via 51 and 52 with compound 53, which has 
been shob'n to be a phcnazothinniL'e compound by its isolation as 
tiic phcnazotiiioniu.il salt of various anions (PuMearer, Fckert and 
Gassner, 1914 ; Garnatt end Gmil = s, 1959; Kciirnarm and Ghri st-mpnulcs 
1921). The cation of B3 tlicn undergoes acid--catelyscd rearrangement 
via the transition stage 54 to the '^^ -esr.ficric fora 55, which 
ce.'jsos a shift of the anionic group to ths 3-position to prodLice 
the pseudo-base, (56). The molecule is finally stabilised by 
migration of a proton from ths 3-position to give laucon'i^uothiazone, 
(n)^  (Kchrimznn, 1952), Leucopheno thiazone (D) is readily oxidised 
by air to the red dye phenothiazone,(E), and it has been postulatei 
that (F.) can be furthcr oxidised via the suiphcxlde to louent "isncl, 
(r)^and finally thionol,(u),(Craig and Tata, 1961),
This rearranp:-ent of rhen^t^iazino sulnhoxide to l-:ucesh-:ro-
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thiazone has been shown to take place in the presence of acetic 
acid (Hilditch and Smiles, 1912). However, when hydrochloric 
acid was used the product was 3-chlorophenothiazine, and in the 
case of lO-alkylphenothiazine sulphoxides the rearrangement 
has been shown to produce S-chloro-lO^alkyl-phenothizines 
(page and Smiles, 1910j Gilman et al., 1954; Schmalz and 
Burger, 1954; Kehrmann and Nossenko, 1913). The rearrangement 
does not take place when the 3- and 7- positions are blocked^ 
(Hilditch and- Smiles, 1912; Page and Smiles, 1910).
B. Metabolism of Phenothiazine,
Initial metabolic studies on phenothiazine provided the 
groundwork for our present day knowledge of the metabolism of its 
derivatives. The biotransformations which it undergoes in the 
body are basically the oxidation reactions encountered by the 
chemist in the laboratory.
Its metabolism has been extensively studied in a variety 
of species. These include sheep (Lipson, 1940; Swales and 
Collier, 1940; Collier, Allan and Swales, 1943; Clare, 1947; 
Harpur, Swales and Denstedt, 1950), cattle (Clara, Whitten and 
Filmer, 1947; Whitten, Clare and Filmer, 1946; Whitten, 1947, 
Whitten and Filmer, 1947; Duthby and Lewis, 1949; Ellison and 
Todd, 1957; Richardson and Todd, 1958), swine (Clara, 1947; 
Collier et al., 1943), horses (Collier et al., 1943), dogs 
(Collier et al., 1943; De Eds and Thomas, 1941), rats (De Eds,
Eddy and Thomas, 1938; De Eds and Thomas, 1942), rabbits (De Eds,
Eddy and Thomas, 1938; De Eds and Thomas, 1941; De Eds and
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Thomas, 1942; Benham, 1945; Collier et al., 1943). and man (De 
Eds and Thomas, 1941, 1942; De Eds et al., 1938). Initial studies 
were carried out on urine since it was noted that the urine of 
animals dosed with phenothiazine took on a reddish coloration, 
suggesting transformation of the administered drug. Also, 
although phenothiazine is practically insoluble in water, sheep 
were found to eliminate 40;^  of a dose in the urine within 48 
hours (Harpur, Swales and Denstedt, 1950).
De Eds and Thomas (1942) showed the presence of leucopheno­
thiazone and phenothiazone^along with small amounts of leucothionol 
and thionolySs metabolic products of phenothiazine in the urine 
of rabbits, rats and man. Such oxidation products would 
account for the coloration observed in the urine of dosed animals, 
Leucophenothiazone and leucothionol were also detected as 
urinary metabolites in sheep (Lipson, 1940), Oe Eds et al.. (1938) 
also found phenothiazine as an acid-labile conjugate in the urine 
of rats and man. This was later reported to be the major 
metabolic product of phenothiazine in swine and man. (Craig and 
Tate, 1961). The latter workers also suggested that, since 
phenothiazine is a weak base, and therefore would not form salts 
under biological conditions, the conjugation probably takes place 
at the nitrogen atom through an acid-labile amide bond.
Further studies showed that phenothiazine and its oxidised 
derivatives (Figure 4) are excreted as metabolites in the urine, 
either in the free or a conjugated form. However, the relative
amounts of each varies from spacioa to species. Collier and co- 
workers carriorj out a series of urinary excretion studio’s on sheep, 
dogs, horses and rabbits, (Collinr, 1940; Collier et el, 1943), 
Leucophenothiazone 'vhich they identified by synthesis, was found to 
be the major metabolite in sliaep, dogs and horses, mostly as the 
ethereal sulphate* Traces of leucothionol were also detected. 
However in rabbits, leucothionol was found to be the predominating 
metabolite. This was confirmed by Gonhani (1945) who also reported 
that the leucothionol is excreted as a conjugate with glucuronic 
acido Leucophenothiazone has since been clotooted as the ethereal 
sul(3hate in the urine of dosed cattle (Ellison, Todd and 
Harvey, 1957),
Although in some cases, it is only the leuco bases of 
phenothiazone and thionol that are excreted in the urine, these 
are oxidised on exposure to ths ai.r to the coloured quinonoid 
compounds, Due to tiie reversible redox systsns operating with 
these compounds, it is usually found that this coloration gradually 
disappears duo to the action of reducing compounds in the urine 
(Clarn, 1947).
A further metabolite of ph.enottiiazine, phenothiazine sulphoxide, 
Was discovered by Clare et al, (1947) in the blood of shsep and 
calves. They postulated that t!ve sulphoxide is for.ned in the 
alimentary tract and absorbed into the portal blood. It is then 
transformed by the liver to leucophenothiazone, conjugated as the 
ethereal sulphate, end excrated in ths urine in this form.
MAJOR METABOLIC PRODUCTS OF PHENOTHIAZINE.
Acid labile Conjugates.
Polypeptide conjugates Phenothiazine--------- =? Sulphoxide
3-Potassium ethereal sulphate^:— Leucophenothiazone^=^5Phenothiazone
3-Glucuronide <- Leucothionol Thionol
Leucoph^nothiazono and leucothionol ijoro also found in the ui'ino 
along with an unidontifiod conjugate of phonothiazine,
With high dosGs of phonotiiiazinc, the sulphoxido in not 
completely transPo ’^-.ibc! by tho liver, and reaches the systonic 
circulation and aqueous honour of the eye. This also occurs 
with calves after doses, causing a photosensitised keratitis
(Clare, 1947), In cal\/es jess than six '-’eeks old,Clare also 
found leijCGphenothiaznne in the urine in association with an 
unidentified polyneptido, Sulphoxide formation '■'Os later :-hown 
to be a major metabolic pethi-»ey of the pharmacologically active 
IC-substituted phenothiazines* A flo'j diagran of the main 
metabolic pathi>;ays of phenothiazine is shown in Figure 4, The 
subject has bean extensively reviewed by Harwood (1953), Craig 
and Tate (jCnl), Findlay (1,950).
C, Chemistrv of the Treo'-iu 11.li.sers ,
As previously described (^g. IS) the t^emnuillisars fore
a homologous series wiIh the nennrsl formula shown, the numbering
convention being the same as for pi'-anothiazine, Cj ossification
is based on the suhpti tuants (an a.-'Uinoalkyl nid^ chain) and
(an electronegative atom or group). They are viscous oily
liquids with an a^'lne odour and an alkaline reaction, but -re
available cew-.c rci ally .in crystalline form as thair salts.
Promazine is m m u  fee tu red as the hydrochloride tak'ing the fom
of i.'ihi t':3 hygroscopic crystals dec J' 'pnc^ing at I'M^C, Chlo rpro'■a zire ,
n
also availrble as the hydrochloride, docioo^^s at ].94"195hg, 
Acepromazine; i-micn is marks ta J as th.3 "aleare, -es a "eltirz
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point of 135“136*^ C, Unlike the parant compounds, these salts 
are readily soluble in water giving a slightly acid solution. 
They are also soluble in methanol, ethanol and chloroform, 
but only slightly soluble in ether and benzene.
Chemically, they are very reactive^with properties similar 
to phenothiazine, which form the basis of a large number of 
colour reactions widely used in their detection and determination 
(Pg, 68), Their reactivity is also borne out by the large
number of metabolic changes which they undergo (Pgs, 5 1 - 6 6  ),
(l) Oxidation and Stability,
Like phenothiazine, their nucleus is susceptible to oxidation, 
and sulphoxides and sulphones are readily formed by reaction witti 
peroxide or permanganate (fiassie, 1954), However, substituents 
at the 2- and 10- positions exert a marked influence on the 
oxidative processes, affecting the course and kinetics of such 
reactions. This influence is also a controlling factor on their 
stability in solution,
Kabasakalian and McGlotten (1959) determined the anodic 
oxidation half-wave potentials of a series of such compounds, and 
reported that their stability increases with an increase in
nüGctronogatlvity of tli3 2»oiibsfituGnt» Thoy also statad thafc
the stability is influincad by tho nroon on tha 10-position, 
elthouqh thn précisa nffact is not predictable, Sinilar 
findings uare reported by Bolt (1965)*
The stability nf several nhonothiazine tranquillisers in an 
aqueous solution \ias investigated by 'dealer (l:60). On refluxinn 
solutions of promethazine (R^ = "CH^CH(de) or ethopropazina
(R^ e )MBt^), dccneposition took place to 10“ -ethyl
phenothiazine, acetaldéhyde, and the corresponding dialkyl^m ine * 
Solutions of promazine or chlorpronazine (CH^  ^ on the
other hand, showed considerable stability*
Persulphate oxidation of phonothiazine derivatives was 
studied by banc and co-uorkers, In initial experiments they 
shotted that promethazine is oxidiserj tn phonnthiazono along with 
other unidantiPied products (f'ano and Sancin, 1961), They 
believed that the reaction proceeded by cleavage oP the side chain 
to form phenothiazine, followed by oxidation of the nucleus to 
pheno thiazcna *
At first they t'nought this cleavage peculiar to promethazine, 
and that ot'tor derivatives were oxidised by a different unspecified 
mechanis.'i. However, in o subsequent investigation, (ilano, Bencin asd 
Tappi, 1963), they studied the reaction on a series of altylemino-'1‘-yl 
phenothiazines, and showed that derivatives possessing a two 
carbon polynethylene chain bet'jeon the nuclear ant sice cmain nitre::' 
ato'S were oxidised tn phenGt'niazon:. and other unidentified
nu inn no id s true turns, Thnss with a thrrjn carbon nolymathylnnc chain 
WGTG oxi'tisad to tha ccrrasnnndi.ng sul nhoxir.'e, only trace a:;ounts of 
quinonas baing found, Pungor (]9u0) investigated the parsulghata 
oxidation of cblorprnnazinn and raoorix-^d tha rici.jor reaction 
product tn bo a dim.ar of inolacular i-zaight 5G0 in which both 
Bininoa.l!<yI side chains ora intact*
(2) Irradiation and fraa radicol formation.
The nucleus is also liable to photochemical oxidation, 
which is apparent from the intense colours experienced tubon 
solutions of such drugs are exnosed to light, (Holmes and Snyder, 
1929j Reid, 1930 ; decree, 1931: Rrown, Cola and Crowell, ]95S;
Ravin, Ksnnon and Swintocky, 19S8). The latter workers - 
related the photoche-mical oxidation of chlorpronazine to an 
uptake of oxygen during irradiation* Brown et al, (l9S5) 
irradiated an alcoholic solution of phenothiaz-i ne, end isolated 
and identified both phenothiazone and phenolhlazine sulohoxide* 
Beckett, Beaven and Robinson (195'5) size ted tfiat the major product 
from irradiation of eyueous solutions of chlorpronazine is a 
dimer in which both chlorine atc-.s have been lost. At least 
twelve products were reported by Huang and Sands (1964) after 
irradiation of aquEious chlorprcnazinc solutions, of u^ich two 
were identified es chlorpronazine sulnhoxide and chlorpro = zzif'S 
M-oxide (tig* o). They also noted that several other products 
gave blue or purple colours 'zith 50^ sulphuric acid, w!"ich Bolt
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(1965) attributed to combinations of hydroxylation and 
dechlorination of the phenothiazine nucleus.
Many reports of the formation of free radicals during 
the oxidation of phenothiazine derivatives have appeared in the 
literature, and it is now believed that such species play an 
important role in the oxidation process, Forrost,Forrest and 
Berger (1958), using electron spin resonance spectroscopy, 
showed the presence of free radicals after ultra violet irradiation 
of aqueous solutions of chlorpromazina, and claimed that the 
intermediate formed was identical to one of the urinary 
metabolites of the drug (Pg. 64), Such species were also 
reported by Pels and Kaufmanh, (1959) during the oxidation of 
acidic chlorpromazina solutions by ferric salts, Piette and 
Forrest (1962) subsequently claimed that the first oxidation
products of phenothiazine drugs are free radicals,
Borg and Cotzias (1962) studied the oxidation of chlor- 
promazine solutions during titration by metal ions, and, by 
following the reaction potentiometrically, demonstrated that the 
process proceeds through a free radical intermediate# The first 
■step is loss of an electron to form a free radical ion, which in 
turn loses an electron to give a dipositive phsnothiazonium ion. 
Reaction of the latter with water gives rise to chlorpromazine 
sulphoxide# The reaction, however, is further complicated by
interaction of the radical and unchanged chlorpromazine leading
to dimérisation of the chlorpromazine and disproportionation of 
the free radical to both chlorpromazine and chlorpromazine
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sulphoxide (Figure 5),
A comparable mechanism for photochemical oxidation was 
subsequently formulated by felrneister and Discher (1954), who 
also claimed that irradiation of aqueous chlorpromazins solutions 
results in formation of free radicals, which disproportionate to 
chlorpromazine and chlorpromazine sulphoxide* They also reported 
that one of the reaction products could be acylated, and concluded 
that hydroxylation had occurred at the 3-position, possibly by 
rearrangement of the sulphoxide (c.f. Pg, 3B ), Figure 5 shows 
a general mechanism of oxidation of substituted phencthiszines 
based on this information*
These investigations bear out the complexity of the oxidation 
reactions of the phenothiazine tranquillisers and it is evident 
that information on this subject is still incomplete. Although 
sulphoxide and sulphone formation are known to occur, other 
oxidation reactions are not so well defined as for phenothiazine* 
The compounds produce intense colours on oxidation which provide 
a useful method for their detection but the course and ease of 
such reactions are difficult to predict or determine. The 
formation of free radical intermediates, and resulting polymers 
has been reported, but it is still not certain whether substituted 
products equivalent to thionol or phenothiazone are present.
Berti and Cima (1956) stated that the formation of such compounds 
is unlikely as the substituted nitrogen would prevent the shift 
in double bond necessary for the reaction.
bl —
(3) Side Chain Transformations*
The side chain at the 10-position is also susceptible to 
several modifications* Oxidation of the terminal nitrogen atom 
to the N-oxide has been claimed by Oapanese workers, although 
the reaction was not proved conclusively (Sumita and hishino,
1960, a,b,c), Chlorpromazins M-oxide has been identified after 
irradiation of aqueous chlorpromazine solutions (Huang and Sands, 
1964). M-oxide formation has also been shown to be a metabolic 
pathway of both chlorpromazine and imipramine, a compound chemically 
related to the tranquillisers (Fishman, Heaton and Goldenberg,
1962; Fishman and Goldenberg, 1962). The side chain has also 
been shown to be subject to déméthylation and cleavage as a resulfct 
of biochemical oxidation (Pg# 62),
D* Metabolism of the Tranquillisers,
Due to their widespread use both in psychiatry and general 
medicine, the metabolism and excretion of these drugs has been 
the subject of much research over the past 15 years. Results so 
far have underlined the complexity of sUch processes, and have 
shown marked variations from species to species (Goldenberg and 
Fishman, 1961; Goldenberg, Fishman, Heaton and Burnett, 1954).
Five major pathways of metabolism have been found, namely, 
oxidation of the sulphur atom to the sulphoxide (Salzman and 
Brodie, 1956; Fishman and Goldenberg, I960), oxidation of the 
terminal side chain nitrogen atom (Fishman, Heaton and Goldenberg,
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1962), déméthylation of the side chain amino group (Ross, Young 
and Maass, 1958; Walkenstein and Seifter, 1959), and hydroxylation 
of the phonothiazine nucleus, usually followed by conjugation with 
glucuronic or sulphuric acid (Lin, Reynolds, Rondish and Van Loon,
1959; Huang, Sands and Kurland, 1961; Beckett, Beaven and 
Robinson, 1963; Fishman and Goldenberg, 1963). These transformation: 
can take place singly, or in combination, giving rise to a large 
number of possible metabolites. At least thirty urinary metabolites 
of promazine have been detected after oral administration to humans 
(Goldenberg et al., 1964), Studies have shown extensive 
localisation of such compounds in the body (Salzman and Brodie,
1956; Fyodorov, 1958; Walkenstein and Seifter, 1959), low 
percentage excretion of dose (Fyodorov and Shnol, 1956; Nadeau 
and Sobolewski, 1959; Beckett et al, 1963; Goldenberg et al.,
1964); and prolonged excretion sometimes lasting several months 
after administration (Forrest, Forrest and Mason, 1959; Huang 
et al., 1951).
(l) Sulphoxide formation.
This was the first important metabolic route to be discovered. 
Salzman and Brodie (1956), using counter current distribution 
and paper chromatography, isolated and identified chlorpromazine 
sulphoxide as a major urinary metabolite of chlorpromazine in 
dog and man. They detected at least three metabolites, only the 
sulphoxide being identified* They also claimed that the drug
b3 «
was extensively localised in various tissues, especially the 
brain, accounting for the low plasma concentration 2^g/ml) 
obtained 30 minutes after injection. In tho dog lO-l^ i/o of an 
intravenous dose (20 mg/Kg) was excreted as the sulphoxide, and 
less than 2fo as unchanged drug. After oral administration to 
man, only 5^ was excreted as the sulphoxide along with trace amounts 
of the parent drug. They postulated that the sulphoxide had 
been further metabolised to unidentified products, since, after 
administration of chlorpromazine sulphoxide to dogs,only 20^ 
of the dose was recovered in the urine unchanged (Salzman, Moran 
and Brodie, 1955). Similar findings hiave been reported in man 
where only 2-3% of an intravenous dose of this metabolite was 
recovered unchanged. (Davidson, Terry and Sjoerdsma, 1957),
Sulphoxidation has since been extensively reported, Huang 
and Kurland (1961) showed that, after repeated administration 
of chlorpromazine to humans, urinary excretion of sulphoxide 
metabolites varied between 1 and 18% of the daily dose, less than 
1% being recovered as unchanged drug, Goldenberg and Fishman 
(l96l) reported that after oral administration of chlorpromazine 
to man and dog 5,9 and 11% of the dose respectively were excreted 
in the urine as sulphoxides. Again the unchanged drug was detected 
in only trace amounts, Sulphoxide formation has also been shown 
to occur in mice (Christensen and bjase, 1956), rate (Ogawa, Kawasaki 
and Yamamoto, 1953; Emmerson and Miya, 1962) and rabbits (Berti 
and Cima, 1956; Goldenberg et al,, 1964),
— b4
Although initial investigations and most subsequent studies 
of this metabolic pathway were primarily concerned with chlor­
promazine, sulphoxidation is also a common metabolic pathway 
of promazine (Ualkenstein and Seifter, 1959), mepazine (Hoffman, 
Nieshulz, Popendiker and Tauchert, 1959), methoxypromazine (Allgen, 
donsBon, Rappe and Dahlbom, 1959), promethazine (Hansson and 
Schmiterlow, 1961), perphenazine (Symchowicz, Peckham, Korduba and 
Pertman, 1962), levornepromazine (Allgen, Hellstrom and Sant’orp,
1963), and such closely related compounds as thioridazine, (Zehnder, 
Kalbersr, Kreis and Rutschmann, 1962) and chlorprothixeno (Allgen, 
Donsson, Nauckhoff, Anderson, Huus and Nielsen, I960).
Sulphoxidation is now generally accepted as one of the major 
metabolic pathways of the phenothiazine tranquillisers although 
the sulphoxide itself accounts for only a small percentage of the 
dose. Sulphone formation, on the other hand, does not appear 
to take place in vivo, although it has been reported for the 
related compounds methylene blue in cats, dogs and rabbits. (Underbill 
and Closson, 1905), and thioridazine in rats, (Zehnder et al.,
1962). It has been postulated that chlorpromazine sulphone 
may be formed in vitro using fortified liver homogenates (Kamm, 
Gillette and Brodie, 1958).
Déméthylation of the terminal side chain amino group was first 
reported by Ross et al.. (l958). They administered chlorpromazine,
(label.lnd at tho FJ-mathyl group luith to rat?, CüHoctad
the exoired CO^ arid ''oaeured its radioactivity. 12-16% of the
administered radioactivity was detected within 6 hours, and
] 4 • /
CO^ was expired at the rate of 0o7-2% per hour over the 12 hours
of the experiment. In the following year they demonstrated 
the déméthylation of labelled chlorpronazine ij-(_^ \gi.tra using 
fortified rat and rabbit liver homogenates (Young, Ross and daass, 
1969).
Walkenstain and Snifter (1959) investigated the urinary
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metabolites and excretion of 'S promazine by both dogs and rats, 
and reported that do 'G thyl ation cnulrl take place in no;'.bina tion 
with sulphoxidation. After intraporiton^al administration 
(^pHmg/Kg) to dogs, they identified to roe urinary rrso taboli tes, 
promazine siil-dioxide (3-5%), des-ietdiylprrnozine (0,75-1%) and 
desmethylpromazirie sulphoxide (2,5 - 3.5%) in adc'ition to the 
unchanged drug (2-3%). Also, on administration of eif-'or cie?. tet'-yl- 
pro-'iazine or promazine .f Lilphoxide to the animils, dest^iet.iyl- 
proniozins sulphnxide tuns al's'ays found in the urine. They 
suggested that pro-.iazi na is separ-^tely da'othylated and oxidised 
to des-Gthylpromazine ?-nd nro-"'azl''in snlphoxi ria, i.-('^ich ere th^n 
oxidised or da methylated rasnentivoly to fore t-We third cGtahclite, 
cjes"‘-e t'-'yIproTtaz.ine sulphnx tde, They also noted in dogs, thr.t 
within .15 ‘minutes of in Irens ri tnnr-«n i. inject inn half the re di.oac t i'vi ty 
detected in the blood i. : o s duo to pro.ra z' n^ metabolites, el thrush 
7 or 5 d y s s 1 a  ^e -1 before 70-^0% of t h -■ re. d i o e c t i v i ty w e s 
rJ-^ t?ct--;' 'hn r.hz urine. The remainder ’-jes excreted in tb-? = ,
R a d i o a c b i vlby iv a s a 1 so do t oct^d i n t h e b .1, ocd up to 4 d a y s a f t o r 
injGictiofi. High donroas of looalisa1m.on wore also foLTid in 
various organs (ii-tng, liver, kidnoy, sploon) from both species
(c.f. Salzman and Hrodie, 1956).
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The met aboli S'H of "'‘5 chlorpromazina by rats was investigated 
by Emmerson and diya (1962), They found 50% of the administered 
radioactivity in the urine over throe days, the re;icinder being 
excreted in the faeces. Three metabolites wore identified in the 
urine, chlorpromazine sulphoxide (5%), and,the sulphoxides of 
desmethylchlorpromazine (5%), and dosdi'-othylchlorprcmazins 
(2%). Chlorpromazine recovered accounted for aporoximately 12% 
of the doso.
Further evidence for the combination of sulphoxidation 
and déméthylation was furnished by Fishcian and Goldenberg (1969).
In the first of a series of sturiics into tranquilliser retabolism 
they detected the presence of 10 metabolites of chlorprn-'azine in 
huinan urine. Using paper chro';iatography, specific spray reagents, 
and ultra violet spectrometry, they showed that six 'ijere su Iphoxi dc 
two being do -o thy la ted, (des-iethylchlor oromazins sulphoxide and 
desdime thylchlorpromazipe sulp-'oxide ),
The follo'jing year they carried out further investigations 
of these metabolites in dog and man (Goldenberg and Fish.ian, I?6l), 
and showed both qualitative and quantitative excretion differences 
between the species. In man dead im e t h y 1 ch 1 o r e r o z i n a sul-'-nxi de 
was the major netaholite (3.7%), f oil eve d by dec’at''ylchl e re r-jm? r i r ■ 
sulphoxide (l,B%), ana' chi crpre:-.azi^ .e sulphoxide (9,d%), '
- 57 ..
i n t h ïï cl on c ! o ? "i 'r t h y 1 c h, 1 o r p rcn a zino ?i u I nho x i d 3 ( 5 „ 1% ) - n d
c h 1 o r p r o ■ -13 7. i n e s > j ]. p !i o >' i ci e ( 5 .1 % ) prod o ■n i n a t a rt ^ On 1 y 1,1%
was Bxcrohod os the d.î do'.'o t'.nyla tnri derivative, ünchanned drijg 
accounted far 0.2 and 2 .8% respectively, Desmnthylchlorpro'nazine 
was detected in dog urine, but hjas found to bo absent in humans.
A further retsholite of chlorpromazine, chlorpromazine N-oxide 
was identified by Fishman at al. (1962) in the urine of dog and
man. Although it is nob a major metabolite in liumans it was founci
in greater quanti ty (0.7%) than the sulphoxide (Q.4%% and i-'cs 
even more abundant in the dog (2-3,5%), N-oxide formation has 
also boon shown to he a motsbnlic path'way of promazine (Goldenberg 
□ t al.jrl964), and im ip ram ine (Fishman and Goldenberg, 1962),
(4 ) Hydroxylation end Coniunntion,
Tho derivatives already described ore all readily extractable 
from urine at an alkaline pH and are referred to as the non-polar 
metabolites. However, a further group exists, present in much 
greater abundance in most species, which are not so readily extract 
by common organic solvents. Known collectively as tlie polar 
metabolitesj the group consists of many hydroxylatod and conjugated 
derivatives. Goldenberg and Fish ^ an (1961) reported that such 
derivatives are the predoninating metabolites in ".an, and that 
qualitative and quantitative differences also sxist in this fractic' 
fro'-’ species to species.
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In 1959, Flanagan and co-workers, using chromatographic 
techniques, reported that chlorpromazine, administered intra- 
duodenally to dogs,was excreted in the bile and urine as "free" 
and "bound" chlorpromazine sulphoxide, (Flanagan, Lin, Novick, 
Rondish, Boclier and Van Loon, 1959). This was demonstrated by 
the fact that strong alkaline hydrolysis, or p -glucuronidase 
incubation, gave rise to an additional group of ether extractable 
metabolites. . The "bound" fraction was found to predominate 
in both urine and bile, the ratios being approximately 3:1 and 
12:1 respectively. The nature of the binding substances were 
not identified.
In the same year Nadeau and Sobolewski reported similar 
results for humans after administration of chlorpromazine or 
levornepromazine. Since both chemical hydrolysis and p -glucuronidase 
incubation produced similar results they assumed that the main 
binding constituent was glucuronic acid. 10-20% of the 
chlorpromazine and 5% of the levornepromazine was recovered over 
24 hours,and 50-98% of the metabolites were glucuronide conjugates.
Further evidence for the presence of conjugated was furnished 
by Lin and co-workers who isolated chlorpromazine metabolites 
using a cation exchange resin, then liberated glucuronic acid 
by incubation with ^-glucuronidase (Lin, Reynolds, Rondish and Van 
Loon, 1959), The metabolites released were shown to possess 
hydroxyl functions, and it was suggested that hydroxylation of 
chlorpromazine followed by conjugation with glucuronic acid is 
an important metabolic route of the drug in humans.
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Many reports of hydroxylation and subsequent glucuronide 
formation have since appeared. Posnsr and co-workers found 
three hydroxylated derivatives of both promazine and chlorpromazine 
in human urine, and suggested that both monohydroxylation (at the 
3-position) and dihydroxylation (at the 3,7 positions)g, followed 
by conjugation^had taken place (Posner 1959; Posner, Culpan and 
Levine, 1963, a,b). Huang and co-workers reported that phenolic 
derivatives qnd their glucuronides were the major metabolic 
products of chlorpromazine in man (Huang and Kurland, 1961, a,b; 
Huang, Sands and Kurland, 1961), Several glucuronides of 
chlorpromazine were isolated from the urino of psychiatric 
patients by Beckett et al. (l963). They claimed that the 
N-demethylated glucuronides were the major metabolic products 
of chlorpromazine in man, but the position of the glucuronide 
group was not firmly established. They detected 7% of the dose 
in 48 hours, glucuronides predominating over non-polar metabolites 
in the ratio of 2:1.
A series of phenolic derivatives of chlorpromazine has been 
identified in the urine of man and dog (Fishman and Goldenberg, 
1963; Goldenberg et al,, 1964), Using paper, thin layer and 
gas liquid chromatography, and comparison with known standards, 
they demonstrated that each member of the series was hydroxylated 
at position 7, and could be found both in the free form and as 
conjugates. Half of the series were sulphoxides, and in certain 
cases demetnylation had occurred.
They also carried cut a detailed study of the metabolism
of p r o"'^ a % i n n i n rt □ g 3 , r b b i t s a n d an (G 'i .1 cl e n h erg g t a 1. , 3964),, 
Hydroxylation was found ho tab,:? place at the 3-posit.ion, and both 
froB and conjugated forms uere present, associated with various 
combinations of sulphoxidation and do'^ e thylat.i on * In man 33% 
of the dose was recovered as 30 derivatives, the ratio of 
phenolic to non-plvrnolic metabolites being 1.4:1, In the 
phenolic fraction glucuronida conjugates predominated accounting 
for 16f: of the doso, the unconjugatod rihenols reprasenting only 
1-2%, The unchannnd rjrug accounted for only 0,2t' of the doss 
and the major metabolites were d e s d i ? a t h y 1 p r o <' vi z i. n e culphoxifie 
(6.3%), dosmothyl pro-'iar^ ine sulphoxide (5.2%), and 3-hydrnxypj^o 'azine 
glucuronide (3.7%). Much s'-ialle?' amounts of metabolites were 
recovered from both dogs (13%) and rabbits (10-13%), Qualitative 
differences wore also obsarvod ar.tongst the tore?:? species.
In a subsequent study (Goldenberg and Fishman, 1963) they 
confirmed that positions 3- anri 7- war? the main sites of 
hydroxylation of promazine and chlorpro^^^aaino respectively.
However, they also noted that hydroxyla.ti'.n of chlornro-'aaine at th'^  
3“pnsitlnp is possible, ao'':^ that di hydroxyla,tion of both co":pounds 
at t:he 3-, 7- positions can occur,
Hydroxylation followed by glucuronide forma tion is now 
regarded as the major metabolic D-ith*-jay for tlie tranquillisers 
in most species, and hesidos promazine and chlorprcmozinc has bean 
reported for several ot:'Gr derive.tivesj, (Tadaau and Sobole'''ski,
1959; Herrmann, Schindler and pLiIver, 1.959; Herrm^r^n and Hijlvar, 
J960; Z-hnrler nt al,, 1962).
other types of conjugates, formed to a lesser extent, have 
been reported by various workers. Beckett et al.. (1953) showed 
the presence of sulphate conjugates of chlorpromazine in human 
urine by aryl sulphatase incubation, 7% of the administered dose 
was recovered over 48 hours, consisting of non-polar metabolites 
(-^25%), glucuronide conjugates 60%) and sulphate conjugates
( 18%). The free metabolites ware excreted mostly as sulphoxides,
whereas the conjugates were in the sulphide form. Other unidentified 
conjugates were liberated in small amounts by acid hydrolysis.
Ethereal sulphates of promazine were also detected in the urine 
of dogs, rabbits and man, after oral administration, by incubation 
with Mylase P (Goldenberg et al,, 1964), In man the sulphate 
fraction accounted for ru 3% of the dose, the ratio of glucuronides, 
sulphates and unconjugated metabolites (including free phenols) 
being 5:5:1. Small amounts of acetylated phenolic derivatives 
were also found.
(5) Additional Transformations.
In addition to the above pathways various minor routes of 
metabolism have been reported from time to time. Initially^there 
were conflicting views as to whether cleavage of the side chain takes 
place in such derivatives. Although at first considered probable 
(Nano and Sancin, 1961),it was quickly discounted by several workers. 
Berti and Cima (1955) suggested that, since the intense colours 
found in the urine of phenothiazine dosed animals were not observed
cifhor Gf]-;iinis br-tion of the tranquillisers, no side chain clcaverr
could hov/c token place, of the side chain wss also
discounted liy Walkens to in and Seifter (1959), who observed that
although dogs dosed with "^S-phanothiazini excreted 10% of the
labelled sulphur in inorganic fom, no inorganic sulphate was formed
by breakdown of the nhsnot'ciczine nucleus after administration of 
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" S promazine, Sinilar findi.ngs were reported by Fyodorov and Shnol
(1956), On the other hand Christensen and daso (1956) recovered
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3-5% of 0 doso of "'S chlorpromazine froii the urine nf nice as free 
inorganic sulphate (23-43% as corhinod sulphate) indicating that 
side chain cleavage and subsequent ring degradation had taken place, 
Ho'i.'ever, cleavage and subsequent hroakdoum was thought to he a 
transformation peculiar to mice,
More recently Geckett et al, (1963) isolated various 
unidentified non-basic phenothiazine derivatives from human urine 
after administration of chlorpromazine. They had aldehydic 
properties, and it \-jas suggested that oxidative deamination had 
occurred to produce an aldehydic side chain, EFince then several 
metabolites have bean reported with properties i-jhich uiould he in 
keeping with oxidised intermediates of sida chain degradation 
(Posner et al,jl963h;. Forrest, Green and Udalo, 1964;
Green, Forrest, Forrest and Berra, 1965), Forrest ot al© suggested 
that cleavage of tha side chain docs take place, in several stages, 
proceeding through déméthylation to priuary or secondary 
amines., These are degraded to an aldeiiydo by oxidative
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deamination. This is than oxidised tr. an arid, n'tich is forthar 
c o n\/nrtod to a c a r b s " i r a ci d d c ?' i v m i- i y r- h y /3 - o x i d r’t i o n ,
Spontaneous dancrboxylcti-m n'^  tho lmt';nr .und gives ris'^*^
to nhonothiozino0 This theory is supportog Sy the identification 
of 2-ch1 oro-i n.. [ p  -pronicmi.r: acid) - pHan ithi azine as a taboil to 
of chlornro'Tiazi nn in hu-^ ian urino ( IFodr i guEC and Sohnusm, 1966),
Loss of the side cFrain, cis a binchenical trans f nru a tion of 
p r crn a z i n o a n":! ch 1 □ rp rnma v i no, \ la s now b a e n d e - znstr - tod in ho th 
man and don (Fishman and Goldenhorg, 196S), bsinn tbin layer 
chrona tography, ultra violet spectroscopy, end cc-ioari sen ui th 
known standards they shovied tlxat pronazine uas da graded ro 
R ( CH^ ) gNMe^—   — — --------  R ( CH^ ) gNHMe — — — >R ( CH^ ) 3KH
R “ Phenothiazine nucleus
V
RH ---------- RCO^H <e------------RCCHgïgCOgHa---------- R(CH ) CHO
phono th iazina sulphoxide, found both in the free for'-' and cnnjug :u 
with gluni.ironio acid. Traces of phenoi'leiazi'"? and pb,Rriotfi.azona 
ware also found, In man tho sulp'-.oxide accoi.'nirr’ for 0*4% of tne 
dnsG wher'-^ as in tha don 0.8% ''las excreted. Tea cor res; mndi ng 
chloro-derivatives of these oxidised nhenothiazines uera obtained 
from chlorniTi’-naziriR , Rimil^r results 'iiere resorted by dcbnsc-n, 
Rodriguez and Rurchfield (1965),
During the dc/elopment of a rapid urinary colou“ test for 
chlorpromazina (Go, 70), Forreot and ca-'jio^ksrs noted t'nat the 
colour found in oositive szmoles was not or j"'uced » i!)zn chlorerc"-
04-
or its sulfimxido rsro o o'dec! tn control urines, (Forrest end Forrest; 
1S57; Forrestj Forrest and dasnn^ 1^5J), They postulated 
that tho colour '■Kes^ due to reaction with a metabolite of chlor­
promazine with an oxidation level beti.veen that of the parent 
drug and the snip'-0x100* Ultra violet irradiation of dilute 
aqueous solutinus nr chlornrcu^azino gave rise to a solution producing 
the ssr,-iO colour as t'-.is metabolite and Idiey clainod that the 
biochemicnlly and photoc!ieuically for:;; ad con pounds were identical 
(Forrest; Forrest and "tsrger^ 19bn) «. Two crystalline derivet.ivos 
were precipitateri f;co:n the irr-edictad chlorprona%ine solution hy 
addi tio''I of exc0ss 2, -n,d.1 pitrn:ibar'1 hydrazine a n s o d i un n t  ];ite,
E ( F * R » cta tGrmina ti nns cn those cO’T'pounds s■ ^awed th31. 0*5^ of ttie 
molecular groups present urero in the for'i: of free r-adicals* From
this they postnl-ated that the nataholite was also a free raclic--ul '"^ ndj 
from spectroscopic considerations, suggested its o tr; I'.'ture 11 be the 
phan^zothioniui hydroxide (A), n co. 'h inn tine ''It’’) thn; free 
radical interred'etc (o), rat.'v~r thnr'. the tbionnl* structure (C),
Fro:.') these inves tig-z t j ons it does app-^or that ^reu raciical 
metabolites of c'ulornro.'.iazi na exist* dcwavsr, -’.any nnrkers have
(CH2)3NMe2
Cl
OH
OH OH
Cl
OHHO'
(A) (B) (C)
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shown the diversity in structures of free radical intermediates 
derived from oxidation of chlorpromazine (Pgs.^7«5o), and more 
research is required before the exact nature of such metabolites 
is elucidatedo
The biotransformations of the tranquillisers described can 
take place either singly or in combination, and a large number of 
metabolic products are thus possible. The task of determining 
the specific metabolic products formed by a particular species is 
further complicated by the slow rates of excretion and low percentage 
of the dose excreted, Dus to these facts the amount of literature 
on the metabolism and excretion of the tranquillisers is overwhelming, 
and it could not be hoped to give a complete account of all the 
variations reported, Tha major routes of metabolism,using 
promazine as an example^are shown in diagrammatic form in Figure 6,
M A L Y T I C A L  PIOCEIURES FOR PHEt'OTHIAZIt'.- DERIVATIVES
III» ANALYTICAL PROCEDURES FOR PHENOTHIAZINE
DERIVATIVES
A * Introduction
To examine drug metabolism both qualitatively and quantitatively, 
suitable methods must be developed for the isolation of ttie drug and 
its metabolites from biological material, and for their subsequent 
separation, identification and quantitation. Many methods have 
been employed for the detection and assay of phenothiazine derivatives 
based on their marked reactivity and tendency to form intensely 
coloured reaction products, However, the application of such 
techniques to the quantitation of metabolites is a mucli more difficult 
problem since in most cases the exact physical, chemical and 
structural relationship of such derivatives to the parent drug 
is unknown.
In addition, there is the.possibility of interference in 
such studies by contaminants extracted from the biological medium, 
possessing similar physical or chemical properties to the drug under 
investigation (Chapter V). For these reasons there is no 
completely satisfactory method for the determination of phenothiazine 
derivatives and their metabolites in biological samples. This 
section reviews the different assay procedures which have been 
used for the tranquillisers, and the techniques developed for the 
isolation, characterisation and determination of their metabolites.
Ba Assay of Phenothiazine Tranquillisers.
(l) Colorimetric procedures.
The most common method of analysis is a colorimetric estimation 
after reaction with an oxidising agent, Eddey and Dgî Eds (1C37) 
determined phenothiazine in pesticide residues from the intensity 
of the red intermediate, believed to ba 3,9-dihydroxy phenothiazonium 
bromide, formed on reaction with bromine water. The reaction was 
later investigated by Cupoles (l942) and Fossoul (l950b), and 
bromination is at present the method of assay for phenothiazine 
advocated by the Association of Official Analytical Chemists 
(A»Q,A.C., 1965).
Dubost and Pascal (1953, 1955) determined chlorpromazina 
in biological materials by oxidising witfi concentrated sulphuric 
acid, and measuring the intensity of the rod product. This 
procedure was subsequently used by Kok (1955), Berti and Cima (1956) 
and Thieme (1956), Hetzel (1961) assayed a series of phenothiazine 
derivatives in biological fluids from the intensity of the yellow 
products obtained by reaction with concentrated nitric acid. This 
reagent had previously been investigated by Fossoul (l95Qa). 
Promethazine has been determined colorimetrically after oxidation 
with sodium persulphate (Fossoul, 1951). Chlorpromazine has been 
determined using an iodic acid-phosphoric acid mixture (Calo et al,, 
1957, 1958), or peroxide in the presence of peroxidase and 
catalase (Cavanaugh, 1957), Other oxidising agents which have 
been employed are bromate (Sandri, 1955), ferric nitrate (teach 
and Crimmin, 1956), ferric chloride (Fels and Kaufmann, 1959) and
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perchloric acid (Kleinsorge and Thalmann, 1959).
However, the specificity of such reactions has not been 
described, and, in most cases, either the reagents used or the 
colours formed are unstable (Hetzel, 1961). Also most of these 
reactions, although suitable for assay of the larger amounts of 
material available in pharmaceutical preparations, would be 
insensitive to the small concentrations of phenothiazines excreted 
in biological,, material * Precise estimations are further complicated 
by the uncertainty regarding amounts of metabolites recovered and 
their intensity of colour formation compared to the parent drug •
Of the reactions described, that using sulphuric acid is the most 
sensitive and employs stable reagents, although colours tend to fado 
with time unless a reducing agent is added (Dubost and Pascal,
1955).
Other colorimetric methods of assay have been developed using 
complexing agents. Overholser and Yoe (1942) used the reaction 
between phenothiazine and palladous chloride for colorimetric deter­
mination of phenothiazine. The method was later used by Cavatorta 
(1959) as a general assay procedure for promazina, chlorpromazine, 
and promethazine. By formation of the lauryl sulphate salts of 
such complexes, Ryan (1959) made the reaction the basis of a 
general assay procedure for unoxidised phenothiazines.
A further procedure was initially described by Brodie and 
Udenfriend (1945). It depends on the ability of organic bases 
to form complexes with sulphonic acid indicators,.e.g. methyl orange*
70
The amount of base is determined by measuring the optical 
density of the complex in solution* The method has been applied 
to the assay of diethazins,(Porter and Silber, 1950), and 
promethazine (Haley and Bassin, 1951)*
Nadeau and Sobolewski (1959a, b) determined chlorprornazine 
and iBvomepromazina in biological materials from the intensity of 
their coloured complexes with potassium iodoplatinate. Forrest 
and co-workers, developed a series of rapid semiquantitative colour 
tests for phenothiazine derivatives in urine. These tests are 
based on a combined oxidation-complexing process in which an 
inorganic ion reacts with a free radical metabolite of the parent 
drug (Pg. 63)* They were reviewed by Forrest et al. (1961).
Drug determination using complexing reagents, however, is 
subject to the same limitations as the oxidation reactions, (Pg*69)* 
There is also the possibility using Brodie's sulphônic acid method 
of reaction with natural organic bases in biological materials 
in addition to the drug under investigation,
(2) Gravimetric, Volumetric and Electrochemical procedures.
Various volumetric and gravimetric procedures have also 
been used for the determination of phenothiazine derivatives. 
Gravimetric methods have included formation of picrates (Uyeo and 
Oishi, 1952), reineckates (Braunigar and Hoffman, 1955) and silico 
tungstates (Blazek and Stejskal, 1956), Reinackate and picrate
derivatives were also used by Yung and Pernarowski (1963) in the 
identification and differentiation of a series of 13 tranquillisers. 
Other precipitation and crystallisation reactions have been 
described by Auterhoff (1952), Haas (1952), Haley and Keenan (l950) 
and Idson (1950)*
Volumetric methods have included non-aqueous titration of the 
dimothylamino group with perchloric acid. Kleckner and Osol 
(1952) determined promethazine, and tlilne and Chatten (1957) 
determined promazine and chlorprornazine by the method. It was 
later extended to the essay of several other phenothiazine 
derivatives in pharmaceutical preparations (Milne, 1959), Non- 
aqueous titration of the sodium tetraphenyl borates of chlorprornazine 
and diethazine, and argentometric titration of their hydrochlorides 
were described by Brauniger and Hoffman (1955),
Several electrochemical methods of analysis have also been 
developed for phenothiazines in pharmaceutical preoarations, An 
amperometric method of determination was employed by Blazek (1956), 
and Kabasakalien and McGlotten (1959) used anodic oxidation half­
wave potentials for determination of a series of phenothiazine 
derivatives. Polarographic methods have also beeh used by Chuen 
and Riedel (l96l) and Porter (1964) who determined chlorprornazine 
after oxidation with bromine water.
However all three types of procedure (gravimetric, volumetric, 
electrochemical) require a high degree of purity in the samples 
under investigation and hence are of little use for the analysis
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of biological extracts. Also, as with colorimetric methods, 
effects due to differences in physical and chemical properties 
between the parent drug and its metabolites are unpredictable.
(3) Spectroscopic procedures.
Ultra violet spectroscopy has been described for the 
determination of chlorprornazine, mepazine and promethazirs (Meyer, 
1957). It has also been widely used for determination of 
phenothiazine derivatives in biological extracts (Pgs.yA^py ).
This method is much more specific and sensitive than colorimetry 
and sulphide and sulphoxide derivatives can be differentiated..
Also all phenothiazine derivatives have extinction coefficients of 
the same order (30,000-40,000) which means that metabolites make 
approximately the same contribution to absorbance as the parent 
drug* The ultra violet characteristics of phenothiazine drugs 
are reviewed on Pg* 104,
Fluorimetry has more recently been used by Ragland and 
co-workers for determination of phenothiazine derivatives in 
biological materials (Ragland et al., 1964, 1965). It has also 
been used for the identification of phenothiazine tranquillisers 
after reaction with potassium permanganate (Mellingar and Keeler,
1963). However, fluorimetry, due to its high sensitivity and 
low specificity, requires rigid purification not only of the 
biological extracts but also of all reagents and apparatus.
(4) Radioactive Labelling.
Radioactive labelling has been widely used for the determination
— / o
of phenothiazine drugs in biological material. The drug under
35investigation is labelled at the ring sulphur atom using S.
Extracts are usually prepared for counting by severe oxidation to
form inorganic sulphate, a scintillant added, and the radioactivity
measured by a scintillation counter. The absolute activity of
the derivatives is calculated by the use of internal reference
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standards, e.g. "^0^, and is expressed as a percentage of the
activity originally administered. This provides a value for the
percentage of dose excreted which can readily be converted to the
concentration or amount of metabolites in the sample.
The technique was first used for phenothiazine derivatives
by Christensen and co-workers in a study of the distribution of 
35S-chlorpromazine in rat and mouse tissues (Christensen and Uîase,
1956; Wase, Christensen and Polley, 1956), The distribution
35and excretion of 5 chlorprornazine, promazine and ch's ormepazine
has been reported in several species after different routes of
35administration (Fyodorov 1958), He also reviewed work on S
phenothiazine derivatives over the period 1955-57. Walkenstein and
Seifter (1959) studied the metabolism distribution and excretion 
35of S promazine in dogs and rats, and the metabolism and excretion
of chlorprornazine by rats was reported by Flanagan et al. (1962)
and Emmerson and Fiiya (1962). Other studies have also been carried 
out using thioridazine and ^^5 thiethylperazine (Eiduson et 
al., 1961, 1963; Zehnder, Kalberer and Rutschmann, 1962).
This labelling procedure is very sensitive and specific to 
the drug under investigation and metabolites present in equal
amounts make equal contributions to the overall activity. However, 
the method is expensive both in the cost oF the counting equipment 
and of preparation of the drugs. Also metabolites ca^ 'not he 
differentiated from the parent compound unless the method is 
carried out in combination with suitable separation techniques (pg, 7:
C, Ultra Violet and Colorimetric Procedures for th.e Determination 
of Meta b n litos in Biologic a 1 l-i a t j ri a .1 s .
Most methods used for the quantitation of phenothiazine 
derivatives in biological materials involve extraction from an 
alkaline medium using an organic solvent, and subsequent extraction 
into acid solution. Concentrations are than measured from the 
ultra violet spectrum of this acidic extract or from, its visible 
spectrum after suitable colour development.
Berti and Cima (1356) determined chlorprornazine and its 
metabolites in biological fluids by passing the fluid through an 
Amberlite ÏRC-50 ion exchange column on to wiich the basic 
phenothiazine derivatives were adsorbed. They then eluted the 
column with concentrated sulphuric acid and calculated the 
concentration of phenothiazine derivatives in the eluote from the 
intensity of the red colour produced. This method, however, is 
non-selective and groups of metabolites cannot be differentiated.
Also, the procedure for colour formation must be standardised to 
give reproducible results,
Salzman and Brodie (1955) reported a more selective method 
of analysis. Both sulphide and sulphoxide derivatives were
extracted from the alkaline biological fluid by heptane containing 
1.5^ isoamyl alcohol. Sulphoxides were then extracted from the 
heptane into a pH 5.6 acetate buffer, an*j the sulphides were 
subsequently taken into 0,IN hydrochloric acid« The amounts of 
sulphide and sulphoxide were measured separately by ultra violet 
spectroscopy of the appropriate extract*
Another selective method of assay was reported by Flanagan 
et al^ (1959), They assayed both unconjugated and conjugated 
metabolites as sulphides and sulphoxides. Unconjugated sulphide 
and sulphoxide derivatives were extracted from the alkaline biological 
material by ether then re-extracted into N sulphuric acid.
Conjugated metabolites were hydrolysed by heating the residual 
material in a strongly alkaline medium on a boiling water bath for 
1 hour, then extracted in the same way as the unconjugated fraction. 
The sulphide and sulphoxide contents of each fraction were then 
determined from the ultra violet spectrum of the appropriate 
extract. The method of calculation involved a simple background 
cancellation.
This method, using a single ultra violet spectrum to calculate 
both sulphide and sulphoxide content, does away with the need for 
complicated differential extraction procedures. It was subsequently 
employed by Bolt (1965) for determination of promazine and chlor- 
promazine,using ethylene dichlcride as the extracting solvent,and 
taking the metabolites into O.IN hydrochloric acid. He determined 
the sulphide and sulphoxide content of the glucuronide, sulphate 
and unconjugated fractions by specific enzyme incubation techniques.
A colorimetric method involving complex formation with 
potassium iodoplatinate was developed by Nadeau and Subolewski (1959) 
The unconjugated fraction, and conjugated fractions after hydrolysis, 
were extracted into isobutanol and a pH3 buffer solution added.
The isobutanol was then evaporated off, thus transferring tho 
metabolites to the aqueous layer. Addition of potassium iodoplatinai 
and a small amount of gum ghatti to prevent precipitation of the 
complex, gave an intensely coloured solution. The concentration 
of metabolites in the sample was measured by comparing the optical 
density of this solution with calibration graphs obtained using the 
same reaction with the parent drug. This method, as with the 
other colorimetric procedures, requires strict standardisation of 
manipulations for reproducible colour formation* It is also less 
sensitive that the ultra violet technique, the colour tenths to be 
unstable, and the procedure is not specific for phenothiazine drugs. 
The methyl orange procedure of Bridie and co-workers (Pg, 59) 
was used by Goldenberg and Fishman (1961) to determine unconjugated 
metabolites of chlorprornazine after elution from paper chromatograms. 
However this method again is not specific for tranquillisers, and 
any other organic bases in a urine sample would also form complexes. 
Some form of purification, e.g. chromatography, is thus necessary 
before this method can be applied to biological extracts with any 
accuracy.
. Of the methods described ultra violet spectroscopy was the 
most sensitive, specific, and least complicated procedure. The
method of Flanagan also did not require differential extraction 
procedures for sulphide and sulphoxide derivatives, their 
concentrations being calculated from a single spectral curve. It 
was thus decided to use this method of determination, with 
modifications for analysis of horse urine (Pg.l09), Visible 
spectroscopy after colour formation with sulphuric acid was also 
used to corroborate results from the ultra violet spectra.
D, Isolation and Extraction of Metabolites,
.Unconjugated metabolites are readily extractable from an 
alkaline biological medium by organic solvents. On the other hand 
conjugated metabolites tend to be insoLü^le in organic solvents, but 
soluble in water* Such derivatives are therefore subjected to 
either enzymic or chemical hydrolysis and the liberated phenothiazine 
fraction then extracted by organic solvents.
Due to the low levels of phenothiazine derivatives excreted 
in urine, large volumes are needed for the isolation of such compounds, 
although only small volumes are needed for chromatography. Salzman 
and Brodie (1956) carried out a largo scale ether extraction of 
chlorprornazine metabolites from dog urine and obtained enough 
material to identify the sulphoxide. Ether has also been used for 
the extraction of promazine (Ualkenstein and Seifter, 1959) and 
methoxypromazine (Allgen et al., 1959), Goldenberg and co-workers 
used ‘ethylene dichloride for the extraction of metabolites of 
promazine, chlorprornazine and imipramine from human urine (Fishman 
and Goldenberg, 1952; Goldenberg et al., 1964). They claimed 
that it was superior to ether in the extraction of sulphoxide
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metabolites^ Salzman and Brodie (1955) used n-heptane containing 
1,5^ isoamyl alcohol for quantitative determination of chlorprornazine 
and its sulphoxide. The same system was used by Allgen et al*.
(1963) for the extraction of metabolites of levomepromazine. Other 
solvents used have included isobutanol (Nadeau and Sobolewski,
1959) and chloroform (Kotionis, 1961),
In addition to extraction procedures, adsorption and 
precipitation techniques have been used for the isolation of 
glucuronide conjugates especially when large volumes of urine were 
available, Kamil, Smith and Williams (1952) precipitated phenol 
glucuronides from rabbit urine by the addition of basic lead acetate, 
but the method is only applicable to non-basic glucuronides when 
present in large concentration. Glucuronide metabolites of morphine 
in human urine have been isolated by adsorption onto charcoal and 
subsequent elution with acetic acid. (Fujimoto and Way, 1958), On 
saturation with potassium carbonate a reddish brown gum precipitated 
from the urine which was dissolved in water and treated with charcoal, 
A continuous extraction technique using butanol has been employed 
For the isolation of glucuronides of chlorprornazine and promazine 
(Beaven, 1962; Bolt, 1965), The butanol extracts were pooled then 
evaporated under reduced pressure to one fifth of their original 
volume, when the glucuronides precipitated out. The precipitate 
was filtered off, washed, and further purified by adsorption and 
desorption from charcoal.
Such precipitation reactions yield the glucuronides in a very 
crude form. It was found in preliminary experiments on horse urine, 
using the technique of Beaven, that precipitates could not be
purified to a sufficient extent to allow identification of the 
glucuronides. The method of recovery adopted, therefore, was 
extraction with ethylene, dichloride as recommended by Goldenberg 
and co-workers, and hydrolysis of conjugates using specific enzymes 
(Pg. .103).
E, Seoaration Techniques,
Several techniques have been used for the separation and 
purification* of individual metabolites* Due to the large number 
of biotransformations undergone by the tranquillisers such techniques 
must be as sensitive as possible to small differences in structure.
(1) Paper Chromatoqraphy.
If
Paper chromatography was widely used for phenothiazines between 
1950 and 1960, but has now been largely replaced by thin layer 
chromatography which is not so time consuming, is more sensitive 
and gives much better resolution. The latter method, in which the 
thickness of the layer can be altered, has proved invaluable for 
preparative work.
Descending paper chromatography of the tranquillisers has 
most often been used (Allgen et al., 1959; Lin et al,, 1959;
Fishman and Goldenberg, 1960; Beckettet al,, 1963), although 
ascending techniques (Salzman and Brodie, 1956) and circular develop­
ment have also been reported (Eisdorfer and Ellenbogen, 1960;
Beaven, 1962),
(2) Paper Electrophoresis.
There are very few reports of the use of electrophoresis for 
purification and separation of"phenothiazins'*metabolites, In
their initial studies of chlorprornazine metabolism, Fishman and 
Goldenberg (i960) separated unconjugated urinary metabolites into 
throe zones by paper strip electrophoresis using 1% potassium 
carbonate as solvent, but they could not achieve further resolution 
by variations of pH, etc. Paper electrophoresis was also used 
by Beaven (1962) and Bolt (1965) for the separation and purificdion 
of crude glucuronide metabolites. The latter worlcsr also used 
continuous electrophoresis over several days. However, this 
method is time consuming and gives no better resolution than thin 
layer chromatography.
(3) Thin Layer Chromatography,
Thin layer chromatography has only been applied recently to 
the separation of "phenothiazine" metabolites. Using this method 
development is rapid and resolution is high. The resolution is 
best illustrated by the work of Goldenberg and co-workers who, 
using this technique, separated and identified over 30 metabolites 
of promazine and chlorprornazine in the urine of man and dog. This 
was achieved by developing 250^ thick silica layers in two dimensions 
For unconjugated metabolites the most suitablesysterns were found 
to be Chloroform-Acetone-Diethylamine (2:7:1) and (88:2:10),
The separation of hydroxylated metabolites and hydrolysed conjugates 
was achieved using Ethyl Acetate-Acetone-Methanol-Diethylamins 
(68:2:20:15) and Acetone-Isoprooanol-l/S Ammonia (9:7:4).
(4) Ion Exchange Techniques.
Ion exchange procedures have been used more for isolation of 
pure metabolic fractions than for separation of individual
D JL  “
metabolitesc This is done either by selective adsorption of the 
phenothiazine derivatives or of the impurities in the biological 
material, depending on the resin used,
Berti and Cima (1956) isolated the "chlorprornazine"content 
from urine samples by selective adsorption on Amberlite IRC-50 
resin, Eiduson and Wallace (1958) removed 95'“o of the phenothiazine 
content from urine samples using this resin» Other cation exchange 
resins were used by Forrest et al, (1951), They employed Amberlite 
CG50 for isolation of unconjugated solvent extractable metabolites, 
end the sulphonated styrene resin,Oowex AG50,for isolation of the 
total phenothiazine content, Forrest et al, (1951) also used the 
anion exchange resin,Oowex AG3X4,for removal of indican and other 
contaminants from urine samples, Lin et al,.. (1959) isolated 
small amounts of chlorprornazine metabolites from human urine using 
Dowex AG50 resin. They also partially separated the metabolites 
using gradient elution with increasingly concentrated ammonia 
solutions,
However large volumes of biological material are required for 
isolation of appreciable amounts of metabolites, and most resins 
are not specific to the phenothiazines, adsorbing other naturally 
occurring amines. The adsorption can also be influenced by 
endogenous electrolytes in the urine,
(5) Gas Liquid Chromatography,
. Like thin layer chromatography, this technique has only 
recently been applied to the separation of phenothiazine derivatives.
Sp\/oraI di.ff2 v'crit star.ionary pliasos and detectors have been 
investingt'^d, and the onti-non teiyioretnre renne for separation 
has been found to he 2i)0-25n°C<, !-‘Ost experi'ients so far have 
boan on standard reference coripoundS) and little work has been 
reported on extracts of urinary metabolites,
Anders and i'annsring (I9h2) chrc'istogrephed a series of 
phenothiazine derivatives using glass columns containing 5E-3Ü, a 
methyl silicone polymer, as the stationary phase, west of the 
compounds wore readtly separated, but those containing piperazine 
rings were found difficult to elute, In the sane year similar 
separations were reported using different concentrations of 5E-30 
(ma so da and IkG'jaua, 1562; Par!<cr, Fontan and Kirk, 1962; I'enden 
Houvel, Haahti and hiorning, 1552), A sories of 15 phenothiazines 
have been identified; using silicone oil as the stationary phase;, 
from the gas chromatographic patterns of their pyrolysis products 
(Font '0 ; Jain and Kirk, 1564), Sranlett (]566) chromatographed 
several tranquillisers on Apiezon L claiming that it produced 1=fs 
tailing of peaks than SF-3d, All of those techniques used hydrogen 
flane or ^ - ionisation detectors.
Gas liq'jid chro'"-a. tography of the tranquillisers has boon 
extensively studied by Gudzinc-jicz and co-ijcrkers. Fortin, Driscoll 
and Gudzinowicz (1953) reported a nethod of calc lating trisir 
relative retention ti'es, by relating then to boiling point 
nu'hers cai culat:;d by theoretical chemistry. In the fcllcuing year 
they develnpad a gas chromatographic “^thoc for quantitation of
1964). Using this procedure they detected chlorprornazine, its 
demethylated forms and corresponding sulphoxides down to concentrations 
of 0*5 mg/litre. They also reported thermal breakdown of 
sulphoxide and N-oxides, and further investigations showed the main 
product of decomposition to be 2-chloro phenothiazine. (Gudzinowicz, 
Martin and Driscoll, 1964). Gudzinowicz (1966) also compared the 
sensitivity of the hydrogen flame and electron affinity detectors 
to such compounds. He found that the sensitivity of the latter 
depended on the grouping at the 2-position, decreasing in the order 
G1>CF^>SCH^>H >OCH^.
Chromatography of chlorprornazine metabolites from human urine 
was also investigated by Dohnson, Rodriguez and Burchfield (1955).
They used a microcoulometer as a detector, (halogen and sulphur 
titration cells), and with the aid of thin layer chromatography 
identified 10 metabolites. There was also evidence of decomposition 
of sulphoxides and N-oxides*
Gas liquid chromatography is tiie most sensitive separation 
technique yet employed for the tranquillisers^detecting derivatives, 
down to submicrogram levels. However the technique also requires 
a high degree of purity in the samples under investigation, which 
is difficult to obtain in biological extracts, (Pg. 25^ * Column 
packings and conditions are also difficult to reproduce and 
decomposition has been shown to occur, especially with metal columns. 
The applicability of the technique to the separation of phenothiazine 
derivatives excreted by the horse has been investigated (Pgs. 241-268)•
F, Location and Identification of metabolites.
After extraction and separation of individual metabolites, 
several techniques may be used for their location and identification* 
These include ultra violet fluorescence, specific spray reagents, 
comparison with known standards, and elution followed by spectroscopy 
In the case of gas liquid chromatography, direct entry of the 
effluent into a mass spectrometer has recently proved a useful 
identification technique (Pg«2A4)*
(l) Ultra Violet and Snecific Soray Reagents.
Due to their fluorescent properties phenothiazine derivatives 
can be visualised under ultra violet light. Sulphides produce 
greenish blue fluorescent spots, sulphoxides appear deep blue, and 
sulphones pale blue, (Eisdorfer and Ellenbogen, I960). The 
sensitivity of the technique is 1-2 yjg and it has been widely used 
for initial location of metabolites after chromatography.
Several general spray reagents have been used for the detection 
of such compounds, 50^ sulphuric acid was used by Salzman and 
Brodie (1956) for the detection of chlorprornazine and its metabolites, 
It produces reddish pink colours witli sulphides and sulphoxides, 
and a purple reaction with hydroxylated derivatives. Its sensitivity 
is approximately 1 yjg.
Another general reagent consists of a few crystals of sodium 
nitrate dissolved in 10ml concentrated hydrochloric acid (Sprogis 
et al,, 1957), It produces a variety of colours with sulphides 
and sulphoxides but does not react with sulphones. Its sensitivity 
is also of the order of 1 yug. The Muniar iodoplatinate reagent 
(Munier and Machebouf, 1949) has also bean used for the detection
of “phenothiazines^ (Eisdorfer and Ellenbogen, 1960). However the 
spray is not specific for the phenothiazine nucleus but reacts with 
the side chain amine group of the molecule. It consists of 5m 1 
^/v aqueous platinic chloride, 45ml 10;^  ^/v aqueous potassium 
iodide, and 50ml water. Its sensitivity has not been described.
Fishman and Goldenberg (1560) used ammonium persulphate as a 
general reagent. It reacted uitit sulphides and sulphoxides 
producing a variety of colours, but not with sulphones. Its 
sensitivity is approximately 2 yug. 3-methyl~2-bsnzothiazolone 
hydrazone produces colours with phenothiazine derivatives in the 
presence of ferric ions (Sawicki et al., 1961 a,b,c). It reacts 
with sulphides, sulphoxides and sulphones but is not specific for 
phenothiazine derivatives. The active species is the aniline type 
grouping within the nucleus, and the mechanism of the reaction is 
thought to be diazotisation at the para position to the nitrogen.
Its sensitivity was not specified.
Several more specific reagents have been developed for detection 
of structural modifications to the parent compounds. An acidic 
ferric chloride dip for paper chromatograms was described by Fishman 
and Goldenberg (i960). It produces a red coloration with sulphides 
but does not react with sulphoxides or sulphones. The solution 
consists of 1^ ^/v ferric chloride in 2.5N nitric acid. Sulphides 
can be detected down to the 5 pq level using the reagent,
A spray using l/o aqueous sodium metaperiodate, which is 
specific for hydroxylated phenothiazines, has been described (Bolt,
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1965)* It produces transient greenish-purpls colours with
hydroxylated phenothiazines which rapidly change to yellowish-brown*
The sensitivity is also approximately 5 yug*
Two sprays have been developed for the detection of déméthylation
of the terminal amino group which differentiate mono- and
didemethylation. Ninhydrin ( Indane-1^2^5-trione ) reacts with primary
amines giving bluish-purple colours, and also has a weak reaction
with secondary amines* The reagent consists of a 1/4 solution of 
* Vninhydrin in lO/o /v aqueous acetic acid. After spraying, the 
plate is heated at 1DG°C for ID minutes. Its sensitivity in 
detecting desdimethyl chlorprornazine was approximately 10 jUg, 
Walkenstein and Seifter (1959) used a nitroprusside reagent for the 
detection of secondary amines. It consists of two solutions,A and 
which are mked in equal proportions immediately before use, A 
is a 3/4 solution of sodium nitroprusside in 10:4 aqueous acetaldehyde, 
and B is a 2% aqueous solution of sodium carbonate* It produces 
a bluish-purple colour with such derivatives and, using dosrhonomethyl 
chlorprornazine, was found to have a sensitivity of 30 yug*
Of the general reagents it was decided to use sulphuric acid 
in combination with the ultra violet technique for location of 
metabolites on thin layer plates. The colours produced are specific 
for phenothiazines, it has high sensitivity and hydroxylated forms 
can be distinguished. All the more specific sprays described were 
also used. The method of spraying is described on Pg. 118,
(2) Spectroscopic Identification.
Many workers have investigated the possibility of determining 
the structure of metabolites by spectroscopic techniques. Ultra
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violet spectroscopy readily differentiates sulphides and 
sulphoxides, and has been used to confirm results using the ferric 
chloride spray. Several attefMpts have also been made at determining 
the nature and the position of substituents from spectre recorded 
after reaction with sulphuric acid* Riedor (i960) used this 
method for a series of 2»substituted phenothiazines and related 
the wavelength of the major peak in the visible region to the nature 
of the substituent. A similar study was carried out by Street 
(1962) who based his identification on absorbance wavelengths in 
the ultra violet region. However such studies produced no informatio 
regarding the position of substituents, Beckett and co-workers 
studied ultra violet and visible spectra of a series of lüethoxy- 
and hydroxy-phenothiazines after reaction with 50)4 sulphuric acid 
and differentiated the l->- 2 3 - and 4- derivatives from their
absorbance maxima in the 340-3B0myj region - (Beckett and Curry,
1963; Beckett, Curry and Bolt, 1964), Thus, provided a 
concentrated enough sample can be eluted, it should be possible to 
differentiate monohydroxylated metabolites by this method.
Infra red spectroscopy has also been investigated as a means 
of determining the nature and position of nuclear substituents.
Many reports of the infra red spectra of both mono- and multi­
substituted phenothiazines have appeared in the literature (Smith, 
1950; Charpentier et al,, 1951; Massie, 1954; Roe and Little,
1955; Cymerman-Craig et al,, 1956; Yale et al., 1957; Hodiff 
and Craig, 1961).
Different functional groups can be recognised by this method
G.Qc hydroxylation, from too O-H stretching frequency, and 
déméthylation, from the ('■-!! stretching frequency, Howo\'8r, duo to 
their proximity, cere should be tok^n not to confuse these two 
frequencieso Sulphoxide derivatives nave also been reported to 
give a strong peak at 1020 cn"^ ' due to the S-Ü stretching vibrations 
(Patterson at al*, .ISP/l), Howover, due to th:-^ complexity of such 
spectra the method should bo used more as confirmation of other 
methods, e,g, spray reagents, ultra violet spectroscopy *
Attempts have also been made to determine the position of 
substitution from such spectra, i-Jndiff and Craig (1961) exa 'lined 
the C-'-j out of plane de format ion modes of the henzenn'. rings and 
reported that 2- nr 3- substituted derivatives have a strong peak 
bethjoon 300 and 550 cm similar to an asymmetric trisubstituted 
benzene, 1- and 4- substituted derivatives on the other hand have 
a strong psak between 750 and 000 cm"^ ' corresponding to a vicinally 
substituted bznzene.
Bolt (1965) studied a large series of substituted phenothiazines 
in three regions of the spectrum corresoonding to the aromatic 
C-H doformation, the C-C skato tel, and the O-H stretch modes» He 
concluded that in tbs 700-900 cm  ^ range- (C-H deformation modes), it 
is possible to tell whether one or both rings is unsubstituted or 
monosubstituted. Also,if monosubstitution occurs,it is possible 
to tell the position, 'Jit i more than one substituent in a ring 
no assign:.'cnt can be "ade. The C-C skeletal node is of no use in 
determining th.a position of substitution* The O-H stretching 
frequency can be liso:’ to a certein extent to give positions of
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hydroxylation but should not be confused with the N-H stretch of 
primary or secondary amines, (Demethylated derivatives).
Such structural assignments are very complicated, and the 
method is probably of much more use when synthetic reference 
compounds are available to fingerprint all the vibrational 
frequencies involved. However, both this technique and ultra 
violet spectroscopy used in connection with the specific spray 
reagents can be of some value in confirming structural assignments
- yu
AIMS OF the: INVESTIGATION
There have been few reports regarding metabolism and excretion of 
the phenothiazine tranquillisers by the horse, although such processes 
have been widely studied in other species (Chapter II), Carey and 
Sanford (1963) detected 7 metabolites of promazine in horse urine 
and found that polar metabolites predominated. Schubert (195?) 
reported prolonged excretion of chlorprornazine over several days after 
a single intravenous injection, and that only a small percentage of 
the dose was excreted* He detected 4 metabolites, the major one 
being chlorprornazine sulphoxide. Since so little information was 
availablôyit was decided to carry out a detailed analysis of metabolism 
and excretion by the horse of the tranquillisers more commonly used 
in equine practice. These processes were followed both qualitatively 
and quantitatively after both oral and parenteral administration.
Interference with analysis of phenothiazine derivatives due to 
contaminants in horse urine was reported by Schubert (1967), and was 
noted during preliminary experiments for the present study (Chapter V), 
Different methods of collection, storage and analysis were therefore 
investigated in an attempt to eliminate such interference*
Experiments were also carried out to evaluate the applicability of 
the methods developed to the detection of small doses of phenothiazine 
derivatives just sufficient to produce an effect. The use of the gas 
chromatograph-mass spectrometer was also investigated for this purpose.
METHODS ; MATERIALS AKO APPARATUS.
IV METHODS, MATERIALS AND APPARATUS
A* Urine Collection,
(1) Introduction.
Harnesses for the continuous collection of urine from geldings 
were described by Lindsey (1925), Howell (1930). and Vender Noot 
et al* (l965). All incorporated a funnel of canvas or similar 
material suspended under the penis, and connected to a collection 
vessel by large bore tubing. Those of Howell and Vender Noot also 
included equipment for the collection of faeces, comprising a large 
rubber lined canvas bag strapped firmly to the buttocks of the 
animal. The former used the further innovation of a lid on the 
bag, opened before defaecation by the upward movement of the horse's 
tail, Vander Noot et al, also described a metabolism stall for 
use in conjunction with their collection apparatus.
More recently a harness was developed using a funnel of 
reinforced latex (Warwick, 1956), which was modified by Nicholson 
(i960) by incorporating a paddle arrangement in the tubing between 
the funnel and the collection vessel* Flow of urine through the 
tubing depresses the paddle thus closing an electric circuit.
This, in turn, operates a pointer on a smoked drum, revolving once 
a day, to give a record of each urine sample collected.
There are comparatively few reports of urine collection 
harnesses for mares, probably due to the difficulty in retaining 
a collection device securely in position. A typical arrangement 
was described by Grandier (i960) in which a collection bag was
connected to the animal in such a way as to cover the vulvar cleft.
In the various harnesses developed the strapping arrangement 
seemed much more complicated than need be, and the funnels 
and tubing were heavy, which would tend to make the equipment 
cumbersome and annoying to the animal* The fact that the funnel 
was connected to a fixed reservoir, thus requiring the use of a 
metabolism stall, or immobility over long periods, would also 
lead to the annoyance of the animal, and the need for frequent 
exercising.
(2) Development of a Harness*
With these points in mind, a harness for the collection of 
urine from geldings was designed for the present work,* which has 
the advantages of being light, with the minimum of strapping 
arrangements, giving maximum freedom to the animals. The 
arrangement can be assembled and fitted within minutes at a 
negligible cost, the collection bags are readily interchangeable, 
and an entire collection can be supervised by one person*
The collection container is a double polythene bag cut in 
such a way as to leave one of the bottom corners slightly lower 
than the other (Fig. 7A). A small hole is cut in this lower 
corner, through which a 3" length of diameter rubber tubing 
is inserted, and firmly bound by thread, to produce a watertight 
junction between it and the polythene. A stopper is then fitted 
to this outlet tube.
* I am grateful.to Miss P.M. Carey for her help in the development 
of this collection harness.
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The top of the bag is firmly bound round a 9" hoop of -g" 
diameter plastic tubing which forms a rigid framework for tho mouth 
of the vessel, Four slits are then cut in the polythene just 
below this frame, and straps A, B, C and D, of 1^" webbed tape, 
are attached (Fig, 7B).
To fit the harness, tha front strap, A, is drawn through a 5" 
surcingle already in position^and secured, Straps fi and C are 
then fastened over the horses back at E (Fig, 7E), and the double 
tape 0 is pulled between the hind legs, over the tail, and secured 
at tho same position (E), Finally this junction is attached to 
the surcingle at F by a strap along the back of the animal, Minor 
adjustments are then made to all straps to ensure tliat the 
harness fits comfortably, with the collection bag in the correction 
position. Figure 8 shows the apparatus fitted to one of the 
geldings used in the present work, (B),
(3) Automatic Collection,
The harness was further developed with a view to automatic 
collection of samples. The apparatus used is shown diagramatically 
in Figure 9, Instead of a stopper, a length of pressure tubing 
was attached to the outlet from the collection bag, and threaded 
up the side of the surcingle, where it was held firmly in place.
It was then led through a series of elastic supports on the ceiling 
of the loose box, and through tha wall to an aspirator in the 
adjoining laboratory. The elasticity of the ceiling supports and 
the length of the pressure tubing were such that the horse had 
complete freedom of movement throughout the collection.
FIGURE 9 «
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The principle is that urine is passed into the bag,connected 
throug^t the aspirator to a vacuum pump. The pump is switched on 
at hourly intervals by a signal from an automatic assay machine, 
removing the urine from the bag to the aspirator. The pump is 
then switched off and the outlet valve from the aspirator is. opened 
by the assay machine, allowing the sample to flow, by gravity, into 
a vessel on the fraction collector. Two final signals from the 
assay machine close the outlet valve and move the fraction 
collector on to the next position.
The fraction collector was assembled by connecting the outlet 
tube from the aspirator to the revolving drum of a kymograph, 
synchronised to bring the tube over flasks set at regular intervals 
corresponding to its movement at successive collections. The 
apparatus has been successfully used for collection of urine over 
periods of up to 48 hours,
(4) Experimental Animals, Sample Collection and Storage,
Details of the horses used, which were either light hunters 
or thoroughbreds, are given in Table 2, Each horse was brought 
in from grass at least three days before drug administration.
This interval allowed a decrease in urinary output, giving much 
more manageable and concentrated amounts for extraction purposes 
than would be obtained from an animal straight from grass. Before 
and after drug administration they were fed a standard diet of 2 
feeds per day. The morning feed (8,00 - 9,00 a.m.) consisted of 
21b* bran and 4 lb, nuts, and the evening feed (4,00 - 5.00 p.m.) 
of 21b. bran and 21b, oats. They also received 201b, hay morning
TABIE 2 EXPERIMENTA L ANIMALS
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and evening.
Collections were made from geldings using the harness described, 
and in the case of mares a catheter was passed at 2 hourly 
intervals. The latter method was adopted since it was found 
very difficult to keep a collection bag in position,especially 
over the prolonged periods involved* An indwelling catheter was 
also considered impractical due to the temperament of the animals*
All samples were stored, in darkness, in sterile containers 
at-20°C, since it had been found in preliminary experiments that 
storage at 4°C allowed a build up of impurities, which tended to 
mask the phenothiazine peaks on the ultra violet spectra of 
extracts (Chapter V).
In each experiment a control sample of urine was taken on 
the first morning, before drug administration, and samples were 
then collected individually for as long as required* The volume 
and pH of each sample was measured. Although, initially, individual 
samples were analysed, it was subsequently found that analysis of 
pooled samples gave much more uniform results (Pg. 14p). 100 ml
aliquots from each sample, unless otherwise stated, were used 
for quantitative analysis by ultra violet spectroscopy, and 300 ml 
was used to obtain qualitative excretion patterns of individual 
metabolites by thin layer chromatography. All residual urine 
was pooled for further structural identification of metabolites*
B. Drug Administration and Dosage.
For the major quantitative and qualitative studies, drugs 
were administered between 9 and 11 a.m. on the first day of each
J . U U
experiment* Intramuscular doses were injected into tho neck
inflammation
muscles, several sites being chosen to avoid/baxjJÔiDcgc due to the 
large volumes involved* F or oral dosing^tablets were powdered,
mixed with treacle, and incorporated in the morning feed*
Drugs and doses, which were considered to be the maximum 
which could be safely administered,were :
Chlorpromazine hydrochloride (Largactil - May & Baker)*
Intr_amuscu 1 ar, as a ^Yv solution « 2 rng/Kg* Oral, 
in powder form - 5 mg/Kg,
Promazine hydrochloride (Sparine « Wyeth),
Intramuscular9 as a 5'^b '^/v solution -5 mq/Kq, Oral, 
in powder form 10 mg/Kg,
Acepromazine maleate* (Acetylpro.nazina - Boots).
Intramuscular, as a 1/ ^/v solution « 0*5 mg/Kg, Oral, 
in powder form - 1 mg/Kg.
Propionylpromayine phosphate (Combelen - Bayer)
Intramuscular, as a I/o ^/v solution « 0.5 mg/Kg,
In addition to these doses, smaller amounts were administered 
to ascertain limits of detection (Pgs, 22~i^ ,23n), and repeated daily 
doses were used for studies into length of excretion. After drug 
administration clinical and physiological effects were recorded 
until the animal returned to normal (Pg.l38).
C. Materials and Apparatus.
(l) Reference Compounds and Ensyme Preparations.
Chlorpromazine, desmonomsthyl chlorpromazine, desmonomethyl 
promazine, desdimethyl chlorpromazine, chlorpromazine sulphoxide
and chlorpromazine N-oxide were kindly supplied by May & Baker,
Ltd., promazine and promazine sulphoxide by Bohn Wyeth and Brothers, 
and aceproniazine and acepromazine sulphoxide by Boots Ltd. I am 
grateful to Dr, F. Leonard of the National Institute of Mental 
Health for samples of 3»hydroxy promazine and 7-hydroxy chlorpromazine 
Ultra violet and mass spectra, colour reactions with the specific 
spray reagents, and Rf values in several solvent systems were 
recorded for each compound. /3-glucuronidase, (Ketodase 5000 units/ml 
was supplied by William Warner & Co* Ltd., and sulphatctBe(Mylase p) 
by Sigma Ltd.
(2) Instruments.
Ultra violet and visible spectra were recorded on a Beckman 
DB spectrophotometer. Gas chromatograms were recorded on an 
Aerograph 1522-B instrument, using flame ionisation detectors.
Mass spectra were recorded on the LKB mass spectrometer-gas 
chromatograph. The thin layer plates were visualised by a 
Minuvis Ultra violet lamp (Desaga),
0, Quantitative Analysis,
(1) Extraction Procedures,
The methods of extraction employed are summarised in Figure 
10, Metabolites were extracted as three fractions - unconjugated, 
glucuronide conjugated- and sulphate conjugated derivatives,
(a) Unconiuqated Metabolites - Procedure 1.
100 ml aliquots of urine were adjusted to pH 9.5 - 10 using
FIGURE 10
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[\! ammonia solution. The white precipitate which formed was 
removed by centrifuging, and decanting the supernatant urine*
(This precipitate contained no phenothiazine derivatives as shown 
by reaction with 50/ sulphuric acid. Its composition is described 
in Chapter V (Pg.l23 ) The urine was then extracted with three
10 ml volumes of 1,2-dichloroethane (previously washed successively 
with half its volume of 0,IN ammonia solution, O.IN hydrochloric
acid, and distilled water), and the organic extracts were pooled*
o *The residual urine was stored at -20 C for analysis of conjugated
metabolites* The organic extract was then washed with O.IN ammonia 
(2 X 15 ml) followed by distilled water (2 x 15 ml), and finally 
extracted into 10 ml O.IN hydrochloric acid. This solution was 
assayed for phenothiazine content by ultra violet spectrometry 
(Pg. 109).
Emulsions formed at any stage of the extractions were 
usually broken by centrifuging at approximately 2,500 revs./min, 
and, if this failed, the addition of a little anhydrous ammonium 
sulphate succeeded.
(b) Conjugated Metabolites - Procedure 2,
As analysis of conjugated metabolites involved prolonged 
incubation of the residual urine from Procedure 1, it was first 
sterilised by heating for 10 minutes on a boiling water bath at 
three successive 24 hour intervals. This avoided the possibility 
of formation of contaminants by microbial action at 37°C,(Chapter U). 
Thereafter it was treated under sterile conditions. After 
sterilisation the urino was divided into two equal portions, one 
for the analysis of glucuronides, and the other of sulphate
1U4
conjugated metabolites,
(i) Procedure 2 (a) - Glucuronide Conjuoated Metabolites*
The first portion was adjusted to pH 4.5 using 5N hydrochloric 
acid, and 5 ml /3-glucuronidase (Ketodase -5,ODD units/ml) were 
added. It was then incubated for 24 hours at 37°C, all glassware 
required from this point being flamed before use* After incubation 
tha pH was adjusted to 9,5 « 10 using N ammonia solution, and 
extraction was carried out as for Procedure 1 with proportionate 
volumes of solvent,
(ii) Procedure 2 (b) - Sulphate Coniuoated Metabolites.
The second portion was adjusted to pH 5,2 using 5N hydrochloric 
acid, and sulphatase (Rylase p) was added in 1/ concentration*
The urine was then incubated for 24 hours at 37^C, adjusted to 
pH 9,5 - ID, and extracted by Procedure 1.
(2) Ultra Violet Characteristics of Phenothiazine Derivatives,
Ultra violet spectra of the phenothiazine derivatives available 
(Pg,100) were recorded in acid, neutral and alkaline solution.
For acid and neutral conditions,solutions (10 mg/ml) ware made up 
in O.IN hydrochloric acid and water respectively, and for an alkaline 
medium a few drops of O.IN ammonia solution were added to the 
neutral sample. Visible spectra were also recorded after reaction 
with 50/ sulphuric acid, 2 ml, concentrated sulphuric acid was 
slowly added drcpwise to 2 ml.of each solution (50 mg/l) under 
constant cooling with running water. Solutions were then allowed 
to stand 10 minutes for maximum colour development, and their 
spectra recorded.
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The compounds had characteristic ultra violet spectra and high 
extinction coefficients (30,000 - 40,000),. With the exception 
of acepromazine and propionylpromazine, all sulphide derivatives 
(i.e. these in which the sulphur atom is unoxidised) had a major 
peak between 250 and 260 mjj and a minor one between 300 and 320 mju* 
These are typical absorbance wavelengths for tricyclic aromatic 
hydrocarbons (Badger, 1954). In acid solution chlorpromazine had 
maxima at 255 and 308 and promazine at 252 and 300 mjj. All 
sulphide derivatives of each drug, had absorbance maxima within 
2 of the parent compound *
Oxidation to the sulphoxide form produced vast changes in spectral 
behaviour, four peaks, one major and three minor, being formed 
instead of two. The major peak appeared between 230 and 240 nyj 
and the minor ones in decreasing order of intensity at 
approximately 270, 300 and 340 m^. In acid solution chlorpromazine 
sulphoxide had peaks at 240, 274, 302 and 342 nyj and the corresponding 
wavelengths for promazine sulphoxide were 230, 272, 300 and 340 nyj* 
Similar spectral differences between sulphide and sulphoxide 
derivatives have been reported for phenothiazine (Houston et al., 
1949), methoxypromazine (Allgen et al., 1959) and mepazine (Hoffman 
et al., 1959). Further oxidation of such derivatives to the 
sulphone causes a lowering in wavelengths of all four sulphoxide 
peaks (Bolt, 1965). Typical spectra of sulphide and sulphoxide 
derivatives, using promazine as an example, are shown in Figure 11.
As previously stated, acepromazine and propionylpromazine 
have a different pattern of ultra violet spectra from that just
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described. In acid solution tho parent drugs prorlucod tb'o peeks
of almost equal intensity at approximately 2^0 and 230 n p  and the
sulphoxide darivativos had a major peak at approximately 255
and a minor one at approxi'iately 315 rr^i. The ultra violet spectra
of acepromazine and its sulphoxide are shoun in Figure 12. The
characteristic spectra of those tuo cor,pounds are probably due to
tho prosoncQ of the side chain carbonyl group directly attached to
the nucleus (an additional chrnmophore to the aromatic system of
the other phenothiazine derivatives), in conjuration ui th tho
aromatic ring, F y analogy \,jith ketone siibsti to teci tojnzeno ring-; this
would load to changes in the vevelcngth end intensity of absorb'xnce
of the phenothiazine nucleus dua to the electron transfer process 
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shown (lurrell; 1951; Scott, 1951),
On reaction !>jith 50\( sulphuric acid all the derivatives studied 
had one major absorbance peek in the visible region between 51S and 
540 my.!. For all derivatives of promazina and acepromazine, includi'-g 
sulphoxidos, this occurred at approxiwat'-cly 515 '■'y.;, whereas for 
chlorpromazine and its derivatives it occurred at apnroximatsly 539 ~-y 
Thiîs phenothiazine derivatives can be divided by their ultra 
violet spectral properties into two gro='pa tfiosa with spectra 
reaemblinp that of promazine and those resembling acepromazine.
The groups can be furt’-er divided fron their spectra
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into sulphide, sulphoxide and sulphone derivatives. Also each 
drug, on reaction with 50;i sulphuric acid, has a characteristic 
absorbance in the visible region between 510 and 540 my;, common 
to all its metabolites. Alteration of the pH of solutions gives 
rise to only small changes in wavelength, which usually increases 
by between 2 and 4 my. on progressing from acidic to alkaline 
conditions,
(3) Soectroscopic Determination of Metabolites of Promazine 
Chlorpromazine,
Two methods of analysis were employed. The first, using 
ultra violet spectroscopy, gave a measure of sulphide metabolites 
in the presence of sulphoxides, and vice versa. The second, using 
the visible spectrum, gave a measure of the total phenothiazine 
content of each extract. Both these methods depend on the fact 
that extinction coefficients are comparable for metabolites and 
the parent compound, Chemical tests were also occasionally 
carried out on urine samples to confirm tlie presence of conjugated 
fractions (Pg.113)
(a) Determination of Sulohide and Sulphoxide Derivatives 
(Flanagan's Method.)
(i) Determination of sulphides in the presence of sulphoxides. 
The ultra violet spectrum obtained from a mixture of sulphide 
and sulphoxide derivatives of a drug resembling promazine in 
spectral characteristics is a combination of the sulphide and 
sulphoxide spectra. Thus promazine produces five peaks at 230,
252, 272, 300 and 340 mjj and a corresponding spectrum is obtained 
from the chlorpromazine derivatives. The concentration of sulphide 
or sulphoxide metabolites in each extract was calculated from 
this single spectrum by a background cancellation method described 
by Flanagan et si, (1959),
For determination of sulphide derivatives a straight line 
was drawn between points A and B on the ultra violet curve 
corresponding to wavelengths of 235 and 270 myi respectively,
A perpendicular line was then drawn from the major sulphide 
absorbance maximum (252 for promazinej 255 for chlorpromazine) to 
intersect AB at C. The difference between the maximum absorbance 
and the absorbance at C was calculated for each extract. This 
value was compared with a calibration curve of absorbance against 
concentration obtained by extracting standard urinary solutions 
of each drug by Procedure 1 (Pg.lOl), and calculating the absorbance 
difference as described,
(ii) Determination of Sulphoxides in tha presence of Sulphides,
The sulphoxide content of extracts was also calculated from 
the ultra violet spectrum by a background cancellation procedure.
The absorbance of the peak in the 270 myi region (272 for 
promazine; 274 for chlorpromazine), and tha absorbance at 315 myi 
were measured. The difference in absorbance between these two 
wavelengths was then compared with a calibration curve of absorbance 
against concentration. This was prepared by extracting standard 
urinary solutions of promazine sulphoxide or chlorpromazine 
sulphoxide by Procedure 1, calculating the absorbance difference
Ill
and plotting it against concentration. Using these methods 
sulphide or sulphoxide concentrations in an extract could be 
determined down to a concentration of 1 mg/litre. Derivatives 
detected in lower concentrations than this were classed as trace 
amounts.
(b) Determination of Phenothiazine Content of Extracts*
The combined sulphide and sulphoxide content of extracts was 
determined from their visible spectra after reaction with 50^ 
sulphuric acid. The reaction was carried out as previously 
described, (Pg* 104), and the maximum absorbance in the visible region 
(515 myi. for promazine; 530 mjj for chlorpomazine) was measured»
This value was compared with a calibration graph of absorbance 
against concentration prepared by extraction of standard urinary 
solutions of promazine hydrochloride or chlorpromazine hydrochloride 
by Procedure 1, followed by colour development and absorbance 
measurement.
Reproducible results were obtained using this method provided 
manipulations were standardised, and metabolites could be detected 
in extracts down to a concentration of approximately 2mg/litre,
There was also good correlation between amounts calculated by 
this method, and the amounts obtained by combining the sulphide 
and sulphoxide contents as determined from the ultra violet spectra. 
The method finally adopted for quantitative analysis was to calculate 
the sulphide and sulphoxide contents of each fraction using ultra 
violet spectrometry, then use the visible spectrum to confirm the 
findings.
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4. Spectroscopic Determination of Metabolites of Aceoromazine 
and Propionylorornozino.
Solutions containing both acepromazine and its sulphoxide, 
or propionylpromazine and its sulphoxide, did not produce ultra 
violet spectra with tho combined absorbance maxima of the two 
solutes (c.f. Promazine and chlorpromazine). Instead, they were 
found to produce one major peak which varied in wavelength between 
240 and 255 nyj depending on the proportions of sulphide and 
sulphoxide present* When the ratio of acepromazine to its 
sulphoxide was 8:2 it appeared at 244 myj, and the corresponding 
wavelengths for ratios of 1:1 and 2:8 were 248 and 255 my; respectively, 
This is probably caused by the proximity in wavelength of the 
major peak for each form (240 and 255 my;), causing them to overlap.
The other maxima normally found at 280 and 315 myj for sulphide
and sulphoxide respectively were absent, except for cases where
the solution was almost entirely composed of one or other derivative.
Since only one major peak is produced by a combination of 
sulphide and sulphoxide derivatives of such compounds,the separate 
amounts of sulphide and sulphoxide derivatives in a sample cannot 
be calculated* Their relative concentrations however, could 
possibly be roughly calculated from the wavelength of the major 
peak* Instead the method adopted was to assay samples for total 
phenothiazine content using colorimetry (Pg.l04),
On subsequent examination of spectra of urine extracts it was 
found that only the glucuronide and sulphate conjugated fractions
gave this single maximum, unconjugatsd metabolites having a 
spectrum corresponding to that of promazine sulphoxide (PgpiG^). 
Thus unconjugated metabolites were assayed by ultra violet 
spectroscopy as for promazine sulphoxide and the conjugated 
fractions were analysed by colorimetry,
( )^ Qualitative Tests for Coniuoated Metabolites.
Before quantitative analysis of conjugated metabolites their 
presence was*usually first ascertained using simple qualitative 
tests,
(a) Glucuronide Conjugated Metabolites,
5 mg naphthoresorcinol were dissolved in 0,5 ml concentrated 
hydrochloric acid and an equal volume of urine was added. The 
mixture was boiled for 1 minute, cooled, and extracted with an 
equal volume of ether. The presence of glucuronides produced a 
purple colouration in the organic layer. Control urine was found 
to produce only a very faint purple colouration using this reaction
(b) Sulphate Conjugated Metabolites,
5 mg barium chloride were dissolved in 0,5 ml 2N hydrochloric 
acid and an equal volume of urine was added. The solution was 
centrifuged and the supernatant liquid was boiled for 1 minute.
On cooling any turbidity or precipitation showed the presence of 
sulphates,
E. Thin Layer Chromatography.
(l) Extraction Procedures.
Procedures were exactly the same as for quantitative analysis,
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using proportionate volumes of solvent, the final stage being 
omitted in each case. To obtain a qualitative picture of 
excretion using tiin layer chromatography (Pg.igs)) 300 ml of 
urine vooregxtracted, whereas for structural determination 
purposes, and occasionally for gas liquid chromatography, much 
larger volumes were continuously extracted. After washing the 
extract as described, (pg. 1Q2),) instead of taking the metabolites 
into hydrochloric acid, it was dried over anhydrous ammonium 
sulphate, evaporated to dryness under reduced pressure, and 
redissolved in a minimum amount of ethylene dichloride or methanol
(2) Continuous extraction.
The apparatus employed is shown in Figure 13, and is designed 
to allow for continuous extraction by any solvent. The glass 
tube and sintered glass funnel are not attached to the urine 
container, so that the depth of the funnel in the urins can be 
altered. For solvents denser than urine the funnel is positioned 
just below its surface. The principle is that solvent from the 
reservoir (an aspirator) is pumped through the glass tube by means 
of a peristaltic pump to the sintered glass funnel, where it is 
dispersed into the urine as small globules. Dispersion of 
solvent is further aided by the mechanical stirrer, which causes 
the globules to spiral downwards through the urine. The solvent 
collecting at the base of the container is returned through the 
open tap to the reservoir, under the action of the pump, and is 
subsequently recycled.
For solvents less dense than urine the situation is as shown 
in the diagram, the sintered glass funnel being positioned at the
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base of tho container, and the outlet tap is closed* In this 
case, the solvent globules spiral upwards to the head of the urine 
column just below the outlet tube, and the collecting solvent is 
drawn back to the reservoir by tne action of the pump* Both 
methods have been used for extraction, over 24 hours, of volumes 
of urine up to three litres*
(3) Preparation of Plates*
Chromatography was carried out on 20 x 20 cm glass plates 
coated with a 2S0p layer of MN Kioselgel (SQOy; for preparative 
work). The plates were activated by heating for 30 minutes at 
lOO^C, and stored in a desiccator until required* 2-10 aliquots 
of extracts were spotted and the plates were developed to a 
height of 15 cm. In order to obtain a qualitative picture of 
metabolism over prolonged periods (Pg. ipc^  layers were divided
into 1 cm strips and 10 A aliquots of extracts from successive 8
hour samples were spotted on consecutive strips*
(4) Solvent Systems*
Each metabolic fraction from promazine or chlorpromazine 
was run in three solvent systems. For the unconjugated fraction
the systems used were:
1 Methanol - Acetic Acid - Water (5:3:2)
11 Ethanol - Acetic Acid (1:1)
111 Chloroform - Acetone - Diethylamine (2:7:1) (Goldenberg 
et al *j 1965) ,
For both conjugated fractions the systems were:
1 Acetone - isopropanol - 1% ammonia (9:7:4) (Goldenberg
117 -
et al*^1965),
11 Ethyl Acetate ~ Methanol - Diethylainina (7:2îl)
111 Methanol - Acetic Acid - Water (5:3:2)
In the case of acepromazine and propionylpromazine only two
solvent systems were used since so few reference compounds were 
available* Unconjugated extracts were developed in the methanol- 
acetic acid-water system and the conjugated fraction in the system 
acetone-isopropanol-1^ ammonia (6:7:5)*
All diagrams of chromatograms shown in Chapter I/I unless 
otherwise stated, were recorded after running in methanol-acetic 
acid-water (5:3:3) for unconjugated metabalites, and in acetone» 
isopropanol"!^^ ammonia (9:7:4) for the conjugated fractions.
(5) Location of Metabolites.
(I) Due to their fluorescent properties, metabolites were 
first visualised under ultra violet light (254 myi)* This method 
of location was also used when elution of spots was required,as 
the short periods of irradiation did not appear to alter their 
molecular structures.
(II) Metabolites were also located by spraying with 50/o v 
sulphuric acid as described by Salzman and Brodie (1956). This
is a general reagent for phenothiazine derivatives detecting both 
sulphides and sulphoxides.
(ill) Ferric chloride was used for location of sulphide 
derivatives. The spray consisted of a 1% ^/v solution of ferric 
chloride (Fe Cl^.hH^O) in 2.5 N HNO^,
(iV) In addition to the sulphuric acid spray, periodate
was used for the detection of hydroxylated metabolites (I^ j aqueous 
sodium rnetaperiodate ) o
(V) Minhydrin was used for location of didemethylated 
derivatives. The spray consisted of a 1% ^/v solution of ninhydrin 
in 10% aqueous acetic acid. After spraying, the plate was
heated at 100°C for 10 minutes,
(Vl) Nitroprusside was used to identify monodemethylated 
derivatives. The reagent consisted of two solutions, A and B, 
which were mixed in equal proportions immediately before use*
A was a 3^ solution of sodium nitroprusside in 10)^  aqueous 
acetaldehyde, and B was a ?.% aqueous solution of sodium carbonate. 
All spray reagents were used on a single plate. This was 
achieved by dividing the layer into 1 cm strips as previously 
described and spotting equal aliquots (lOA ) of the extract on 
each strip. After development, three consecutive strips were 
sprayed with each reagent, two uncoated glass plates being used 
to shield the layer on either side. When a spray produced no 
coloration, further plates were spotted with progressively larger 
aliquots of extract (up to 50 A ) to confirm that no reaction had 
taken place.
(5) Elution of metabolites.
For elution purposes, 0,5 ml aliquots of extract were
streaked on 20 x 20 cm layers 0.5 mm in thickness. The aliquots
were applied using a pasteur pipette, with a plug of cotton wool
fitted at the tip, to avoid damage to the layer and control the
flow of extract. After development the streaks were either 
visualised under ultra violet light, or located by spraying the
end strips of the plate with 50;^  sulphuric acid, the middle portion 
being protected by a glass plate. In both cases the position of 
streaks were outlined using a metal marker*
Each area of silica containing a phenothiazine derivative was 
then scraped off, and corresponding areas from different plates 
were combined in conical flasks. The minimum amount of solvent 
necessary for extraction (5-10 ml) was added to each flask, and 
the mixtures placed for 1 hour on an automatic shaker. After 
shaking^the mixture was centrifuged and the supernatant eluate decante 
Individual metabolites were eluted for ultra violet spectroscopy 
using 0,IM hydrochloric acid. Using reference compounds it was 
found that the minimum amounts of metabolites which would give 
interpretable ultra violet spectra on elution into 5 ml of acid 
ranged between 5 and 20 jug. Sulphide derivatives of chlorprornazine 
could be detected down to 5 ^ g, whereas both hydroxylated and 
sulphoxide derivatives were not detectable below 8 ^ g , The 
corresponding figures for promazine were 8 jug and 12 yug. The 
minimum amount of acepromazine and its sulphoxide were 10 and 20 
jjg respectively. Attempted elution with organic solvents proved 
unsuccessful, although small quantities were occasionally eluted 
by methanol. The difficulties are considered in the discussion
(Pg* 262)'
F. Gas Liquid Chromatography.
(1) Packing of Columns.
Appropriate amounts of SE-3Ü (l^ or 5^) and Chromosorb W 
were weighed out and the 5L-30 dissolved in toluene. When 
column coating was required Epicote 1001 was also added to the 
toluene in 10^ concentration* The Chromosorb was then added to 
this solution and the toluene allowed to evaporate. The packing 
was drawn into the chromatographic column by suction from a 
vacuum pump, the column being constantly shaken to ensure 
uniformity of packing. Each column was preconditioned by 
heating for 24 hours at a temperature 50°C above the norntal 
operating temperature.
(2) Operating Conditions.
The optimum operating temperature for the stainless steel 
columns packed with 5^ 5E-30 was 250°C. The conditions were:
Column - 5 x o.d, stainless steel; Stationary Phase - 5,4 
SE-30; Support - Chromosorb W (50-80 mesh); Column Temperature 
250°C; Injector Temperature 275°C; Detector Temperature 275^C; 
Carrier Gas Flow Rate - 40 ml/minute. Such columns were also 
used over a range of temperatures between 150 and 300°C, and in 
each case injector and detector temperatures were 25C° above 
that of the column.
The optimum operating temperature for the glass columns 
packed with 1% SE-30 was 200°C. The conditions were; Column- 
5* X I" o.d.,glass; Stationary phase - 1^ SE-30; Support-Chromosorb 
W (50-80 mesh); Column Temperature 200°C; Injector Temperature 
225°C; Detector Temperature 225°C; Carrier Gas Flow Rate-
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30 ml/minute.
The L.K.Bc gas chromatograph-mass spectrometer was also 
fitted with glass columns (8' x packed with 1% 58-30. The 
operating temperatures ranged from 150 « 300°C.
Go Miscellaneous Procedures.
(l) Oxidation of Propionylprornazine to Prooionylpromazine 
Sulphoxide.
Since safhples of propionylprornazine sulphoxide were unavailable 
this compound was synthesised from the commercially available sulphide 
in order to determine its spectral and chromatographic properties.
The method employed was based on that of Kano and Fujimoto (1957) 
for oxidation of chlorprornazine to its sulphoxide,
50 ml propionylprornazine phosphate injectable solution,
(Combelen » 10 mg/mlwas adjusted to pH 9,5 using N ammonia solution 
and extracted with 3 x 10 ml ethylene dichloride. The extract 
was then evaporated to dryness under reducad pressure and the 
residue taken up in 5 ml ethanol. 3 drops of 30/o hydrogen peroxide 
were added and the solution stirred.
This solution was then refluxed for 4 hours, and the solvent 
was evaporated off. The residue was recrystallised three times 
from acetone and subsequently used for ultra violet spectroscopy 
and thin layer chromatography. The yield of sulphoxide was less 
than 10^,
Attempts at oxidation of some of the standard inference compounds 
(e.g. demethylated and hydroxylated derivatives) were unsuccessful.
This was probably due to the small amounts of such compounds 
available, and the low yield obtained from the reaction.
(2) Determination of 6.glucuronidase activity in horse urine.
Two samples of urine, a test and a control, (iml), were 
centrifuged, the urine decanted, and adjusted to pH 4*5 using 
1.1 ml acetate buffer.# 0,1 ml O.OIH phenolphthaleiinglucuronic 
acid substrate was added to the test sample and both were incubated 
at 37^C for 24 hours, 1 ml 10:'^ aqueous sodium carbonate was then
r
added to both samples, followed by 1 ml substrate to the control. 
Each was made up of 10 ml with distilled water and the absorbance 
of the test at 55Gmjj read against the control.
Tee glucuronidase activity was read from a calibration graph 
of absorbance v activity. This was prepared by adding different 
volumes of phenolphthalein (0,05, 0,1 & 0,2 ml) to 1 ml urine and 
1 ml sodium carbonate, making up to 10 ml with water, and reading 
the absorbance against a urine blank. One unit of activity was 
defined as the amount of enzyme liberating 1 yjg phenolphthalein 
under the conditions of the experiment,
* 3,25ml acetic acid and 5,79 om sodium acetate were made up to
450 ml water, the pH was adjusted to 4,5 and the volume made up 
to 500 ml.
STORAGE ^00 HANDLING OF HORSE URINE.
w STORAGE AND MANGLING OF HORSE URINE.
A, Precipitate from Alkaline Urine*
As previously described (Pg,103/ a white precipitate is 
obtained on rendering horse urine alkaline* The compound was 
isolated after centrifuging, washed with water, and dried in a 
desiccator* The resulting white powder did not burn and was 
thus presumed to be inorganic* It was insoluble in organic 
solvents, water, O.JN ammonia, and 0*IN hydrochloric acid.-
Infre red spectroscopy showed very strong peaks at 1450 and 
880cm  ^which suggested that a carbonate was present* This was 
confirmed by production of carbon dioxide on reaction with chromic 
acid* Group separation and a subsequent flame test showed the 
presence of calcium* This was also confirmed by a white precipitate 
with ammonium oxalate*
Microscopic examination of the precipitate showed mostly 
the crystal forms of calcium carbonate, amorphous calcium carbonate, 
and calcium phosphate although traces of oxalate crystals were 
also present. Biochemical analysis of electrolytes before and 
after centrifuging also showed a large decrease in calcium levels 
(l80mg/lD0ml to 6 mg/lOOml)* Thus the major constituent of the 
precipitate was calcium carbonate,
B, Interfering compounds in urine,
(l) Introduction,
During preliminary quantitative experiments it was noted
that an additional peak appeared on the ultra violet spectra of 
some extracts of urine stored at 4^C, This peak at times appeared 
within 24 hours of sample collection, and always appeared within 
one week, thereafter increasing in intensity with length of storage 
of the urine. Since the maximum occurred at 278 mjj it tended to 
interfere with the ultra violet determination of metabolites by 
masking the phenothiazine peaks. Figure 14 shows a. topical spectrum 
of this contaminant superimposed on the spectrum of promazine 
sulphoxide, '
Due to the gradual increase in intensity of this peak withi 
time it was postulated either that some organism, dormant in the 
urine, was slowly producing a compound responsible for the absorbanc; 
or that microbial organisms from the air, or sample containers, 
wore acting on a substrate in the urine giving rise to the 
contaminant. On the other hand it could be caused by slow reaction 
between endogenous compounds in the urine. The theory of 
bacterial action was supported by the fact that incubation of 
control urine, at 37°C for 24 hours, immediately after collection, 
always produced a very intense absorbance at 278 mJJ,
It was also noted that there is an increase in p-glucuronidaee 
activity with time in urine stored at 4°C. Figure 15 shows a 
typical increase in such activity in a control urine sample, and 
increase in the absorbance of its extract, over a period of 1 month. 
For the first 15 days the values follow each other closely,after 
which the glucuronidase activity falls off rapidly, the absorbance
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remaining at a fairly constant level* It has also been found 
after incubation of control urines at 37^C that p-glucuronidase 
levels usually exceed 40 units/lOO ml,,having been negligible 
before incubation.
It was at first thought that this build up in activity 
resulted in the hydrolysis of endogenous unidentified glucuronide 
conjugates, giving'rise to a gradually increasing interference on 
spectra of extracts. After two to three weeks this interference
r '
reached a maximum either dua to tlia glucuronide' substrate being 
exhausted, to the fall off in activity, or to a combination of 
both. However, if such substrates are present they would be hydroly; 
during the normal p-glucuronidase incubation after sterilisation 
(Pg,104), Thus the rise in activity seems to be a coincidence.
The process,however, does reach a point of exhaustion. This can 
be seen from the fact that control samples stored at 37^C, extracted 
by procedure 1, then subsequently incubated with ^ -glucuronidase, 
show very little interfering absorbance (Pg,13o),
(2) Treatment of Urine,
Since prolonged incubation procedures are involved in the 
assay of conjugated metabolites it was attempted either to remove 
the interfering compound when formed, to eliminate the organism by 
sterilisation, or to inhibit its action by more sophisticated methods 
of storage,
(a) Effects of Ion Exchange Resins.
Initially, attempts were made at removing the contaminant,
I
Eiduson and Wallace (1958), whilst determining phenothiazine
derivatives in human urine, removed 95/b of the phenothiazine 
content from standard samples using a cation exchange resin, 
Amberlite IRC50, An anion exchange resin, Dowex AG3X4, was used 
by Forrest et al, (i960) to remove indican and various contaminants 
from human urine.
This suggested the possibility of using one of these resins 
to selectively remove either the drug and its metabolites, or the 
interfering compound,from samples of horse urine, A series of 
preliminary dxperiments was carried out to evaluate their usefulness
Standard solutions of promazine hydrochloride (/^6mg/l) and 
promazine sulphoxide (^12mg/l) were made up in a series of 
phosphate buffers (pH 6,0, 7ol and 8,3), and a borate buffer 
(pH 9,3), The ultra violet spectrum of each solution was then 
recorded,
1,5 gm, Ambsrlite IRC50 resin was added to 50 ml of each 
standard promazine solution, and the mixture was shaken for 4 hours. 
After filtering, the ultra violet spectrum of each sample was run 
using the appropriate buffer as reference. The loss in pheno­
thiazine content was then measured from the percentage decrease in 
absorbance of the major peak. The same procedure was carried out 
with 50 ml samples of the standard promazine sulphoxide solutions,
A similar procedure was also adopted using Dowex resin, 1 gm of 
this compound being added to each of the standard solutions.
The experiment wasalso carried out on a sample of control 
urine which showed the interfering absorbance on the ultra violet
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spectra of its extracts. It was divided into four portions 
which were then adjusted to pH6, 7*1, 8*3 and 9,3 respectively*
1,5 gm amberlite ÏRC50 resin was added to a 50 ml aliquot of each 
portion* The mixture was shaken for four hours, filtered, extracted 
by Procedure 1 (Pg.lOl), and the ultra violet spectrum recorded*
The same process was repeated for each of the four portions using 
1 gm Dotuex resin and any loss in absorbance was recorded*
The results of the experiment (Table 3), show that over the 
pH range examined, although the Dowex resin is very efficient in 
removing the interfering compound, it is even more efficient at 
removing promazine and promazine sulphoxide* The Amberlite resin, 
especially at alkaline pH, does not remove a great amount of 
promazine or promazine sulphoxide, but at the same time, is not 
very effective in removing the interfering compound.
Since these initial experiments did not produce the desired . 
results, and since it seemed much time consuming work would be 
involved in finding a selective resin, it was decided to investigate 
sterilisation procedures.
(b) Effects of Filtration*
The possibility of sterilising the urine using a Seitz filter 
was investigated, A sample of control urine was extracted by 
Procedure 1, the ultra violet spectrum of the extract was recorded, 
and no interfering peaks were found. The remaining urine was 
divided into 2 portions. One half was filtered through a 14 cm 
HB/EKS Carlson-Ford bacterial filter pad, then stored under sterile 
conditions at 4°C in a refrigerator. The other portion was put
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straight into storage. An aliquot of each was submitted for 
bacterial examination by attempting culture on Blood Agar, The 
filtered sample proved to be completely sterile, whereas the 
unfiltered one showed most of the common microbes found in any 
contaminated medium.
Samples of each portion were extracted by Procedure 1 and 2 
at randoTi intervals, over a period of six weeks, and ultra violet 
spectra were ^recorded. The sterilised fraction showed no abnormal 
absorbance over this period using either procedure. The other 
fraction gave an abnormal peak when treated by Procedure 1 which 
gradually increased in intensity throughout the experiment. When 
treated by Procedure 2 this portion produced a very intense 
absorbance in every sample. These results suggested that Seitz 
filtration might be of use in preventing interference,due to 
contamination,on the ultra violet spectra. However, the possibility 
that the drug and its metabolites might be removed by the filter 
had also to be investigated.
Promazine hydrochloride was added to a control sample of 
urine to give a concentration of 6mg/l, and the sample was 
divided into two portions. One portion was filtered through the 
Seitz filter and the other was used as a control. Both fractions 
were extracted by Procedure 1 and their ultra violet spectra 
recorded# On comparing the absorbance of each portion it was 
found that approximately 80;^  of the promazine had been removed by 
the Seitz filter. On repeating the experiment using promazine
- 132
sulphoxide ( ^ 1 2 m g / l approximately the same amount was removed*
This ruled out the possibility of using this method of sterilisation 
to remove the contaminant*
A duplicate set of experiments was also carried out using 
a millipore filter instead of the Seitz filter. Again no signs 
of interfering absorbance were noted in extracts over 6 weeks from 
the filtered urine, but approximately 50^ of the added promazine 
or promazine'sulphoxide was removed.
(c) Effects of storage.
Various methods of storage were also investigated in an 
attempt to inhibit formation of the contaminant. A pooled sample 
of control urine was divided inbo 100ml aliquots in sterile bottles. 
Groups of six samples were then treated and stored as described.
Each group was stored in the dark to avoid the possibility of 
photochemical reactions*
Group 1. Samples were stored at 4°C in stoppered bottles.
Group 11, Nitrogen was bubbled through the urine for 15 minutes,
the bottles were then stoppered and stored at 4*^ C.
Group 111, Samples were adjusted to pHl.l, (the pH of O.lNHCl),
using concentrated HCl. The bottles were then stoppered 
and stored at 4°C.
Group IV. Samples were stored in an incubator at 37°C in stoppered 
bottles.
Group V» Samples were stored in sealed polythene bags at -20°C 
in a deep freeze.
Group VI* Samples were stored under a layer of toluene at 4°C
in stoppered bottles,
GroupVll. Samples were heated in a boiling water bath for
five minutes, cooled and stored at 4°C in stoppered 
bottles,
Immediately after collection a 100ml sample of the pooled 
urine was assayed by Procedure 1 to ensure no interfering compound 
had been originally present. One sample from each treated group 
was then assayed at weekly intervals by Procedures 1 and 2,
Results are shown in Table 4, After analysis by Procedure 
1, the concentration of the interfering compound gradually increased 
in four of the groups,i.e. that stored at 4^C, that stored under 
toluene, that stored under nitrogen, and that stored at pP, 1.1,
In addition, the group stored at 37°C, produced a very intense 
absorbance in every case. Thus these five methods of storage 
would not eliminate the formation of the interfering compound and 
were not further considered. On the other hand, by the end of 
three weeks, neither the group stored at -20°C, nor the heated 
group,produced any absorbance when assayed by Procedure 1, Thus 
it was decided to adopt one of these methods of storage.
On considering samples assayed by Procedure 2, it was found 
that every sample, with the exception of the group stored at 
37°C, gave an intense peak at 278m^ showing that incubation 
accelerates production of contaminants. Also since those samples 
which had been stored at 37°C, after extraction by Procedure 1 
gave very weak absorbance on further incubation, it was assumed
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that the source of the interfering compound had been exhausted
during the initial storage period. However, the peaks were not
so weak as to render this method of storage applicable,
(d) Sterilisation for Procedure 2,
Although samples which had been treated either by heating or
by deep freezing could now be assayed by Procedure 1 without
interference, the incubation stage for conjugated metabolites still
gave rise to interfering absorbance. Thus further experiments
were carried out in an attempt to eliminate contaminants in assays
by Procedure 2, This involved more stringent sterilisation of
ttis urine, and afterwards carrying out the procedure under completely
sterile conditions,
A 100 ml aliquot of control urine was assayed by Procedure
1 and was found to have no abnormal absorbance. The residual urine
was then extracted by Procedure 2, and produced a peak at 278 my;
so confirming the presence of organisms capable of producing the
contaminants. Three 100 ml aliquots of the same urine were then
analysed under sterile conditions by Procedure 2, The first
sample was extracted without any previous treatment, the second
o
was first heated for 15 minutes at 100 C, and the third was first 
heated for 10 minutes at 1GD°C at three successive 24 hour intervals. 
The first sample showed interfering absorbance at 278 myi, and the 
second still showed the presence of the impurity,although the 
intensity of the absorbance had halved. In the third sample only 
a trace of the interfering compound was found. Thus it seemed 
that the secono, more rigorous method of sterilisation would
prevent the formation of contaminants during the prolonged 
incubation step.
To ascertain the applicability of this technique to the 
assay of urine samples containing phenothiazine metabolites, 
standard urinary solutions of promazine (5mg/l) and promazine 
sulphoxide (12 mg/l) were made up. Two 100 ml aliquots of each 
solution were extracted by Procedure 1 firstly without treatment, 
and secondly after heating for 10 minutes at 3 successive 24 hour 
intervals. The resulting spectra showed that the heating had 
no noticeable effect on the concentration of either promazine or 
its sulphoxide.
It was thus decided to store samples at -20°C when any length 
of time would be involved between collection and analysis. Also 
when analysis of conjugated metabolites was required the residual 
urine from Procedure 1 was first sterilised repeatedly as described.
LEGEND FOR DIAGRAMS
Unless otherwise stated the symbols employed in graphs and 
diagrams are as follows:
(a) Quantitative Studies
# = Total metabolites 
□ ~ Unconjugated sulphoxides 
A  ~ Glucuronide sulphoxides 
O  “ Glucuronide sulphides 
■ = Sulphate conjugated sulphides
(b) Thin layer chromatography
(i) Solvent systems.
Unconjugated metabolites;- Methanol-acetic acid- 
water (5:3:2)
Conjugated metabolites;- Acetone - isopropanol - 
1^ ammonia (9:7:4)
(ii) Spray reagent - 50^ sulphuric acid
(iii) Colour formation 
Purple
Reddish pink 
Bluish purple 
Yellowish brown□
UI results 
A, Effects of Druqs.
After administration of each drug, any visible effects on 
the animal were noted. With the larger doses used for quantitative 
studies (Pg. 99) the usual signs already described after 
tranquilliser administration (Carey and Sanford, 1963) were again 
noted for every drug* Such effects included lowering of the head, 
drooping of eye/^ancl lower lip, resting the hind leg, yawning, 
snoring, slight unsteadiness when standing, and a general dopey 
appearance. In geldings the penis was relaxed.
After intramuscular administration, reaction to the drug was 
usually first noted between 20 and 40 minutes after injection, the 
drug having maximum effect over the first 4 to 8 hours. However 
effects were still noticeable after 12 hours, and occasionally up 
to 24 hours. After oral administration, usually one hour elapsed 
before the drug showed a noticeable effect, which was most marked 
for a further 3 to 6 hours* Signs of tranquillisation had 
usually disappeared by 18 hours after administration.
Every drug caused a lowering in rectal temperature, usually 
of the order of 1 - 2F^ over the first 4 hours after administration* 
However, on one occasion, (Horse 2 - Promazine I.M. - 5 mg/Kg), a 
drop of 4F° was recorded within 3 hours. The temperature had 
usually returned to normal by 12 hours after administration.
Administration of each drug also usually gave rise to a slight 
tachycardia, the increase in pulse rate being approximately
5 - 1 0  beats/minute. However, on one occasion, (Horse 2 - Promazine 
I.M. - 5 mg/Kg,), an increase of 28 beats/minute was recorded at 
6 hours after injection. In every case the rate had returned to 
normal by 12 hours* Effects on respiration were variable and 
unpredictable. In some cases no difference was noted, whereas on 
other occasions s^all rises or falls were recorded, unrelated to 
the drug or route of administration.
The excitement reaction already described did not occur, but 
untoward reactions were noted on two occasions. On the first 
occasion, after intramuscular administration of chlorprornazine 
(2mg/l<g) to horse 4, the animal appeared to react normally to the 
drug. Thus, after 4 hours, a bar, which had been placed across 
the top half of the loose box door in case of abnormal reaction, 
was removed. Within 2 hours the animal tried to leap the door 
but was caught by the hind legs in the process causing considerable 
cuts and grazing. On the only occasion that propionylprornazine 
was administered (intramuscular - 0.5 mg/Kg), the horse (7) at first 
showed slight signs of tranquillisation. However, at 15 minutes 
after injection it rapidly became very dopey, unsteady on its feet 
and pawed the ground, and within 3 minutes went down anaesthetised. 
Four hours elapsed before the horse returned unsteadily to its feet, 
and it still appeared rather groggy after a further 12 hours.
The period of anaesthesia was accompanied by a fall in rectal 
temperature of 5F°,
After administration of the smaller doses of each drug used 
for limit of detection studies (Pgs.22(f^;^o) * visible signs were
only noted after the largest of the three doses and only to a 
slight extent,
B. Quantitative studies of metabolism*
Initially quantitative studies were carried out on each urine 
sample passed. However, results obtained using this method were 
difficult to analyse due to large variations in concentration 
over short periods of time,and the difference in time intervals 
between successive samples. In addition, investigation of every 
urine sample meant analysis of a large number of samples, which was 
later found unnecessary. Typical graphs obtained using this 
procedure, and the method subsequently adopted are shown in Figure 
16* It can be seen in the former case that the interval between 
samples differs considerably, and large differences occur in the 
amounts excreted from sample to sample, making the results very 
different to interpret. In the latter case, with larger regular 
intervals between samples, the variations in the amounts excreted 
in successive samples are not so pronounced.
The method adopted was to pool samples obtained over fixed 
consecutive periods of time, analysis being carried out on an 
aliquot from each pooled sample as previously described (Pgd.01 ) 
Periods of 8 hours were chosen since this seemed to give the most 
uniform results. The concentration of total metabolites, and their 
concentration in individual metabolic fractions, was determined 
for each pooled sample. The amount excreted over successive 8
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-hour intervals was then calculated by multiplying this concentration 
by the urinary volume for t^e period, and the rate of excretion 
(mg/hr) was obtained by dividing each amount by 8c This rate was 
plotted against time for successive pooled samples to give an 
excretion pattern.
Such graphs were plotted for each drug. The doses and 
methods of administration employed are described on page 99 . 
Metabolites were analysed as previously described in six groups 
dependent on their chemical structure, i.e. sulphoxids derivatives, 
(all metabolites having a sulphoxide grouping), and sulphide 
derivatives, (all metabolites in which the ring sulphur atoin is 
unoxidised, including N-oxides), of the unconjugated, glucuronide 
conjugated and sulphate conjugated fractions. Rates of excretion 
were plotted for each group, and combined to give the total rate 
of excretion,
(1) Promazine.
(a) Intramuscular Administration•
Rates of excretion were plotted for six experiments (Horses 
1, 2, 4, 7, 5a & 5b) after intramuscular administration of promazine 
hydrochloride (5mg/Kg as a solution). It was noted that the 
patterns for the rate of excretion of total metabolites fell into 
two groups. A graph depicting the average of these rates for each 
group is shown in Figure 17* In the first group, noted in three 
experiments, excretion rapidly reached a maximum ( /v 12mg/hr) wühin 
8 hours of injection, then tailed off gradually and irregularly, 
whereas in the second group the maximum ( /v 5mg/hr) was not attained
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until between 24 and 32 hours. In the latter case rates of 
excretion over the first 16 hours ware low, and after 32 hours 
they again diminished gradually and irregularly. In both cases 
metabolites could still be detected at 96 hours after administration 
For each horse, excretion of individual metabolic groups over 
successive samples was irregular,and continued in at least one of 
the groups for the duration of the experiment. Unconjugated 
metabolites occurred almost completely in the sulphoxide form.
Their rate of excretion was low and did not exceed 2.5 fiig/hr for 
any horse, the average rate being aporoxinately 0,5 mg/hr over 
the 96 hour period. Unconjugated sulphide derivatives were 
detected in small quantity in only one case, (Horse 4), from 
approximately 32 hours after injection. On average, unconjugatcd 
metabolites accounted for less than 2;o of the dose.
Excretion of glucuronide conjugated sulphoxide derivatives 
also continued for at least 96 hours in five experiments, but one 
horse (7) showed no trace of such metabolites. Their average 
rate of excretion over 95 hours was less than 2mg/hr, Glucuronide 
conjugated sulphide metabolites were much more abundant.
However, horse 5 which was dosed twice, only showed trace amounts 
of such derivatives. The other four horses excreted variable 
amounts over eacti experiment and in no case were they detected by 
80 hours after injection, Glucuronide conjugates, on average, 
accounted for approximately 9/o of the dose.
Sulphate conjugated metabolites were only detected occasionally
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in trace amounts as sulphides after this route of administration. 
Typical examples of excretion of individual, groups of metabolites 
for the two total types of excretion are shown in Figures 18 and 
19.
The percentage of the dose excreted, and values for the 
separate metabolic fractions are given in Table 5. Glucuronide 
conjugates predominated in every case, their average ratio to 
unconjugated metabolites being approximately 5:1, The percentage 
of dose excreted was low for every horse, the average value being 
approximately 11/à.
(b) Oral Administration
Rates of excretion were plotted for three horses (4, 5, 8) 
after oral administration of promazine hydrochloride (10 mg/Kg, 
given as crushed tablets in treacle). The two total excretion 
patterns described after intramuscular administration were again 
noted. In one horse, (4)>a maximum rate (^55 mg/hr) was attained 
within 8 hours, which then decreased rapidly but regularly, 
excretion being complete by 48 hours. For the other two horses 
excretion started at a low level and increased gradually to a much 
less marked maximum (^25 mg/hr) between 16 and 24 hours after 
dosing. It then fell off rapidly and irregularly and was complete 
by around* 48 and 72 hours respectively. Patterns of excretion 
of individual metabolic groups gre shown in Figures 20, 21 and 22.
Unconjugated metabolites were again excreted almost entirely 
as sulphoxides although trace amounts of sulphide derivatives were
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found from one horse, (4) during the first 24 hours after 
administration. The percentage of the dose recovered in this 
fraction was low ('^ l/o), as were the rates of excretion (<6 mg/hr) 
Excretion of such metabolites was complete by 56 hours for horse '
B, and by 48 hours for horses 4 and 5.
Each horse excreted glucuronide conjugates metabolites 
almost entirely as sulphides, although traces of sulphoxide 
derivatives were noted in one experiment (Horse 4). Their rate 
of excretion was also so high compared to the other two fractions 
that it determined the shape of the total excretion pattern «
Horse 4 attained a maximum rate (^^45 mg/hr) within the first 8 
hours, whereas maxima were not observed for horses 5 andS until 
between 16 and 24 hours after administration, Glucuronide 
conjugated metabolites, on average, accounted for approximately 
7.5% of the dose and were detected until between 40 and 56 hours 
after dosing.
Sulphates were excreted in similar amounts to unconjugated 
metabolites, as sulphide derivatives, after this route of 
administration, although small amounts of the sulphoxide form were 
excreted by horse 8 between 56 and 72 hours. Their rate remained 
at a low level and attained 2,5 mg/hr in only three samples during 
the three experiments. They accounted for approximately 1.5% 
of the dose.
The percentage urinary excretion, and values for each 
metabolic fraction are given in Table 5, Glucuronide conjugated
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reached a maximum (^Img/hr) between 16 and 24 hours after
injection, and was complete by 40 hours.
Much smaller amounts of sulphate conjugated metabolites were 
detected accounting for approximately 1% of the dose. They existed 
almost entirely as sulphide derivatives, although traces of the 
sulphoxide form were excreted during the first 8 hours. Their 
excretion was complete by 32 hours after injection.
(d) Summary.
(i) After oral and intramuscular administration of promazine 
total rates of excretion either rapidly attained a maximum value 
within 8 hours, or slowly rose to a smaller maximum between 24 and 
32 hours, diminishing gradually and irregularly in both cases. 
Intravenous administration,which was carried out only once,produced 
a maximum rate within the first 8 hours.
(ii) The percentage of dose excreted after all three routes 
was low, being approximately 10}^ , Excretion of metabolites was 
most prolonged after intramuscular administration (>96 hr.) compared 
to an average duration of 56 hours for both oral and intravenous 
routes. Rates of excretion in successive samples were irregular 
after oral and intramuscular administration, büt were more regular 
after the intravenous route.
(iii) Glucuronide conjugated metabolites predominated after 
both oral and intramuscular administration, but were present in 
approximately equal amounts to the unconjugated fraction after the 
intravenous route. Sulphate conjugated metabolites were detected 
in only small amounts after all three routes. After oral and
intravenous administration they accounted for approximately 1/u 
of the dose, whereas intramuscular injection produced only trace 
amounts,
(iv) Unconjugated metabolites were detected almost 
entirely as sulphoxides, irrespective of route. Conjugated 
metabolites on the other hand, consisted predominantly of sulphide 
derivatives,
(2) Chlorpromazine
(a) Intramuscular Administration,
Rates of excretion over three experiments, (Horses 4, 5a, 5b), 
were plotted after intramuscular administration of chlorpromazine 
hydrochloride (2mg/Kg as a solution). However, neither of the 
total excretion patterns noted after intramuscular administration 
of promazine (Pg,141) was immediately obvious. On both occasions 
horse 5 attained a slight maximum rate between 24 and 40 hours 
after injection, (1.5 mg/hr between 24 and 32 hours for horse 5a 
and 2 mg/hr between 32 and 40 hours for horse 5b) and metabolites 
were detected until w  54 hours. Horse 4 attained a much higher 
rate of excretion. It rose to a maximum of 5,7 mg/hr between 16 
and 24 hours after administration, and excretion was not complete 
until 96 hours,
Glucuronide conjugated metabolites again appeared in greatest 
concentration, and were the biggest contributing factor to the 
total excretion pattern. Horse 5, on both occasions, excreted this 
fraction almost entirely as sulphoxide derivatives, although traces 
of sulohide metabolites were also detected. It excreted
-Lbb -
glucLfronides until /v 54 hours after injection, and, with the 
exception of one sample, their rate did not oxceed 1 mg/hr.
Horse 4, on the other hand, excreted glucuronides entirely in tho 
sulphide form up to 96 hours after injectiono The rate attained 
two maxima, of the order of 6 mg/hr, between 16 and 48 hours. 
Glucuronide conjugated metabolites on average accounted for 
approximately 8^ of the dose*
Unconjugated metabolites were excreted entirely as sulphoxide 
derivatives, and in all three experiments their rate of excretion 
was less than 0.5 mg/hr* This fraction was detected from horse 4 
for the duration of the experiment, whereas they were not excreted 
by horse 5 after 64 hours. Samples voided by horse 5a during the 
first 16 hours contained no trace of unconjugated metabolites, but 
they were subsequently detected until 56 hours after administration 
Such derivatives were responsible for approximately 1.2^ of the 
dose.
In all three experiments only trace amounts of sulphate 
conjugated metabolites were found almost entirely as sulphides. 
Excretion patterns of individual metabolites are shown in Figures 
24, 25 and 26.
Table 6 shows percentages of dose excreted as individual 
metabolic groups and once more bears out the predominance of 
glucuronide conjugates. Their average ratio to unconjugated 
metabolites was approximately 7:1, The total percentage excreted 
was also low at 10/^ . An interesting feature of the results is 
the considerably higher rate of excretion of glucuronides by horse
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4 compared to the other animals,which was also noted after 
administration of promazine^ (Pg*14o)
(b) Oral Administration*
Chlorprontazine hydrochloride, (5 mg/Kg, given as crushed tablets 
in treacle), was administered orally to horses 5 and 7, the latter 
being dosed twice, and excretion of metabolites was followed over 
96 hours* Two types of total excretion were obtained similar to 
those experienced with promazine. Horse 5 attained a maximum 
rate (/v35 mg/hr) within 5 hours which then fell off gradually and 
irregularly, and no metabolites were detected after 00 hours.
Horse 7, on the first occasion, attained a maximum rate (31.6 mg/hr) 
between 8 and 16 hours after administration, with a second maximum 
( 3Q mg/hr) between 24 and 32 hours. In the second experiment 
the maximum also occurred between 24 and 32 hours but was much 
smaller (14,8 mg/hr). For this horse the lengths of excretion 
were 95 and 80 hours respectively* Individual excretion patterns 
for each of the experiments are shown in Figures 27, 28 and 29, 
Glucuronide conjugated metabolites, again forming the main 
fraction, were the deciding factor in the shape of tha total excretion 
pattern. They were present almott entirely in the sulphide form 
although small amounts of sulphoxide derivatives were detected 
from horse 5, For all three experiments glucuronides were excreted 
for longer than any other group (80-9ohr) and, on average, accounted 
for 23/ of the dose.
The unconjugated fraction were excreted almost entirely as 
sulphoxides, although small amounts of sulphide derivatives were
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detected from horse 7 between 48 and 64 hours. Their rate of 
excretion never exceeded 3 mg/hr and they were not found after 72 
hours from either horse*
Sulphate conjugated metabolites were present in amounts 
similar to the unconjugated fraction, ( /v 1,5^), almost entirely 
as sulphides, although small amounts of sulphoxide derivatives were 
occasionally detected. With the exception of one sample their 
rate of excretion was less than 2,5 mg/hr, and was complete by
r
between 72 and 80 hours.
Table 6 shows the percentages of dose excreted as individuaal 
metabolic groups. Glucuronide conjugated metabolites again formed 
the major fraction having a ratio to the other groups of approximately 
18:1:1, A greater percentage of dose was recovered after this 
route than after intramuscular administration of chlorpromazine, 
accounting for approximately 27^*
( c ) Summary
(i) Both types of total excretion pattern noted after 
administration of promazine were noted after oral administration 
of chlorpromazine. However only the second type was found after 
the intramuscular route. The percentage of the dose excreted was 
low being approximately 10^ after intramuscular injection, and 27^ 
for the oral route.
(ii) Glucuronide conjugated metabolites were the predominating 
fraction occurring mostly as sulphide derivatives. In one horse 
this group was excreted predominantly in sulphoxide form, but this 
seems to be a metabolic abnormality peculiar to the horse (Pg,187),
“  i D O
Sulphate conjugated metabolites also were found almost entirely 
qs sulphides and unconjugatsd metabolites as sulphoxides. Only 
trace amounts of sulphates were detected after intramuscular 
administration, whereas they accounted for approximately 1*5^ of 
the dose after the oral route* The ratios of glucuronides to 
sulphates to unconjugated metabolites after oral and intramuscular 
administration were 18;1;1 and 7:0:1 respectively,
(iii) As with promazine, excretion of chlorpromazine was 
prolonged and irregular, lasting up to 95 hours after oral 
administration and 64 hours after the intramuscular route,
(3) Acepromazine and Propionylpromazine,
As previously described, (PgjLDS) phenothiazine derivatives 
having a ketone group in conjugation with the aromatic ring, (i,e* 
acepromazine and propionylpromazine), have different ultra violet 
spectra to those of derivatives lacking this combination, (i.e. 
promazine, chlorpromazine, etc,) The former compounds have two 
absorbance maxima at approximately 240 and 280 mjj, and their 
corresponding sulphoxides produce two peaks at ^  250 and 310 njju.
The latter, on the other hand,absorb at ^250 and 300 mjj, and their 
sulphoxides produce four peaks at approximately 230, 270, 300 and 
340 -mjj.
During initial studies on acepromazine, extracts of metabolites 
produced neither of the spectra described for derivatives of this 
compound, but unconjugatsd metabolites had ultra violet spectra 
with four peaks at 230, 270, 300 and 340 ry' corresponding to that 
of sulphoxide derivatives of promazine (Figure 30), This suggested
FIGURE 30
1-6
LU
U
<
QÛ
a:
s
<
1-2
U.V. SPECTRA
1 /
'I
0*8 • \
I
0*4
\
UNCONJUGATED ACETYLPROMAZINE 
METABOLITES
ACETYLPROMAZINE
SULPHOXIDE
\
\
/ I
' A ' VV
A  A /
\
260 300
WAVELENGTH
340
fh=3v 6! tc'i dcir:" tiv-r.-, rmve n i t r In^u th-2 pida clinin c^rnun
pt. the 2-nppition c n 0 ehely ^ or th't l:hi.p ?uhs titue n hep b-’Pn 
reduced 'oi tl ie ccrTrpu.-r ,dtn'] spcnnd-try olcnhgl ^ - cocue roinr) in eithe:
case by nuidc tion to the sulyhoxido Torru The no no rot for^nulre of 
sun h n r o !uc ts 2 rn i
R
CH(OH)Me
0
Since both these co lyuionr's ni\re ultra w i d o t  s^'octra sijnilar 
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typical of the situation prawiously u-scribed (Pg, 112) uJiarc 
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visible spectra of standard solutions of acepromazine treated with 
sulphuric acid. Conjugated metabolites of propionylpromazine were 
also assayed in this manner.
(a) Intramuscular Administration «
Excretion patterns were platted after intramuscular administrati< 
of acepromazine maleate, (0.5 mg/Kg as a If^  solution), to horses 
4, 5 and 8. Also, to confirm that the excretion data, and 
metabolic routes found for acepromazine were typical of phenothiazine 
derivatives with a conjugated ketone grouping, a similar dose of 
propionylpromazine (as the phosphate) was subsequently administered 
to horse 7. Urine collections in this case were made twice daily 
for 5 days after injection, and 100 ml aliquots from each sample 
were analysed.
For both drugs, unconjugated metabolites predominated in the 
form of sulphoxide derivatives of promazine. The rates of 
excretion after administration of acepromazine were low, being less 
than 0,25 mg/hr throughout the three experiments, and were not so 
irregular as with promazine or chlorpromazine. Two types of total 
excretion pattern were again obtained. Horses 4 and 8 attained a 
maximum rate (/v 0.2 mg/hr) within 8 hours of injection, whereas for 
horse 5 the rate rose to a slight maximum (0.25 mg/hr) between 8 
and 16 hours. In all three cases excretion then tailed off 
gradually and was complete by 32 hours. Excretion patterns for 
the three horses are shown in Figure 31. Metabolites of 
propionylpromazine, almost entirely as unconjugated derivatives, 
were readily detected up to 54 hours after injection and were
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presont in trncs a-nount-- at 75 hours. Table 7 gives data conoprning 
the concentrations found in each sa'solc after administration or 
this drug,
G-lucuranida and sulphate conjugated metabolites of both drugs 
uere present in only trace amounts^ indicating that metabolites 
remain unconJugoteri after this route of adriinistration, Table B 
shoi-is the percentage of the dose excreted in each of the metabolic 
groups * Cnee more, percentages wore 1 on, the average for acenrcmazin 
being 5'%
( b ) 0 r a J _ gi -ajgt nrg«
Acoproenzine naleqte (1 mg/Kg^ gtvan as crushed tablets) was 
administered orally to horses 5 and B. the former being dosed ori 
two occasions, Gn plotting the total rates of excretion against 
time) only tho first type of pattern obtained after promazine 
administration (Go, l^G) was noted, with slight maxima of between 
0,5 and 1 mg/hr during the first a hours. However, both types 
of excretion wp.re found for unconjugated metabolites, I'f ich again 
predominated, ■ In this fraction horses 5s and 8 attained maximum 
rates, (a^DoQ anri 0,4 mg/hr respectively), between G and 16 hours 
whereas horse 5b achieved a slight maximum (^0,4 mg/hr) within 
8 htours. Excretion patterns for individual groups of metabolites 
are shown in Figures 52, 35 and 34,
The uncnnJugeted fraction w-s again excreted as sulphoxide 
derivatives of pro-'vazine and, i-.dth the exceitj.on cf one ser-ple, 
their rate did not exceed 0,5 mo/hr thra,uohnut the terse sxoeri-.ent e.
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They were detected up to 40 hours after administration and accounted 
for approximately 2% of the dose. Sulphate and glucuronide conjugatt 
metabolites, on the other hand, were found only during the first 
32 hours after dosing, representing 1,1^ and 0.8^ of the dose 
respectively.
Table 8 shows the percentage of the dose of acepromazine 
excreted as the different metabolic groups in individual experiments.
Of interest are the low percentage total excretion (^^4^), the 
presence of sulphate conjugated metabolites after this route of 
administration and the predominance of unconjugated
. metabolites {^2%)* The average ratio of unconjugated to 
conjugated metabolites was approximately 1:1,
(c) Metabolism of Acepromazine by the Don,
Since an extensive literature survey revealed no previous 
reports on the metabolism and excretion of acepromazine or 
propionylpromazine, it was decided to investigate whether the 
routes of metabolism found for such ketonic derivatives are peculiar 
to the horse or are found in other species. Thus a series of 
experiments was undertaken to study the metabolism and excretion 
of acepromazine by the dog,
Acepromazine maleate was administered either orally (0,5 mg/Kg 
given in tablet form), or intramuscularly (l mg/Kg as a 1^ solution) 
to a series of 6 dogs, comprising 3 greyhounds and 3 mongrel breeds.
Dogs were housed in a metabolism cage to allow collection of urine 
over 24 hours, 500 ml aliquots from each 24 hour sample were 
analysed for the six metabolic groups as described for the horse, (Pq *io.
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It VJBS found bt.et notaholitno wore Bxcrntnrl in small 
concentration after either routa nf actiinistratinn, Unconjugatsd 
metabolites wars detected as sulnhoxiHc dorivativos of promazino, 
and both conjugated fractions n r o u U C R d  ultra violet spectra with 
maxima varying from sarnpls to sample as experienced with the horse. 
Thus metabolism of acepromazine appears tn be similar for both the 
horse and the dog*
(d) Summary.
(i) Acepromazine and propionylpromazine undergo two major 
routes of metabolism. They either lose the side chain ketone group 
at the 2-position and are not further conjunatecJ or retain t''is groi'p 
and are conjugated with glucuronic or sulphuric acid* Sul.nhoxirie 
formation ta[<es place in the unconjugsted fraction which predominates
(ii) After in ramuscular administration of acepromazine, 
both types of total excretion pattern obtained with promazine 
wore noticed, uihereas only the first type was evident after the 
oral route* In both cases the fall off in excretion was much 
mors regular than for the other compounds investigated, and no 
metabolites were detected after 40 hours *
(iii) Unconjunated derivatives accounted for almost all 
metabolites detected after intramuscular ad'oinistration 1*3," of 
dose), and aporoximately half the amount excreted after the oral 
route, when total recovery was approximately of the nose*
A , Com n ,amrison of '-a ta be 1 i ^qf J:he pf Bren t 0 r u os ,
(a) Con luxation of ietahrlites.
The metabolic routrs followed by each dru^ were found to decand
on the substituents on the nucleus. Thus promazine and chlor­
promazine, and presumably other derivatives in which there is no 
ketone grouping in conjugation with the aromatic ring, are excreted 
predominantly as glucuronide conjugates. When promazine or 
chlorpromazine was administered intramuscularly the average ratio 
of glucuronides to unconjugated metabolites was approximately 5:1, 
and after oral administration the corresponding ratio was 
approximately 10:1, Acepromazine and propionylpromazine on the 
other hand, are metabolised and excreted predominantly in the 
unconjugatsd form as sulphoxide derivatives of promazine. After 
intramuscular administration of acepromazine the conjugated 
fractions were found in only trace amounts, and after oral dosing 
the ratio of glucuronides to sulphates to unconjuqated metabolites 
was 3:4:8.
(b) Percentage of dose excreted.
The percentage of dose excreted also varied from compound to 
compound, metabolites of chlorpromazine being detected in greatest 
amounts. After oral administration of this drug approximately 
21% of the dose was excreted, compared to id^ for promazine and 
4^ for acepromazine, and after intramuscular dosing the corresponding 
figures were 10/, 11/ and 1,3/, This order for the percentage of 
each drug excreted, (i.e. chlorpromazine > promazine >  acepromazine), 
cannot be related to the size of dose administered, since this 
decreases in the order promazine ^ -chlorpromazine p> acepromazine, 
the ratio being approximately 10:5:1, The percentage also takes 
into account differences in the size of dose.
(c) Duration of Excretion.
The duration of excretion of the different drugs was found to 
decrease in the order promazine > chlorpromazine > acepromazine, 
and this may possibly be related to dose. The determination of 
lengths of excretion is governed by the limits of detection of the 
procedure used. Using the more sensitive methods of thin layer 
chromatography it has been shown that metabolites can be detected 
for approximately 24 hours longer than by ultra violet analysis, 
(P9*198)> and length of excretion again appears to be related to 
dose.
After intramuscular administration of promazine, excretion 
lasted at least 96 hours in every experiment, whereas metabolites 
of chlorpromazine were only detected for this length of time on 
one occasion, and no evidence of acepromazine derivatives was 
found after 32 hours. After oral administration, excretion of 
promazine and chlorpromazine lasted between 72 and 96 hours and 
acepromazine metabolites were detected up to 40 hours,
(d) Total Excretion Rates,_
Total rates of excretion of acepromazine metabolites with 
one exception, (Horse 5 after intramuscular administration), attained 
a maximum within 8 hours, and thereafter fell off regularly as would 
normally be expected. After administration of chlorpromazine 
this type of excretion was only noted on one occasion, (Horse 5 after 
oral administration), and the fall off was much more irregular. 
Instead, the rate tended to rise slowly and irregularly to a maximum 
between 16 and 40 hours, diminishing in a similar fashion. Two 
distinct types of excretion were noted for promazine, the first
corresponding to that found for acepromazine, but with a much 
more irregular fall, and the second rising slowly to a maximum 
between 16 and 32 hours then decreasing irregularly.
5* Effects of route of administration on excretion.
The presence of measurable quantities of sulphate conjugated 
metabolites after oral administration appears to be the most important 
difference between this route and intramuscular injection. Following 
oral administration of promazine,sulphate conjugated metabolites
r
represented approximately 1,4/ of the dose, and corresponding
percentages for chlorpromazine and acepromazine were 1.3/ and 1,1/,
After intramuscular administration, in every case, sulphate conjugated 
metabolites were found in only trace amounts. This fraction
accounted for 1,2/ of the dose after intravenous administration of
promazine. This will be discussed later (Pg.269),
A further d ifference between oral and intramuscular 
administration was the much larger proportion of the dose excreted 
after the oral route. This was most noticeable for chlorpromazine 
or acepromazine. For chlorpromazine there was a clear difference, 
the total percentages excreted being 27/ after oral administration 
and 10/ by the intramuscular route. Corresponding percentages for 
acepromazine were 4/ and 1,3/, With promazine, however, the 
average percentages of the dose excreted were approximately the 
same for both routes, being 10i after oral, and 11/ after intramuscular 
administration.
Figures 35, 36 and 37 show the percentages of dose excreted 
over successive 8 hour intervals after different routes of administration
of promazine, chlorpromazine, or acepromazine. For all three 
drugs metabolites were excreted in greater amounts after oral 
administration during the first 32 hours than after intramuscular 
injection. Thereafter the rate was approximately the same for 
both routes. After intravenous administration of promazine rates 
of excretion were of the same order over the first 32 hours as 
for oral administration.
Other differences noted were in the lengths of excretion after
r
the different routes. After intramuscular administration of 
promazine, metabolites were detected for at least 96 hours in every 
experiment, whereas after oral dosing excretion was complete by 
64 hours. The corresponding length of excretion after intravenous 
administration, determined in a single experiment,was 43 hours.
For chlorpromazine,excretion lasted between 80 and 96 hours after 
oral, and, with one exception, for 64 hours after intramuscular 
administration. The length of excretion of metabolites of 
acepromazine was approximately the same for both routes of 
administration, being 40 hours after oral dosing and 32 hours after 
intramuscular injection,
6, Comparison of Individual Horses,
The amounts and types of metabolites excreted during these 
experiments could neither be related to the age nor the sex of the 
horses. However peculiarities were occasionally noted for 
individual animals.
(a) Excretion by Horse 4.
Horse 4 excreted metabolites in much greater amounts than
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other horses. After intramuscular administration of promazine 
urinary metabolites accounted for approximately 22/o of the dose 
which was more than twice the percentage excreted by other horses* 
Similarly, after oral administration of promazine it excreted 
13,6/0 of the dose, whereas horses 5 and S excreted 9,3% and 7*4% 
respectively. Corresponding percentages after intramuscular 
administration of chlorpromazine were 18,5% for horse 4 compared 
to 5,5% and 4,6% for horse 5.
The larger percentages appear to be due to a larger excretion 
of the glucuronide conjugated fractions by this horse. After 
intramuscular administration of promazine it excreted 18,1% of the 
dose in this form compared to an average of 7.4% for the other 
five experiments (9,6%, 7,8%,7,5%, 6,1 • and 5,9%), The 
corresponding figures after intramuscular chlorpromazine were 
17.2% compared to 4,8% and 3%, and after oral administration of 
promazine were 11,2% compared to 5,2% and 6%, Percentages excreted 
in the unconjugated form ware of the same order within each series 
of experiments, as was the case for. the sulphate fraction.
After intramuscular administration of chlorpromazine, horse 
4 excreted metabolites for at least 95 hours whereas no metabolites 
were detected from the other two horses after 64 hours. However 
after both routes of administration of promazine the length ofexcretio 
by all horses (including horse 4) was of the same order within each 
series of experiments (95 hours after intramuscular and 54 hours 
after oral administration). Thus the larger amounts of metabolites 
excreted by horse 4 must be due to a greater rate of metabolism and
187
not to prolonged excretion of metabolites^
Unconjugated metabolites of promazine and chlorpromazine were 
excreted by most horses entirely as sulphoxide derivatives. Horse 
4 however once more proved an exception. After intramuscular adminis­
tration of promazine it also excreted this fraction in the sulphide
form from 32 hours after injection until the end of the experiment, 
and after oral administration such derivatives were detected during 
the first 24 hûurs. However, the larger percentages of metabolites 
excreted by this horse were not a reflection on the presence of 
these sulphide derivatives. Unconjugated sulphide metabolites 
were also excreted in trace amounts by Horse 7 from 48 to 72 hours 
after oral administration of chlorpromazine,
(b) Excretion of coniugotsd metabolites,
Glucuronide conjugated metabolites of promazine or chlorpromazine, 
as a rule, were excreted almost entirely as sulphide derivatives.
Horse 5,however, after intramuscular administration of chlorpromazine 
excreted this fraction predominantly in the sulphoxide form, only 
trace amounts of sulphide derivatives being detected. It also 
excreted glucuronide conjugated sulphoxide metabolites after oral 
administration of promazine or chlorpromazine, and after intra­
muscular administration of promazine.
Similarly, although sulphate conjugated metabolites of 
promazine or chlorpromazine were normally excreted almost entirely 
in the sulphide form, small amounts of sulphoxide derivatives were 
occasionally detected. They were excreted by horses 5 and 7 
between 4C and 64 hours after oral administration of chlorpromazine
and ware also found towards the end of excretion of the sulphate 
fraction after oral administration of promazine to horse 8 (56 to 
72 hours after dosing,)
(c) Consistency of excretion patterns for individual horses,
The consistency of patterns of metabolism and urinary excretion 
for individual horses was investigated on three occasions by repetitio 
of experiments. Comparison of results from such duplicate 
experiments showed that, for the most part, metabolism and excretion 
proceeded along similar lines.
Horse 5 received promazine intramuscularly on two occasions.
The respective percentages of dose excreted were similar, (9,1% and 
7,1%), but the ratio of the glucuronide fraction to the other two 
fractions combined was considerably different,- On the first 
occasion this was ^^2:1,whereas on the second occasion, the figure 
was /w 6:1. In both experiments unconjugated metabolites were
excreted as sulphoxides up to 96 hours. However traces of sulphide 
derivatives, absent in the first experiment, were detected during 
the first 40 hours on the second occasion. In both cases glucuronide 
conjugated sulphoxides were excreted over 96 hours although traces 
of sulphide derivatives were also found during the first 32 hours of 
the second experiment. Sulphate conjugated metabolites were found 
in only trace amounts on both occasions.
This horse also received chlorpromazine intramuscularly on two 
occasions. Again the total percentages excreted (5,5% and 4,6%) 
were similar, whereas some difference existed in the ratio of 
glucuronides to the other fractions (7:1 and 2:1), In both cases
unconjugatsd metabolites were excreted entirely in sulphoxide 
form although, in the first experiment,samples collected during 
the first 15 hours contained no trace of this fraction. Similarly 
glucuronide conjugated metabolites were excreted on both occasions 
as sulphoxides up to 55 hours after injection. The corresponding 
sulphide derivatives were found in only trace amounts. As already 
described, excretion of glucuronide conjugates in the sulphoxide 
form seems to be a peculiarity of this horse (Pg.lSV).
Horse 7 received chlorpromazine orally on two occasions.
In this case the percentages of the dose excreted differed 
considerably, being 39.5% and 15.6%, However, the ratio of 
glucuronide to unconjugated metabolites was similar (^22:1 and 16:1)* 
In both cases unconjugated metabolites were excreted in the 
sulphoxide form for approximately 72 hours, although traces of 
unconjugated sulphides were found during the first experiment 
between 43 and 72 hours of dosing, Glucuronide conjugated 
metabolites were excreted entirely as sulphides over 80 hours on 
both occasions. Sulphates were excreted predominantly as sulphide 
derivatives for 56 hours on the first occasion and for 72 hours 
in the second experiment. However, in both cases trace amounts 
of sulphoxides were also detected when excretion of this fraction 
was almost complete. These results are summarised in Table 9,
7, Initiation and Termination of Excretion.
In addition to pooling urine samples over 8 hour periods,
100 ml aliquots from the first sample voided after drug administration 
were analysed in an attempt to determine how soon metabolites‘were
TABLE 9
Experiment Horse Drug Route % Excreted Ratio* Unconjugated Glucuronides Sulphates
1 5 Promazine I.M. 9,1 2:1 SO SO Trace
2 7.1 6:1 SO SO Trace
1 5 Chlorpromazine I.M. 5.5 7:1 SO SO Trace
2 4.6 2:1 SO SO Trace
1
7 Chlorpromazine Oral
39.5 18:1 SO S sm
2 15.6 8:1 SO S S «
* Denotes ratio of glucuronides to other two fractions, SO = Sulphoxides. S = Sulphides,
Table 9. Comparison of Duplicate Experiments on Individual Horses.
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excreted. Also, in experiments where excretion had previously 
been found to last for at least 96 hours, collection was continued 
up till 102 hours and thereafter at 24 hour intervals until 
metabolites were no longer detected.
Such experiments have shown that, for the most part, excretion 
of metabolites does not commence until between 2 and 4 hours after 
administration. After intramuscular administration of chlorpromazine 
to horse 5, no metabolites were found in the first two pooled eight 
hour samples, whereas on the second occasion they were detected 
within 3 hours in the first sqmple voided. Initiation of.excretion 
for the other horse (4) dosed in this manner was within 4 hours of 
injection.
During all three experiments after oral administration of 
chlorpromazine, metabolites were detected in the urine within 4 
hours of dosing. The first sample obtained from horse 7 on each 
occasion, at 30 minutes and 1 hour respectively after administration, 
contained no metabolites.
After oral, intramuscular, or intravenous administration of 
promazine, excretion of metabolites did not commence until between 
2 and 4 hours. A sample was obtained from horse 5 within 40 
minutes of oral administration but it contained no metabolites. 
However, on both occasions that this horse received an intramuscular 
dose of promazine, excretion hid commenced in samples collected 90 
minutes after administration.
Metabolites of acepromazine, with one exception, were detected 
within 3 hours of administration. No urine was voided by horse 
4 until 16 hours after intramuscular injection, but the first sample
had a strong concentration of metabolites. Also a sample 
collected from horse 5 within 90 minutes of intramuscular 
administration, contained measurable amounts of metabolites.
In experiments where metabolites were excreted over 56 
hours, (i.e. intramuscular injection of promazine or chlorpromazine), 
they were still detectable at 102 hours after administration, but, 
in every case, excretion was complete after a further 24 hour 
period,
8o Urinary Volume and dH,
As previously described,both urinary volume and pH were 
measured for each sample passed. On average, samples were 
obtained every 3 hours. However, occasionally two samples were 
obtained within 1 hour , and, on one occasion 16 hours elapsed before 
the first sample was passed. Also urine was excreted much more 
frequently between 10 p.m. and 10 a.m., but this did not result 
in an increase in urinary volume over the period.
Volumes of urine collected over successive 8 hour intervals 
ranged between 1000 and 2500ml, and the average volume voided was 
approximately 1600 ml. Individual samples ranged in volume from 
200 to 1500 ml. However, on several occasions volumes of less 
than 100 ml were obtained, and on one occasion 2500 ml was voided. 
There was no relation between frequency of excretion and the 
volume of urine passed.
On several occasions it was noted that the frequency of 
excretion was much less during the first 24 hours after drug 
administration than for the remainder of the experiment. It was
thought that this might be due to an antidiuretic effect of such 
drugs on the horse. To clarify the situation urine collections 
were made from three horses for 24 hours before drug administration, 
and volumes were compared with those subsequently passed. As can 
be seen from Figure 38, there is a decrease in urinary volume in 
every case during the first 24 hours. However, this could be due 
to a decrease in water intake during the maximum effects of the 
drug,
r
Urinary volumes were also compared after oral and 
intramuscular administration of each drug to investigate any 
relationship between them and the greater percentages of doss 
excreted after oral administration* Figure 39 shows the average 
urinary volumes passed over successive 8 hour intervals after oral 
or intramuscular administration of chlorpromazine. However, no 
obvious difference can be seen between the volumes voided after 
each route. This was also true for acepromazine and promazine.
The pH of urine samples, varied between 7,0 and 8.5, However, 
occasionally it varied between 5 and 7 over a whole experiment, 
but was not related to an increase in amounts of metabolites
t
excreted. Table 10 shows the volume, pH, and rate of excretion for 
successive 8 hour samples over the first 48 hours after administration 
of chlorpromazine. As can be seen there is no obvious relationship 
between the rates and the volume or pH of the samples. This was 
also true for promazine and acepromazine. After intramuscular 
administration, several samples from horse 4 had a.pH of less than 
7 and rates of excretion were greater than in corresponding samples
PIGURB 38.
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from horse However, samples with a pH of more than 7 also
produced greater rates of excretion than horse 5# As previously 
described (pg,182) greater rates of excretion than normal at pH 
values above 7 were a noticeable feature of metabolism by Horse 4. 
Thus the increased rates must be attributed to some other aspect 
of metabolism by the horse, and not to the acidic pH of its urine.
8. Summary*
(i) Two^typos of excretion were noted. In the first the rate 
reached a maximum within 8 hours of administration, whereas the 
second type rose slowly to a maximum between 16 and 40 hours. 
Acepromazine, followed the first course, whereas both patterns 
were noted after administration of promazine or chlorpromazine.
(ii) Percentages of dose recovered were low, being 
approximately 19^  ^for chlorpromazine, lO^ o for promazine, and 3^ 
for acepromazine. Excretion of promazine and chlorpromazine was 
also prolonged, in certain cases lasting more than 96 hours. No 
metabolites of acepromazine were detected after 40 hours,
(iii) Using promazine or chlorpromazine conjugated metabolites 
predominated, whereas, after administration of acepromazine or 
propionylpromazine, the unconjugated fraction was in greatest 
evidence. Sulphate conjugated derivatives of each drug were 
present in small amounts and were only detected in trace quantities 
after intramuscular administration,
(iv) Unconjugated metabolites of promazine and chlorpromazine 
were mostly in the sulphoxide form, whereas glucuronides and sulphate;
wereexcreted as sulphides. On the other hand, acepromazine 
and propionylpromazine were metabolised in the unconjugated 
fraction as sulphoxide derivatives of promazine and in the 
conjugated fractions as a mixture of sulphide and sulphoxide 
metabolites of the parent drug.
(v) The percentage of dose excreted decreased in the order 
chlorpromazine > promazine > acepromazine, whereas the duration 
of excretion^fell off in the order promazine >  chlorpromazine> 
acepromazine.
(vi) Larger percentages were recovered after oral 
administration than after intramuscular injection.
(vii) No relation was found between amounts or types of 
metabolites excreted and the age or sex of the animals.
In duplicate experiments on individual horses metabolism and 
excretion proceeded along similar lines although several differences 
were noted.
(viii) Excretion of metabolites commenced between 2 and 4 
hours after administration,and when excretion lasted longer than 
96 hours no metabolites were detected by 126 hours. No correlation 
was found between urinary volume, pH and amounts of metabolites 
excreted,
C# Qualitative Studies of Metabolism,
Excretion of metabolites was also followed over successive 8 
hour intervals using thin layer chromatography. This technique
provided separation of individual metabolites for subsequent structur 
determination. 300 ml aliquots from each 8 hour sample were 
extracted for chromatography as previous’y described (Pg. 113),and 
spotted on consecutive 1 cm. strips of a chromatography plate. 
Development and subsequent colour formation gave a qualitative 
picture of excretion of individual metabolites. The residual urine 
was pooled, and used for further structural determination,
(l) Metabolism of Promazine,
(a) Unconjuoated Metabolites,
Figure 40 shows a typical chromatogram of unconjugated 
metabolites extracted after intramuscular administration of promazine 
hydrochloride. Marked variations exist in the concentration and 
number of metabolites detected in successive samples. In some 
cases even larger variations in intensity were noted, occasionally 
to such an extent that a metabolite excreted during the initial 
stages of an experiment was not detected in a few subsequent samples, 
but later reappeared. This was specially true of metabolites PI 
and P3, and was noticed once for P2. In addition, trace amounts 
of metabolites other than those recorded were occasionally detected. 
The most commonly occurring had Rf values of 0.73 (Ql) (i.e. between 
Ml and P5) and 0,23 (Q2) (between PI and P2) in the methanol/acetic 
acid/water system,and gave a reddish pink colour with sulphuric acid. 
At least seven unconjugated metabolites were detected by 
their colour reaction with 50y^  sulphuric acid, and their fluorescence 
under ultra violet light. Further investigation of their 
structure was carried out by comparison with known standards in three
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solvent•systems, the use of specific spray reagents, and elution 
techniques (Pg.lis). A summary of the results is shown in Table 11.
Of the seven metabolites detected, three have been positively 
identified* P2 had the same Rf values as promazine sulphoxide, 
(0,39, 0,03 and 0,6l), in each solvent system and, on elution 
with 0*1N hydrochloric acid, its ultra violet spectrum corresponded 
to that of a sulphoxide derivative of promazine. It had a pink 
colour react,ion with 50^ sulphuric acid, and no reaction was 
observed using the periodate spray, confirming the absence of a 
hydroxyl function* No colour was observed with the ferric chloride 
solution, confirming the oxidation of the ring sulphur to the 
sulphoxide form, and tests for déméthylation of the side chain using 
ninhydrin or nitroprusside sprays were also negative. It was thus 
concluded that this metabolite was promazine sulphoxide.
Spot P4 was identified as the parent drug. Both compounds ran 
to the same heights in the systems used and, on elution, this 
derivative had an ultra violet spectrum identical to that of 
promazine. A reddish pink reaction with sulphuric acid, and no 
reaction with sodium periodate, indicated that hydroxylation had 
not occurred. A reddish pink reaction to the ferric chloride spray 
confirmed that the ring sulphur atom was unoxidised, and tests for 
déméthylation using ninhydrin or nitroprusside both proved negative.
The Rf values for Ml, (0.63, 0.14, and 0,93) were almost 
identical to those of 3-hydroxy promazine, (0.61, 0*15, 0,93), 
and its ultra violet spectrum correspond to that of a sulphide 
derivative of promazine. The presence of a hydroxyl function was
confirmed with both 50^ 4 sulphuric acid and sodium metaperiodate.
There was no evidence of déméthylation using either of the specific 
amine spray reagents, and a reddish pink coloration with the 
ferric chloride spray confirmed that the compound was unoxidised 
at the sulphLir ptom. Thus Ml was identified as 3-hydroxy promazine* 
Due to a lack of reference standards the other four metabolites 
were not completely identified. Spots PI, P3 and P5 produced a 
pink coloration with sulphuric acid, and their ultra violet 
spectra were typical of sulphoxide derivatives. This was 
confirmed by a lack of reaction with the ferric chloride spray.
There was no evidence of déméthylation or hydroxylation. Spot 
M2, on the other hand, had a purple reaction with both sulphuric 
acid and periodate indicating that it was hydroxylated, It had 
a reddish pink reaction with the ferric chloride spray, and its 
ultra violet spectrum was typical of a sulphide derivative. There 
was no evidence of déméthylation.
Thus the unconjugated urinary metabolites of promazine in 
the horse are promazine sulphoxide (P2), 3-hydroxpromazinG (Ml), 
the parent drug (P4), three sulphoxide derivatives which do not 
appear to be demethylated or hydroxylated (PI, P3, PS), and a 
hydroxylated derivative occurring in the sulphide form (M2),
(b) Glucuronide Conjugated Metabolites.
Figure 41 shows a typical chromatogram of glucuronide 
conjugated metabolites of promazine excreted over successive 8 
hour intervals after intramuscular administration. The
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metabolites shown srn no!: the "ctuol oonjugato"' forms, but thoir 
Q 0 n i. n 0 n b t i n e d o f t o i" h y d r .1. y sis utith ^ -glucuronidase. As w i t h 
the unconjugated metabolites, excretion iras still detectable at 
95 hours, although variations in intensity end num'oers of spots 
from saiepl-3 to sample Mora not so marked.
At least 11 metabolites mere teci.ed using tlie sulphuric acid 
spray and fluorescence under ultra violet light, six of which,(Xl - X5), 
constituted the major fraction. Spots XI - X5 reacted both ujith 
sulphuric ecid end periodate indicating that hydroxylation had 
occurred. X6,on the o ther hand, showed no evidence of hydroxylation * 
done of the metabolites showed any reaction with ninhydrin 
or nitroprusside sprays, Each spot was eluted with O.lTl 
hydrochloric acid and the ultra violet spectra of the eluates were 
recorded. XI, X2, X4 and X5 had spectra typical of sulphide 
derivatives of promazine, i'.? he re as those of X3 and X5 corresponded to 
the sulphoxide for:'!. Their reaction, or lack of reaction, with 
ferric chloride solution confirmed these states of oxidation,
X5, tha major metabolite, had similar Rf values, (0.40, 0,53,
0,60)j in each solvent system to 3-hydroxy-promazina, (0,41, 0,55,
0.6l), and, as previously described, behaved chemically as a 
hydroxylated sulphide derivati'va. Furthor confirmation of the 
position of hydroxylation mas obtained by elution of X5 with 
methanol, and subsequent reaction with 50 '. sulphuric acid as described
by Feckett, Curry and Salt, (1964), The combined ultra violet and 
visible spectrum of the product had ' axi -e at 2^3, 343, 37? 563 np
di f farm t im tire it fro: tha 2- and 4.. dariuativsa by the neat at
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372 wj.u The reaction else otto in ted witti the other five 
metabolites but it w^ -s imnonsihle to isolate nnongh of each to 
ohtein a sotisf h c tf'ry spec tri.'c ,
Thus, after artiii li s tral ion of n rum a zinc hydrochloride to the 
horse, at least 11 netnboil:os are excreted conjugated with 
glucuronic acid* Six of these,XI - X6,btere tec tod in every 
sawnle en,;.lysed, XS tuas ic'snti f i ed as 3-hydroxy nrcnazinc and 
corrosponr.'s to spot dl in the uneonjugâter! fraction. Spots XI - X4 
lusro also hydroxylated but due to a lack of reference standards,
and difficulty in elution, the exact position of hydroxylation in
teach ii'etabolite cocO.d not be do to rained* XI, X2 and X,4 ere sulphid'^
derivatives, 'jheress X3 is in tlio sulphoxide foru, and none of the.n 
apnoaror! tn be do'lathy 1 aten * The rr\:ioinj.ng matabolite, (X5 ), 
shows no evidence of da^ 'iOt'^ 'ylation, and is in the sulphoxide form. 
Conjugation could taka pl^cs through a side chain hydroxyl group Ljhict 
would have no reaction with the periodate spray, Tha other 
metabolites only snoesred occasionally end tended to give e hi.Lie 
coloLirotinn with sulphuric acid compared to the purple snots of 
tha hydroxy 1 ato• ! dari\jn t ive.s airc -idy racorderJ, Tha chgr.ica 1, 
spectral and cliro .latcgraphic properties of the glucuronide 
nietabol.i'.os are shown in Table 12,
( c ) 3 LI .11 h a ta con )u ■-1 eted n e t =' h o 1 i t e s ,
Sulphate conjugated metabolites war? detected in only small 
amounts after intramuscular a'',-'inistration, during the first 4:1 hours. 
Four '■^p.tabclitr0 ':orn detected '■ihich corresponded in physical and 
chc.'-.icol pronertics to the :^nins X2, X3- X3 and X5.
FIGURE 42
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obtained after hydrolysis of the glucuronide conjugates. From 
the size and intensity of the spots they appeared to be present 
in equal concentration.
(d) Oral Administration.
Similar metabolic patterns were obtained in each fraction after 
oral administration. Metabolites PI - P5, Ml and M2 were again 
detected in the unconjugated fraction, and spots XI - X6 were 
detected in the glucuronide fraction, but in both cases they were
r
only found up to 80 hours after administration. The sulphate 
conjugated group were found in much greater amounts than after 
intramuscular administration and were also detected up to 80 
hours. In this case five sulphate conjugates were found which, 
from their chemical, spectral, and chromatographic behaviour, were 
identified as compounds X2 - X5. Further experiments using 
continuous extraction of 2 litre volumes of urine showed that 
compound XI is also present conjugated with sulphuric acid.
The results for both routes of administration suggest that 
the main pathway of metabolism of promazine in the horse is 
hydroxylation followed by conjugation, predominantly with glucuronic 
acid, and to a lesser extent with sulphuric acid. A summary of the 
main metabolic products of promazine in the horse is given in Figure 42
(2) Metabolism of Chlorpromazine.
(q) Unconjuqated metabolites.
Marked variations in the intensity and number of spots were 
again noted from sample to sample, and certain metabolites were
- -
found to disappear for a number of samples, only to reappear later* 
Figure 43 shows a typical chromatogram of unconjugated metabolites 
excreted over successive 8 hour intervals after intramuscular 
administration of chlorpromazine hydrochloride. In addition to 
the derivatives recorded trace amounts of unconjuqated metabolites 
were found with Rf values of 0,83, (CQl), (between metabolite HI 
and the urinary pigments), and 0,50, (CQ2),(ettached to the top 
of metabolite CP3), The former gave a reddish pink reaction with 
sulphuric acid, and the latter a purple colour. No reaction 
was observed with any of the other spray reagents and, due to 
the small amounts excreted, no interpretable ultra violet spectra 
were obtained on elution.
Five unconjugated metabolites were detected by their colour 
reaction with sulphuric acid, and their fluorescence under ultra 
violet light. Their chemical, spectral and chromatographic 
properties are summarised in Table 13, Four, (CPl-4), had a 
reddish pink reaction with 50;o sulphuric acid. The fifth (Hi) had 
a purple reaction with both this reagent and sodium metaperiodate 
indicating that hydroxylation had taken place.
Spot CP3 ran to the same height as chlorpromazine sulphoxide 
in each solvent system, and their ultra violet spectra were 
identical. No reaction was observed with ninhydrin, nitroprusside, 
periodate or ferric chloride confirming that the compound is a 
sulphoxide derivative in which neither hydroxylation nor déméthylation 
has taken place. Thus spot CP3 was identified as chlorpromazine 
sulphoxide.
FIGURE 43
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The ultra violet spectrum and Rf values of CP4 in each solvent 
system were identical to those of chlorpromazine. A positive 
reaction with the ferric chloride reagent confirmed that the ring 
sulphur atom was unoxidised,and there was no evidence of 
déméthylation or hydroxylation* It was thus concluded that CP4 
represented the parent compound. The other two compounds, (CPl,
CP2,) wore not fully identified. Both had ultra violet spectra 
corresponding to sulphoxide derivatives, and no reaction was observed
r
with ferric chloride, periodate, ninhydrin or nitroprusside.
The remaining unconjugated metabolite, (Hi), had a purple 
colour reaction with the sulphuric acid and periodate sprays, 
indicating hydroxylation had taken place. Its Rf values in the 
systems used, (0.73, 0,29, 0,87), corresponded to those of 7-hydroxy 
chlorpromazine, (0.73, 0,30, 0.87) as did its ultra violet spectrum*
No reaction was noted with the ninhydrin or nitroprusside sprays,
HI was therefore identified as 7-hydroxy chlorpromazine.
Thus the major unconjugated metabolites of chlorpromazine in 
the horse are chlorpromazine sulphoxide, (CP3), 7-hydroxy chlorpromazine 
(h i), the parent compound, (CP4), and two sulphoxide derivatives,
(CPl, CP2), in which neither hydroxylation nor déméthylation take 
place. Two other metabolites were detected in trace amounts, one 
of which was hydroxylated,
(b) Glucuronide Conjugated Metabolites,
Figure 44 shows a typical chromatogram following excretion of 
glucuronide conjugated metabolites after intramuscular administration
FIGURE 44.
GLUCURONIDE CONJUGATED METABOLITES OF
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of chlorpro-.azine. Ao I 'i tli promazine, the spots represent the 
genins obtained by anzy'Tia tic h.ydrolynis of the nonjogated 
forms. Seven metabolites were found in this fraction. Spots 
Yl, Y5, Y4, Y5 and Yo ned a purple colour reaction uiith both 
sulphuric acir! and pei'iodatc indication that they were hydroxy la t d ,
Y2 and Y7, on the ot'ier hand, shoiued no evidence of hydroxylation»
Only one of these derivatives was fully identified. Spot Y5 
ran to the same height in the solvent syster^s used, and had an 
identical ultra violet spectrum in 0,1M hydrochloric acid to 
7 - h ydroxy chi o r pro ^ a z i no, T ri e r e lua s no r o a c t i o n ui i t h n j. n ' : y d r .1 n 
or □?: nitroprursidc, but a reddish pink colouration urns obtained with 
ferric chloride. Thus this metabolite was identified as 7‘-;iydroxy 
chlorprnnazina. Of the remaining hydroxylsto'd ccmponnds, Yl, Y4 and 
Y5 had ultra violet spectra corresponding to sulphide derivatives 
of clilorpro lazi nr, and had a pink colour reaction with ferric 
chloride solution. However, they had no reaction Mit'n ninhydrin 
or ni troprusside, Using the same tech ni pLios it was concluded 
that spot YS corresponded to a sulphoxirJe derivative of chlor:‘U'C'iOzi" , 
Compounds Y2 and Y7 had ultra violet S'lectra typical of 
SLilphoxide ierivativas of c'llnrpro'■?zi no but t h e r w ^ s  no evl'"'e^ca 
of hydroxylation or da-athyl-tion. As with pro"ezino metabolite 
X5,conjugation in these compounds could taka plac'' hhruga. a si-do 
clip in hydroxyl group which wnul d have no r--action with the pe  ^k-t. 
spray, A su" -ary of the results is given in Tabla It'-,
( c ) ngj 1 ■ ^h e tjg^ Cg r j  pj - to“ i i t "i s .
Sul'h 3 ta renbjg’:teh oa tab "litas ’Tra uo"' in only s - ell
FIGURE 45
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qu^ntikios c!urir,j kh^ f.irsi: hours ofter introriusc!ilor
acl'oin: strn bion, Only f-jor ^'otoholr tos uoro dotoob^h in oooh 
9amp 1G whic'i corros-^ or-d .d 5 n ch-■•;■>ica 1, opsctr•?.], and chro".31cprph2 c 
proportion to CQ-tpcundn Y2j Y?, Y5 and Y7 found i n tho nlucuronide 
f r a c t i o n ,  Furthor analysis of sulphates using 2 litre vnlt.imes 
of pooled urins sliowad that oexpounds corresponding to Y/' end Yn 'i.’sr* 
also present,
(ri) Oral '".r! 1 inistration^
Oral ad") in i strati on nave similar metabolic patterns to those 
oh ta i nod after ii^ trar-uscula r injection., although a greater abundance 
of metabolites uas nobod in the sulphate fraction.. Host saiiules 
contained five such metabolites corresponding in che^ ni cel, 
spectral and chromatographic properties to Y2, Yo, Y4,Y5 and Y?. 
Furtna-? analysis using larger sanpltus of urine shoi'iGU that all 
ttiG gonins obtained in the glucuronide fr -ction I'jsre also present 
as sulphate conjugates, A sueisry of metabolism of chlor^romazine 
by the horse is givan in Figure 45.
(3 ) jf. taboj i spy o^ f J\ c n^ r o ■.iszine ,
( 3  ) Linjr 0 n J lyga t e y . e _ r .  = g h «
Only 003 major mstaholite, (A2), was found in the unconjugated 
fraction, present until 5G hours after in'ranuscular administration, 
and 72 hours after' the oral route, nouever, tun minor metabolites, 
(Alj An), were occasionally found in s:;cll amnunbs. The 
chromatographic, che-ical and spectral prcnerbies of the 
Linconjuoated f ractim ere recorded in ~ehj.e 15.
Scot 12, on elution, : r...nuc-d -p ultra vinf^r
FIGURE 46. 
METABOLITES OP ACEPROMAZINE,
1 2  3 4
A3
B4
B3
A2
B2
AI
1. UNCONJUGATED
2. PROMAZINE SULPHOXIDE
3. 3 -HYDROXY PROMAZINE
4 .CONJUGATED
1,2=METHANOL-ACETIC ACID-WATER (5:3:2) 
3,4 = ACETONE -  ISOPROPANOL- 1% AMMONIA
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corresponding to a sulphoxide derivative of promazine. It had 
a pink colour reaction with sulphuric acid, but no reaction was 
observed with ninhydrin, nitroprusside, periodate or ferric 
chloride. It was thus identified as a sulphoxide derivative of 
promazine in which neither hydroxylation nor déméthylation had 
taken place. Its Rf values in the solvent systems used were not 
comparable to those of promazine sulphoxide itself and due to the 
lack of standard reference compounds it was not further identified,
t
Metabolites A1 and A3 had ultra violet spectra typical of sulphoxide 
derivatives of promazine.
They also produced a pink colour with 50^ sulphuric acid, and 
no reaction with ferric chloride confirmed that they were in the 
sulphoxide form. Neither ninhydrin, nitroprusside nor periodate 
sprays produced any evidence of déméthylation or hydroxylation.
Four metabolites, (B1 - B4^, were detected in both the 
glucuronide and sulphate fractions up to 40 hours after adrninistratior 
Their chemical, spectral and chromatographic properties are summarises 
in Table 15. Each had a purple colour reaction with sulphuric 
acid and metaperiodate, indicating that hydroxylation had taken 
place. On elution, the ultra violet spectra of 81, B3 and 04 corres­
ponded to that of acepromazine, showing that no oxidation of the 
nuclear sulphur atom had occurred, whereas that of 82 was typical 
of a sulphoxide derivative of acepromazine. This was confirmed 
using the ferric chloride spray, and the specific amine reagents 
showed no evidence of déméthylation.
Thus acepromazine is metabolised by the horse to three
" 222 -
unconjugated (Al, A2, A3) and four conjugated derivatives (B1 - B4) 
occurring both as glucuronides and sulphates. Al, A2 and A3 are 
sulphoxide derivatives of promazine, 81; 83 and 84 are hydroxylated 
sulphide derivatives of acepromazine, whereas 82 is a hydroxylated 
sulphoxide. These routes of metabolism were also found in the 
dog* A chromatogram of the individual metabolites is shown in 
Figure 46,
(4) Metabolism of Propionyloromazine*
The major metabolites of propionylpromazine in the horse 
are shown in Figure 47, Two metabolites, (PRl, PR2), were found 
in the unconjugated fraction,which, on elution with O.IN hydro­
chloric acid, produced ultra violet spectra corresponding to sulphoxi 
derivatives of promazine. They produced a reddish pink colouration 
with 50/O sulphuric acid, but no reaction was observed with any 
of the other specific reagents.
Each conjugated fraction also contained two metabolites,
(ph i, PH2), but neither could be eluted in sufficient amounts to 
produce an interpretable ultra violet spectrum. They had positive 
reactions with both sulphuric acid and periodate, and no evidence 
of déméthylation was observed. Only PH2 had a positive reaction 
with the ferric chloride spray, showing that its nuclear sulphur 
atom was unoxidised.
The major metabolites of propionylpromazine in the horse 
are therefore two unconjugated sulphoxide derivatives of 
promazine which are neither hydroxylated nor demethylated, (PR1,PR2), 
and two hydroxylated metabolites, conjugated to either glucuronic
FIGURE 47
I.M COMBELEN-QUALITATIVE EXCRETION PATTERNS
1 2 3 4 5
I
1. UNCHANGED DRUG
2. SULPHATES
3. GLUCURONIDES
4. UNCONJUGATED 
5.SULPH0XIDE
or sulphuric acid, one of which, (PH2), is a sulphide and the other, 
(p h i), a sulphoxide,
D, Limits of Detection of Urinary Metabolites,
Intramuscular doses of each drug, approximating to the 
minimum amount necessary to produce a noticeable effect, were 
administered over periods of 2 to 3 weeks to determine whether 
they were detectable at such levels. Details of the doses 
administered^, volumes analysed, periods of collection, and 
metabolites detected are given for each drug,
(1 ) Promazine,
Promazine hydrochloride, (0.3, 0.5 or 0,7 mg/Kg as a 5^ 
solution), was administered intramuscularly on nine days over a 
two week period. On the remaining days the horses received a 
control injection of saline. Urine was collected and pooled for 
approximately 6 hours after injection and separate aliquots of 300 ml 
were used for qualitative and quantitative analysis. From initial 
studies this was found to be the smallest volume from which 
metabolites could be detected using the spectroscopic technique. 
Details of the doses administered and results obtained using ultra 
violet and visible spectroscopy are shown in Table 16.
After injection of 0,5 or 0,7 mg/Kg. the unconjugated fraction 
was just detectable by ultra violet spectroscopy but they were not 
always detectable from the visible spectrum after reaction with 
sulphuric acid. No unconjugated metabolites were found using either 
form of spectroscopy after the 0.3 mg/Kg dose. Sulphate conjugates 
were found only occasionally in trace amounts.
TABLE 16
H
f i
rH
f i
o
to
fi
a
f i
H
4J
(3
•H
Htu
■P
t p
f i
to
■p
o
f i
P
P
Xtu
t p
o
f i
p
p
o tu
tu fi
CL •p
to N
tu §IP O
p P
•H CL
CO
•H P
> O
X) CO
f i tu
f i CO
O
p X)
tu
t p 1— t
o «p
•p CQ
> S
to
f i
p P
p O
r-H
fi f i
o
S •p
o p
P f i
t p p
p
to to
p •p
r-H fi
fi
to
(U X)
pd ‘fi
(D
(H
fiH
Ü
g
a-
(U
I—I
•H
to
•H>
4J
(U
r—I
O
>
fi
i3
totu
X )
•H
§
:
grH
o
totu
4Jfi
A-fiU)
■S4->CibDfi
?
I
to
(Unfi
•H
g
S
;i-L
O
to
(U4Jfi
fiCO
X»
tu4JfibOfi
?I
S'
p
4- 4- 4-
4-
co co co
(U
s
s
(U
g
(U
s
s
tu
N .
S
Oco oco oCO oco oco
1
e m co co to to
tu O O O O O o o o O
co
o
Q
CM CO 00 O'
;
ü
g
CL
CO
tu
X3
•H
fi
co
co
üütu
a
to
tu
X)
X
,§
CLt-H
fico
oco
XJ
.2fi■p
0
1 
ü
otu
CL
to
o
%
XJtu
.2fi
•g
g
jj
o
(U
CL
CO
rCt*ïH
CO•rH>
4-
— ZZD —
Glucuronide conjugated metabolites were only detected 
occasionally in small concentration as sulphide derivatives. Howeve 
their appearance was not dependent on the dose administered. For 
example, after an initial dose of 0.5 mg/Kg. no glucuronides 
were detected, whereas doses of 0.7 mg/Kg and 0,3 mg/Kg on days 
2 and 3 gave rise to weak ultra violet spectra typical of sulphide 
derivatives of promazine. This seemed to indicate a build up of 
metabolites refter successive daily dosage, but since their concen­
trations were so close to the limits of detection for the technique 
this could not be fully established.
Representations of thin layer chromatograms following 
excretion of individual metabolites after such doses are shown in 
Figures 48, 49 and 50. The greater sensitivity of this technique 
allowed detection of metabolites in most samples. The unconjugated 
fraction was found in every sample, but only three metabolites were 
detected corresponding in chemical, spectral, and chromatographic 
properties to PI, P2 (promazine sulphoxide) and P3 (Pg.203)' PI. 
and P2 occurred in most samples, but P3 was only detected on one 
occasion (Day 7).
Five glucuronide conjugated metabolites, corresponding to 
compounds XI - X5 were detected in small concentration on days 10 
and 11. However, over the rest of the experiment the number 
appearing was variable, ranging from 4 on the second day to none 
on day 8 (Figure 49).
Sulphates were detected in small concentration throughout 
the experiment. Six metabolites were detected on days 10 and 11,
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five of which produced a purple colouration with sulphuric acid, 
and corresponded in physical and chemical properties to compounds 
XI “ X5, The sixth compound, (Rf = 0,65), had a reddish pink 
reaction with the sulphuric acid spray. Its ultra violet spectrum 
was typical of a sulphoxide derivative of promazine, and no colour 
was observed using periodate, ferric chloride, ninhydrin or 
nitroprusside solutions. It was thus concluded that this compound 
represented a sulphate derivative of promazine conjugated through 
nitrogen. It was detected on days 2, 3, 7, 9, 10 and 11, Apart 
from days 10 and 11, the number of sulphate conjugated metabolites 
found in any one sample varied between 2 and 4, Spots XI and X2 
were detected in every sample (Figure 50),
(2) Chlorpromazine,
A similar experiment was carried out after intramuscular 
administration of chlorpromazine hydrochloride, (0,1, 0,3 or 0.5 mg/Kg 
as a solution). As for promazine 300 ml was found to be the 
smallest volume necessary for detection of metabolites by 
spectroscopy. The doses administered and results obtained by ultra 
violet and visible spectroscopy are shown in Table 17,
Concentrations of metabolites were again on the limits of 
detection. No unconjugated derivatives were found after doses of 
0.1 mg/Kg and, with the exception of the initial dose (0.5 mg/Kg), 
where there was no evidence of metabolites, only small amounts were 
detected after the 0,3 or 0,5 mg/Kg doses. No sulphates were 
detected by this technique and glucuronide derivatives were only 
found in the first three samples, (0.5, 0.3, 0.1 mg/Kg respectively), j
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Chromatograms of individual metabolites are shown in Figures 
51 ; 52 and 53, Only two unconjugated metabolites were found 
corresponding in chemical, spectral and chromatographic properties 
to compounds CP3 (chlorpromazine sulphoxide) and CP4 (the parent 
drug). Either one or the other was present in most samples, 
but they were only found together on days 2, 10 and 11 (0,3 mg/Kg 
doses in each case),
Glucuronide conjugated metabolites were present in all 
samples, A maximum of four was detected on days 1, 2, 3, 10 and 
11 corresponding in physical and chemical properties to compounds 
Y3, Y4, Y5 (7-hydroxychlorpromazine) and Y6, For the rest of 
the experiment the number of metabolites detected in each sample 
varied between 1 and 3, As in the unconjugated fraction the 
number of spots was not related to dose.
Six metabolites were found in the sulphate conjugated fraction. 
However, not more than four were detected in any one sample, 
and on three days (4, 7 and 11 ) no metabolites were present.
Three spots had a purple colour reaction with sulphuric acid and 
corresponded chromatographically and chemically to compounds Y4,
Y5 (7-hydroxy chlorpromazine), and Y6, The others, (Zl, 22, 23) 
produced a reddish pink colour with tlis reagent, having Rf 
values of 0.07, 0.17 and 0.33 respectively, and from their 
reaction with specific sprays appeared to be nonhydroxylated 
sulphoxide derivatives, Zl was present in three samples (2, 3 and 9), 
whereas Z2 and 23 were only found on days 10 and 1 respectively.
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The chromatogram of sulphate conjugated metabolites is shown in 
Figure 53.
Thus for chlorpromazine, as with promazine, metabolites 
obtained from 300 ml of urine after such low doses were on the 
limits of detection of the spectroscopic and chromatographic 
procedures employed. The individual metabolites corresponded to 
those obtained after higher doses, although spots were much less 
intense. Small quantities of additional metabolites, which 
appeared to ljg nonhydroxylated sulphoxides, were occasionally 
found in the sulphate fraction,
(3) Acepromazine.
Intramuscular doses of acepromazine maleate, (0,02, 0,04 and 
0,08 mg/Kg as a 1/ solution), were administered to horse 5 on 7 
days over a two weak period. Saline was injected on control days 
Urine was collected and pooled over 5 hours after injectiooyand 
in this case 500 ml aliquots were used for qualitative and 
quantitative analysis. Ultra violet and visible spectra of 
extracts using this volume showed no evidence of phenothiazine 
derivatives, although spots were detected by thin layer chromatography 
However, using 1 litre of urine after doses of 0,08 mg/Kg,weak ultra 
violet spectra typical of sulphoxide derivatives of promazine 
were obtained from the unconjugated fraction.
Figures 54 and 55 show chromatograms following excretion of 
individual metabolites. Only one derivative was found in small 
amounts in the unconjugated fraction, which corresponded in
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physical and chemical properties to metabolite Al* All four
metabolites, found after larger doses (81 - 84) were present in 
the glucuronide fraction. However, only 81 - 83 were detected 
after doses of 0,02 mg/Kg and no metabolites were detected after 
saline administration. 81 - 84 were also found in the sulphate
fraction, i^etabolites were detected in all three fractions on every 
day that the drug was administered,
E. Summary of Qualitative Results,
t
(I) Promazine,
In addition to the parent drug 30 metabolites were detected, 
nine of which were unconjugated derivatives, P2 was identified 
as promazine sulphoxide, P4 as the parent drug, and Ml as 
3“hydroxypromazine, PI, P3 and P5 were sulphoxide derivatives 
showing no evidence of hydroxylation or déméthylation and Ml and 
M2 were hydroxylated sulphide derivatives. Two other unconjugated 
metabolites, (Ql, Q2), appeared occasionally in small concentration 
and were not hydroxylated, 11 metabolites were detected in both 
glucuronide and sulphate fractions, X5 was identified as 
3-hydroxy promazine, XI, X2 and X4 were hydroxylated sulphides,
X3 was a hydroxylated sulphoxide, and X6 was a non-hydroxylated 
sulphoxide. No evidence of déméthylation was found in any of the 
derivatives. The other five metabolites in each fraction (Pg,20$ 
appeared only occasionally- in small concentration,
(II) Chlorpromazine,
20 metabolites were detected in addition to the parent drug, 
each fraction accounting for 7 derivatives. In the unconjugated
fraction CP3 was identified as chlorpromazine sulphoxide, CP4 as 
the parent drug, HI as 7-hydroxy chlorpromazine, and CPI and CP2 
as sulphoxide derivatives which were neither hydroxylated nor 
demethylated. The other two unconjugated metabolites, (CQl, CQ2), 
appeared only occasionally in small concentration. CQ2 appeared 
to be hydroxylated. In the glucuronide and sulphate fractions 
Y5 was identified as 7-hydroxy chlorpromazine, Yl, Y4 and Y5 were 
hydroxylated sulphides, and Y3 a hydroxylated sulphoxide,
r
On the other hand Y2 and Y7 showed no evidence of hydroxylation,
(ill) Acepromazine and Propionylpromazine.
3 unconjugated metabolites (Al, A2, A3) were detected as 
sulphoxide derivatives of promazine in which neither hydroxylation 
nor déméthylation had taken place. Four metabolites were found 
in both the glucuronide and sulphate fractions^ Bl, 83 and 84 
were hydroxylated sulphide^ and 32 a hydroxylated sulphoxide 
derivative of acepromazine.
Six metabolites of propionylpromazine were detected, two in 
each fraction. The unconjugatad derivatives, (PRl, PR2),were 
sulphoxide derivatives of promazine, and compounds PHI and PH2, 
obtained after hydrolysis of either conjugated fraction were 
both hydroxylated, PHI was in the sulphoxide form whereas PH2 
was unoxidised.
Using small doses sufficient to produce an effect, 
metabolites could Just be detected from 300 ml of urine. In the 
case of acepromazine, 1 litre of urine was required before 
metabolites could be detected by spectroscopy.
F, Gas Chromatoaraphy and Mass Spectroscopy*
Since many metabolites were not fully identified using thin 
layer chromatography with specific spray reagents and ultra violet
spectroscopy, the possibility of using the much more sensitive
techniques of gas liquid chromatography and mass spectroscopy for
further structural determination was investigated*
(l) Stainless Steal Columns,
Initial studies were carried out on the series of
reference compounds available using stainless steel columns*
Optimum working temperatures were decided upon from a series of
preliminary experiments* (Pg* i2l9o However, each compound
produced more than one peak which was thought to be due to thermal
decomposition catalysed by the metal walls of the column (Pg* 83) «
On injecting 0.25 pi of a solution of promazine hydrochloride 
in methanol (7,5 mg/ml) at a column temperature of 250°C, two 
peaks were obtained with retention times of 0,8 and 1,7 minutes. 
Since chlorpromazine had previously been reported to decompose to 
2-chloro-phenothiazine during gas chromatography (Gudzinowicz, 
Martin and Driscoll, 1954), it was assumed that the peaks were 
due to partial thermal decomposition of promazine to phenothiazine, 
(i.e. loss of the nitrogen side chain). This was confirmed by 
chromatography of the solution under the same conditions after 
addition of a few milligrams of phenothiazine. Two peaks appeared 
corresponding to those obtained from the promazine hydrochloride 
solution alone, but the first (Rt = 0,8 minutes) was greatly 
enlarged. The identity of the decomposition product was later 
confirmed by mass spectrometry (Pg.247)* By comparison of
- Z4Z
the area under each peak, the extent of decomposition was found to 
be approximately 20;^  over the range of operating temperatures 
studied (l50 - 3D0°C).
Injection of 0.5 pi of promazine sulphoxide,(7 mg/ml in 
methanol) under the same conditions,gave rise to five chromatographic 
peaks with retention times of 0,?., 1.6, 1*7, 3,9 and 5.0 minutes*
That at 0,3 minutes corresponded to the retention tine of 
phenothiazine3 and addition of a few milligrams of promazine 
hydrochloride to the sulphoxide solution caused an enlargement in 
the peaks at 0.8 and 1,7 minutes. Thus promazine sulphoxide was 
broken down thermally to 4 decomposition products on steel column, 
two of which were identified as promazine and phenothiazine.
This was later confirmed by mass spectrometry, Decomposition was 
approximately 50;^  over the range of temperatures studied* (150-300°C),
Chlorprornazine and its sulphoxide were also thermally 
degraded on metal column. Using the same chromatographic 
conditions as for promazine the parent drug produced two peaks,
(Rt ^ 1.2 and 2,4 minutes), which, as was later confirmed by mass 
spectrometry, corresponded to 2-cnloro phenothiazine and chlor- 
promazine respectively. Decomposition was of the order of 20;c 
over the temperature range 150 - 3G0°C, Three peaks (Rt = 1.2,
2.4 and 6.3 minutes) were obtained from the sulphoxide, the first 
two corresponding to 2-cnloro phenothiazine and chlorprornazine 
respectively. This was also confirmed by mass spectroscopy. As 
with promazine sulphoxide the extent of decomposition was 
approximately 501 over the temperature range studied.
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Other derivatives of promazine and chlorprornazine were also
thermally degraded over this range. Chlorprornazine N-oxida 
produced two peaks (Rt = 1*2 and 2*6) at 25G°C, the first
corresponding in retention time to 2-chloro phenothiazine. Both 
monodemethylated promazine and chlorprornazine were also decomposed. 
Desmonomethyl promazine had peaks at 0,9 and 2,0 minutes, and the 
corresponding chlorprornazine derivative at 1,4 and 2,7 minutes.
As with the parent drugs decomposition was of the order of 20;'j.
However, in neither case did the peaks correspond to phenothiazine, 
or its 2-chloro derivative.
No satisfactory peaks were obtained front 3-hydroxy promazine 
or 7-hydroxy chlorprornazine on metal columns under such conditions. 
Instead tailing peaks were obtained at 0.8 and 1.2 minutes 
respectively, corresponding to phenothiazine and 2-chloro phenothiazine. 
Decomposition, in this case, appeared to be IQO/o,
Chromatography of acepromazine and its sulphoxide was also 
investigated on metal columns, and decomposition was again noted,
0.5 pi acepromazine (7 mg/ml in methanol) was injected at 250^C and 
two peaks (Rt = 2,9 and 5.0 minutes) were obtained. It was 
later shown using mass spectroscopy that the peak at 2,9 minutes 
corresponded to 2-acetyl phenothiazine. Chromatography of acepromazine 
sulphoxide under-the same conditions gave rise to four peaks 
(Rt = 1.8, 2.9, 5,0 and 6.3 minutes), those at 2.9 minutes and 5.0 
minutes corresponding to 2-acetyl phenothiazine and acepromazine 
respectively. For the parent drug the degree of decomposition was 
approximately 30i^  and, for the sulphoxide of the order of 50^,
By successive dilution of solutions of standard reference 
compounds, it was found that their limits of chromatographic 
detention for the conditions described were of the order of 1
(2) tpicote Treated Columns.
The degree of decomposition using metal columns would not 
allow a suitable separation, or identification*of individual 
metabolites extracted from biological fluids. It was thus 
attempted to p;revent such reactions by coating the columns with a 
compound that would not catalyse decomposition. The compound 
employed was Epicote 1001 resin and the method of preparing the 
columns is described on Page 120,
However, on chromatographing the standard reference compounds, 
the resin was found to inhibit decomposition to only a small 
extent. The same number of peaks were found with approximately the 
same retention times for each compound as when using the untreated 
columns, but there was an overall decrease in the percentage 
decomposition. Approximately 12';'t of the parent drugs, chlorprornazine 
N-oxida, and the demethylated derivatives ware decomposed.
However, the extent of decomposition of the sulphoxides ( 'v 50;:) and 
of the hydroxylated derivatives ( /v 100;^ ) remained of the same order.
(3) Glass Columns and Mass Soectroscooy,
Since it was not possible to obtain single chromatographic 
peaks using either metal columns or their pre-treated analogues, 
further experiments were initiated using an all glass system. Each 
standard reference compound was chromatographed using 5' x
glass c“lu!’:ns nackeri with I"' 5E-30 at a ta;'neraturG of ROl/'c, I'hicli 
from prsliminary exsarimants was found to bo tha optimum 
tarn pa rat Lire for this system. DeteJJ.s of the conditions osiployad 
and preparation of tha columns are described on î^-age 120, Using
this system each compoi'nd produced only one peak*
Since only single peaks were obtained using glass colmns in 
the Varian Aerograph instrument, the possibility of obtaining 
similar results using the glass cnl ir^ ns of the LKP Gas Chromatograph 
Mass Spectrometer was also investigated. This would alloj 
determination of the molecular weight of individual metabolites and 
complement structural elucidation by ultra violet, thin layer 
chromatographic and chr-niical techniques. Details of the operating 
conditions of the instrument are described on Page 121,
Each solution, having been run using glass columns on the gas
chromatograph alone, was therefore subsequently run on the gas
chromatograph-mass spectrometer, and, with the exception of sulphoxi 
derivatives, singl.e peaks were obtsined for each coLinound.
( a ) '
The mass spectrum of promazine obtained i n this manner showed 
a molecular weight of 2B^, The rnsss numbers of the '"^ ajor break- 
doi'.in frag-npnts were 239, 225, 212, 199, loO, 167* A line diagram
of the spectrum is snoi-'n in Figure 56,
Oesmoncmethyl-aromazine also gave only one peak on tha gas 
chromatogreph-^ass spectrometer, corresponding to a compound of 
molecular 'weight 270. The major hraaktJcun frayants again 
appeared at 23SF 225, 23 2, 199, 130, 157. The spectre" is
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3"hydroxy promazine s'^owed a nol.ecu.lnr weight of 300,
The mass numbers of the Ler^rtkdown products in this case ware 
exact].y 16 nass units rraater than the corresponding products 
from promazine being 255, 241, 228, 215, 196 and 165*
In the case of promazine sulphoxide three peeks wore obtained 
and the instriricnt was temperature prograrr-icd from 150 to 200^6 at 
a rate of 5^/ninute to give arienucte separation, Tha mass 
spcctru:'! of ths first peak, (Rt “ 5.6 nin), showed a molecular 
weight of 199 and a fiiajor breakdown product at 167, corresponding 
to the spectrum of phannthiazj 0 0 (Figure 57). The second psr-k 
(Rt = 7,3 minutes), showed a molecular weight of 264 end major 
degradation products with mass numbers of 239, 225, 212, 199, 166 end 
167 corresponding to the breekdoL.in pattern of oromezine (Figure 
56a) c The remaining peak (Rt :: 3,7 minutes) had a molecule^ weight 
of 300 and the niain products of degre’dation h-d mass rrjmhers of 
234, 255, 239, 225, 212, 199, 180, 167, which correspondes to the 
mass spnctru'T of promez.ine sulphoxide (Figure 53), Oecomnosition 
probably took ploco in the molecular separator betw'^en the two 
instruments *
Thus promazine and its derivatives have characteristic hr-oekdoL.m 
patterns in the mess spectrometer, Figur-^ 59 shcvis a scho" a tic 
representation of th'^  cc" - mounds involved, 11 is postulated t-'st
promazi'-'e in broken do. in hy progr=ssiv^ degre z tion of the sid^ 
chain giving dirivatives, F , I eo'i 6 'jith m-'s-' ’^lumbers of 239, 225, 
and 212c rnmeitni g then gi th;3r loses the r-neir.rier of ah- sida
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c h a 5. n to cj i \j a n h ■ n n t hi i a 7. i n c  ( ^  ) 5 o r 1 :: a 0 s t h .1 rion « u .1 p h i' r a t  r-' - 10 
givG coop non:! D, ( ] n U ) G and 0 than loon t'no au Ip do?.' a ton and tho 
r ani a i n da r of 11", 0 si do c h a i n r a s p e c t i \> a I y , gi v 5 n g c on p o u n d H ( 1 n 7 ). 
l i !h ic h  f u r th 3 r  d n c o ' i p o s o s  t □ conp..iuncl 3 ,  ( l 5 2 ) ,
OasmnnoTtethylproncoina arKij (hy analogy uith dasrii-'iathyl'- 
chlorpronozino), dasdli'othylp ro-ip7 ino fnlloo exactly the sa'oe 
brea!<down pattern. Prone7 ino sulplioxide is degraded to pro larine 
and thereafter to t'nu pronazine derivatives C 5 0 , F , G , H , I, and 3 , 
Houevor; tho oxygen a ton can a In o re-» a in ciuring tha first degradation 
of the side, chain givi no co-npDi'nd E (2 üh), and is subsnnijontly lost 
to give F (239). Thus the major derivatives found on the mass 
spectr'.n of prorazine sulphoxide have ness numbers 3 Fn, 255, 239,
225, 212, 199, 190, 167. 3-hydroxy oroxaziri.-, on the other hand, 
d o e s  not apnear to lose the hydroxyl group until it is brohen 
dtnmn to c o m p o u n d  p. Di 10 to the hydroxy] group, co-pounds sericeous 
to C,n,F,G,'--, and I are formed ulth a "^ass number 16 more t^icn the 
corresponding pro lazine frag-ments. The r^' a " numbers of the a j o r 
breakdoi'in products of the hydrnxy derivative arc 360, 255, 2 ^1 , 2 2 2 , 
215, 196, 183c
Apart frc'! molecular iv'eight considerations, promazine and 
its derivatives are t'-erFifore also rearily recognisable fro."' the 
characteristic patterns of their mass soectra. As uill be described 
(bg. 253), the nsin i'dndrancss to usir-g the gas chrc^atogra^h-maes 
spectrometer for metabolic studies on si..'ch co"-rounds are deco'-ons 1 1 Ic^  
of sulphoxides, and difficulty is purificati-n of the sa-plas to 
2 sufficirnt extent to gi\/e iosn ti " ia'-; ^  c ^
( b ) OilQroj'o T':v/J.j'ye
Ghlorprc:'^ -’zinc has a mass spectru-i showing o molecular mainht 
of 318, and tha mosses of the -'ajor hreok.down products ora 273, 259, 
246, 233, 214 and 199, By subtracting 34 mass units from each of 
those numbers, (as would be the case if the chlorine ».'as replaced 
by hydrogen), the pattern would be 254, 239, 225, 21.2, 199 and 180 
whioit correspond to proFiazine dorivotiv/es B,F,1,C,G and D, Thus 
the breakdown of chlorprornazine in the mass spectrometer proceeds 
in a similar fas'nion to promazine, (Figure 60).
The respective molecular weights obtained for desmonomethyl- 
and desdi'nothylchlorpro-’rEizine uiera 304 and 290, and in both cases 
the mass numbers of the major degradation derivatives ijere 273, 259, 
246, 233; 214 and 199.
Chlorprornazine M-o.xid-*^  had a mass spectrufn with breakdown 
fragments of mass numbers 334, 318, 273, 259. 233, 214 and 199.
As with 3-hydroxy pro-lazine, 7-hydroxychlorpro-azi no also 
appeared to retain the hydroxyl function during 'iost of the 
degradation process. Derivatives in tha breakdown pattern had 
mass numbers of 334, 239, 275, 262, 249, 23B and 2B1.
Three peaks were obtained on t'-'e cf.ro'ietogr-m of chlorpro-azina 
sulphoxide. At 250°C their retention times were 0,3, 1,3 and 
2,9 minutes. Ths first peak roprsssntsd a compound of molecular 
weight 233, with a major degradation product of -ass number 231, Th,
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corresponded to the nolsculor weight of Z-chloro-phrnothiezine,
CÎ n d b y a n a 1 □ g y i j; i r. h t h ? other chi c r o - c; e t' ,i \j 5 i v e s s 11 .'died, degradet 5, c n 
of this co^ .ipoLind uioulrl give 9 derivative of ess 201. Thus 
although no reference connound was available, the first peak was 
assuiTed to represent 2-chlaro-phonothiarioe, The peek 2 f I*,3 
minutas corrasno'idcd in mn I ocular weigh t end breakdo'.jn pattern 
to chlorpronazino ^ The third peek showed a r-olecul.i^r weight of 
334 and major degradation products at ness numbers 318, 289, 273,
259, 246, 214} 199 ancl 167, corresnonding to the spectrirn of 
chlnrnro^■ 'azin'c si! 1 pnc)>;ida «
Thus chlnrproviazine sui phoxids is partially decn-yTTised in the 
gas chro'eatonraph-n;ass st.rectroneter to rhlurpro':'e?ine and 2 - 
chlorcphnnothiazine. This adds support to the cnnclusinr that 
these are the major products of decomposition on metal cclcMna 
(Pg. 262). Also the breakdown products of chlorprc•ezine end its 
derivatives in the mass s-'ectrcieter correspond to ths hresk.iown seri 
shoi'o for pro" a zinc ( Figure 59), except that the chlorine atci is 
not broken free the nucleus,
(c) o lejd.jiii,
Acenrowo zine and its s'.'l ;'hcx''de '-.’or'" al.'^ o run d~ the gas 
chrÜnatcgraph-mess spectrometer, "^ ho riass cp^r^irur’ 0 accpronaz'^e 
showed a riolecular \'eight of 326 and the figures for the "iejcr 
degradation pror’ucts iv'ere 231, 267, 254, 241, 22? end 222, These 
ness nurbers, with the exception 212, corresccnp to thc=e for 
the breokdo'jn of pronezime 'rith- 42 n:ss r'nits aoded, (i.e. t''r- 
increase in -ass on addit ion of rn eor^yl grore), flers r. : e r 
2 i / CO : r--‘'or'is on t-'-.r '?■ - ;->r = '^O'r-'--'- 'ot r ' pram-zin", \ z"''z": u"
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C)o Thus eceprrr-asinn is in the nass spectrometer in
the same warmer as promazine, the acetyl group remaining attached 
to ths niicleus until frag-ients of mass number loss than 220 are 
obtained y (Ft ni ire 61).
Aceprnrnazine sulphoxide, like the other t'wo sulphoxides, 
producQd threo chromatogrphic poa\<s, At 2 5 0 C their reten15 on 
times were 1,3, 2,8 anr' 4o8 minute s. The peak at 1.3 minutes 
shouad a rnolc3culnr weight of 241 which would correspond to 2-acetyl 
phenothiazineV Thus, by analogy, with the mechanism of 
decomposition or the other tvjo sulphoxides, although no reference 
compound was available, the first peak was identified as 2-acetyl 
phenothiazine. The molecular weirfit and hreakdown pattern of the 
second peak was identical to that of acepromazine. The peak 
occurring at 4,8 minutes showed a molecular weight of 342 and had 
derivatives of degradation of mas'' 326, 267, 281, 267, 254, 241 and 
222 corresponding to the mass spectrum of acepromazine sulphoxide.
It was thus concluded that acspromaz:'na sulphoxide bad been theri ally 
decomposed in the gas chromatograph-mass spectrometer to ac.apromazire 
and 2-acetyl phenothiazine.
The characteristic fingererint pattern and clearly defined 
molecular weight obtained for each compound using the mass 
spectrometer, and the single peaks obtained for most derivatives cm 
the gas chro.netogrsph, sugsasteri that this combination of instrument" 
night be of considerable use in the structural determination of 
metabolites,
(d) Studies on Urine Extracts.
To determine the best operating parameters, urine extracts 
were first chromatographed on glass columns, (ipSE 30), using the 
gas chromatograph alone. The samples were then run on the gas 
chromatograph-mass spectrometer, and spectra were recorded at 
each peak. Preliminary experiments were carried out on "promazine" 
extracts, a series of increasingly concentrated samples (10:1 - 400:1) 
being chromatographed,
t
In each case a large number of peaks were recorded (over 30 for 
the most concentrated samples). This was' especially true for 
"conjugated" extracts. However, on examination of their mass 
spectra, only one or two at the most from each extract resembled those 
of phenothiazine derivatives. The others, due to contaminants 
extracted from the urine, had molecular weights ranging from 150 to 
400. They often had cracking patterns showing intermediates 
which could have been breakdown products of phenothiazine derivatives, 
suggesting that separation was not complete. However, further 
attempts at separation by temperature programming between 150 and 
250°C were unsuccessful. The parent drug (Figure 62), promazine 
sulphoxide and a hydroxylated derivativa were occasionally detected 
by this method using the more concentrated extracts.
Thus, due to contaminants this technique is not so applicable 
to separation and identification of urinary metabolites of 
promazine as was at first anticipated. Similar results were obtained
using chlorprornazine and acepromazine. Metabolites may be detected
occasionally, but the chances are much greater that they will be
FIGURE 62
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masked by contaminants. The method would be of much greater use 
if extracts could be more thoroughly purified. Elution of spots 
from thin layer plates was attempted but no "phenothiazine" spectra 
were obtained,probably due to the low recoveries of such compounds 
from plates using organic solvents (Pg,ü9),
At present the method is to some extent a matter of trial end 
error since so many peaks must be investigated but is of use in 
indicating, by cracking patterns, that "phenothiazines" have been
t
administered*
DISCUSSION
- ZDX
VII DISCUSSION
Detailed studies of drug metabolism and excretion in the horse are 
rare. Most investigations have been aimed primarily at the detection 
of potential doping substances rather than at quantitative evaluation 
of their metabolic routes, and the methods published are not always 
sensitive or specific, Schubert (1967) investigated methods of detection 
of a series of drugs and their metabolites after administration to this
f
species. These included salicylic acid, phenylbutazone, caffeine, 
amphetamine and chlorprornazine, However, the studies were mostly 
qualitative in nature, and the reports were not detailed, Nicholson 
(1968) investigated the metabolism and length of urinary excretion of 
phenobarbitona, pentobarbitone and their metabolites^ and determined the 
percentages of dose excreted. He also studied the metabolism of 
ephBdrine by the horse, but only semiquantitativs results were reported 
(Nicholson, 1969),
Compared with the mass of information on metabolism of the 
phenothiazine tranquillisers by man, dogs and rats (Chapter II) little 
has been reported on such processes in the horse, Carey and Sanford 
(1963) detected the presence of 7 metabolites of promazine in horse 
urine, but did not identify them, Schubert detected 4 metabolites of 
chlorprornazine one of which was identified as the sulphoxide. He 
found that only a small percentage of the dose was excreted, although 
excretion lasted for several days.
Nearly all reports on the excretion of phenothiazine tranquillisers 
have been concerned with pooled 24 or 48 hour urine samples and
quantitative excretion patterns have only occasionally been investigated 
over smaller time intervals. Since so little information was available 
on this subject the present study was designed to follow metabolism and 
excretion of the tranquillisers more commonly used in equine practice 
in detail over such small time intervals. Due to the large number of 
biotransformations of such compounds found in other species, excretion 
of metabolites was followed continuously in six major groups (Pg,14l).
This gave a pattern of variations in rates of excretion of individual 
metabolic groups over successive 8 hour intervals until excretion had 
reached the limits of detection of the technique. Since such compounds 
are usually administered to horses in a single dose, compared to the 
repeated daily administration to humans, and since only a very small 
percentage of the derivatives recovered is unchanged drug, a knowledge 
of such metabolic patterns is of the utmost importance in dealing with 
cases where administration of tranquillisers to horses is suspected,
Carr (1962) reviewed the metabolism and excretion of psychoactive 
drugs and summarised the complexity of such processes in the following 
words, "The phenothiazine derivatives that are used in the treatment 
of psychiatric states pose many atypical problems in psychophermacology• 
Not the least of these are their unusual metabolic patterns and individual 
excretion differences that vary with the different drugs and different 
patients". The present study has shown that such processes are also 
complex and irregular in the horse, 30 urinary metabolites of 
chlorprornazine, 20 of promazine, 11 of acepromazine and 6 of pronionyl- 
promazine have been detected. The number and amounts of individual
metabolites of each drug were also found to vary considerably over i
successive 3 hour intervals, v.txioh would explain the irregular 
excretion patterns of !r,ctobolic groups obhairiGu by spectroscopy 
(Pcj, 141).
Sovnral wetabolites were not fully identified due to a lack 
of suitable reference standards, and chenical modification, (e,g, 
sulphoxide for ’stion), of those available could not bes accomplished due 
to limited supplied (Pg.121). Thus ssvoral analytical techni cues via re 
used for structural determination including a series of specific spray 
reagents end elution folloi-jscj by spectroscopy, Deters i notion of the 
position of substitution of hydroxylated derivatives was also atte.ipte- 
using the spectroscopic method of Bockott et al. (1933), However, in 
most cases insufficient r.^ atoria], could be eluted to give a satisfactory 
spectrun. This seems to be due to a co’-ibinatian of the small amounts 
excreted and strong binding of the phenothiazine derivatives to the 
silica gel coating of the thin layer plate,
Sulphoxide formation and hydroxylation, major metabolic routes i n 
othe^ species (Chapter IX), were both detected. The latter was this 
major routs for promazine and chlo' pro lezins was follovi'ed by
conjugation, predominantly with glucuronic acid an-' to a lessor extent 
with sulphuric acid. On the other hand, sulphoxide formation, 
accompanied by loss of the side chain ketone grouping at t'lo 2-positinr 
uias the major route for acoprc-nzine and propicnylorciazi no,
Déméthylation, W'lirh bias been widely renorted in othe^ species 
("oss et al,^1958; Ualk^nstein and Snifter, 1959; Goldsnrarc and 
Fi.sh'-'an, 1961: Beckett at a)., 3-63^, dip not appear to take place. 
However, the specific reray reagentr, ninny irio arm! nitro" T'ussidr, U'"? 
to detect this trr nsfor.mo ti cn era nearly sensitifs (.-g,111;, ’.lea fr ' ■
preliminary experiments on standard demethylated "phenothiazines" it 
is clear that the success of these reactions depends to a great extent 
on the conditions employed, the ontimum conditions varying from compounc 
to compound. Thus on spraying standard spots of desdimethyloromazine 
and desdimathylchlorpromazine with the ninhydrin reagent (Pg. 118) 
the former produced a colour reaction within 5 minutes of heating, 
whereas the latter produced only a faint colouration after 10 minutes. 
Increasing the concentration of the ninhydrin solution did not result 
in a corresponding increase in the intensity of colouration. It was 
also noted that the nitroprusside spray (Pg. 118) did not always 
produce a colour reaction with desmethylchlorpromazine or desmethyl- 
promazine. The reason for this is not apparent, but could be due to 
small differences in the length of time between mixing the two 
solutions and subsequent spraying, or to the amounts of reagent sprayed, 
Thus SOI ne of tha metabolites detected using the more sensitive 
sulphuric acid reagent may be demethylated, but either due to the small 
amounts excreted or failure of the derivatives to react, the 
transformation was not detected.
Two spectroscopic techniques were used for quantitative analysis 
(ultra violet spectroscopy and visible spectroscopy after reaction 
with sulphuric acid), the latter being used to corroborate the results 
of the former. There was good agreement in every case. However, in 
preliminary experiments a build up of contaminants was noted in urine 
stored at 4°C which tended to mask the absorbance of phenothiazine 
derivatives in extracts (Chapter V). Since the rate of formation of 
contaminants increased considerably on incubation of the urine at 37^C 
and since their formation could be inhibited by sterilisation of the
urina, the interference was attributed to bacterial action. In 
addition, a build up of p-glucuronidase activity was noted in urine 
stored at 4°C which could also be inhibited by storage at - 20°C or 
sterilisation, but this did not appear to be the cause of the build up 
of contaminants (Pg.l27), In view of these facts, storage at -20°C, 
thorough washing of extracts, and, in the case of conjugated metabolites, 
strict sterilisation (pg,13$ should be adhered to in the analysis of 
phenothiazine derivatives in horse urine.
Quantitative excretion patterns were variable and irregular (Pg.l4l), 
Eiduson et al.(1963) reported variable rates of excretion of thioridazine 
over successive short time intervals after oral administration to man* 
They also found that there was a correlation factor of 0,73 between 
amounts excreted and urinary volume,but, since they could find no such 
relationship after administration of chlorpromazine, they assumed this' 
type of correlation was peculiar to thioridazine, Fisher et al,(1949) 
studied the urinary excretion of caffeine in several species and reported 
that amounts excreted were dependent on urinary volume. In the present 
study however, no correlation could be found between the amounts 
excreted or the irregular excretion patterns and urinary volume.
Several workers have reported relationships between amounts of drugs 
excreted and urinary pH (Ueiner and Mudge, 1964)» Salicylic acid is 
excreted at a much greater rate In alkaline urine (Smith et al., 1946; 
Gumming et al,, 1964), The urinary excretion of amphetamine by humans 
is also dependent on pH,greater amounts being excreted in acidic urine 
(Beckett and Rowland, 1964). During studies into the metabolism of 
ephedrine by the horse, Nicholson (1969) noted that much greater amounts
of norephedrine were excreted in acidic urine than in alkaline urine.
In the present study the urinary pH, in the majority of cases,varied 
only slightly between 7 and 8,5, and the slight variations observed could 
neither be related to amounts excreted nor the irregular excretion 
patterns. Occasionally horses excreted acidic urine (pH 5,0 - 7) over 
a whole experiment but this was not accompanied by a corresponding 
increase in amounts of metabolites excreted. The occurrence of low oHt '
values was not related to the age or sex of the animals and, since all 
feeds were standardised (Pg, 9 7 could not be related to diet. Neither 
could it be related to the feeding habits of the animal while at grass, 
since at least three days were allowed to elapse before starting any 
experiment, during which the animal was fed the standard diet. This time 
interval also allowed for a decrease in urinary volumes to much more 
manageable amounts (Pg,97), Racehorses have been reported to excrete 
acidic urine (down to pH 4.8),which was assumed to be due to the 
increased exercise which these animals undergo (Chapman, 1969), Thus 
the pH of urine collected during the present studies may be related to 
the activity of the animal before and during experiments*
The variable rates of excretion over successive 8 hour intervals did 
not appear to be related to urinary volume or pH, On the other hand, 
extensive localisation of phenothiazine derivatives has been reported 
in various organs and tissues (Salzman and Brodie, 1955; Fyodorov, 1958; 
Walkenstein and Seiftsr, 1959), Variable rates of release of metabolites 
from such organs (lung, liver, kidney, spleen) over successive intervals 
of time could give rise to the variable rates of excretion of metabolites* 
In addition to the irregular excretion patterns of individual 
metabolic groups, two types of excretion pattern of total metabolites was
noted. In the first the rate reached a maximum within 8 hours of dosing, 
whereas in the second the rate rose to a much smaller maximum at 
approximately 24 hours after administration. Both types were noted 
after administration of promazine or chlorpromazine, whereas only the 
first type was noted after acepromazine administration. The patterns 
were neither related to the age nor the sox of the animals, but in 
duplicate experiments on the same animal, similar types of pattern were 
obtained. Neither was the type of pattern obtained related to the
t
route of administration.
The animals were equally tranquillised whan either pattern was
recorded, and so presumably had approximately similar brain concentrations
of the drug. Walkenstein and Seifter (1959), on the basis of tissue
35distribution studies using S promazine, suggested that the parent 
phenothiazine derivatives have a lower blood-brain barrier than their 
metabolites and, as a result,the drugs are highly localised in the brain, 
whereas the metabolites are more highly concentrated in other organs (lung, 
liver, kidney, spleen, etc. ) Thus, if brain concentrations are similar, 
the type of pattern obtained must depend on the concentration of 
circulating metabolites in the blood.
If we assume the exponential pattern the type normally to be 
expected there are several possible explanations for the much slower 
second type. Firstly, the delay in reaching a maximum rate could be due 
to an inability of the animal to metabolise the drug. However, very 
little unchanged drug was found in the urine and there was no prolongation 
of action when the second pattern was noted. Thus this explanation 
must be discounted. Another possible explanation could be poor urinary
excretion of metabolites, but volumes of urine voided and pH were 
similar in each type of pattern. Similarly failure of the kidneys in 
certain animals to excrete metabolites would be another possible 
explanation. On the other hand the second excretion pattern could 
be due to localisation of metabolites in various organs. If different 
animals had different capacities for binding metabolites then this 
would explain the two types of pattern.
The latter two explanations seem the most feasible. However, such
t
hypotheses cannot be proved until much more information is available 
correlating blood concentrations, tissue distribution, metabolism, 
excretion and pharmacological activity of such compounds.
The percentage of dose excreted in every case was low. After 
oral administration 27% of the dose of chlorpromazine, ID/o of promazine 
and 4^ of acepromazine was excreted. The corresponding percentages 
after intramuscular administration were 10/^ , 11;: and 1,3^. This is in 
agreement with work carried out in other species,although individual 
reports vary considerably (Emmerson and Hiya, 1963), Nadeau and Sobolewski 
(l959) recovered 5 - 20>o of daily oral doses of chlorpromazine from human 
urine over 48 hours. Dubost and Pascal (1953) recovered 7% of a dose 
of chlorpromazine .from a 24 hour sample of rabbit urine, Beckett et 
al, (1963) also recovered 7/b of an oral dose of chlorpromazine from humans 
over 48 hours.
The latter workers postulated the low recovery was either due to 
predominantly biliary excretion of metabolites, or to poor absorption 
of the drug from the alimentary tract, or to poor reabsorption of
metabolites excreted in the bile. However," in the present study 
recovery was low after parenteral as well as oral administration and 
thus cannot be attributed to poor absorption from the intestine. Also 
approximate pK values measured for the parent drugs were between 6 and 8 
(Promazine hydrochloride, 7,2; chlorpromazine hydrochloride, 6*5), which 
would not hinder their absorption from the intestine.
Biliary excretion and poor reabsorption would lead to high concentratic
of metabolites in the faces, Faecal excretion of phenothiazine
metabolites has been reported by several workers (Fyodorov and Shnol,
1956; Emmerson and Hiya, 1963; Eiduson and Geller, 1963). They
35measured radioactivity in the faeces after administration of S labelled 
tranquillisers and assumed this was due to phenothiazine metabolites. 
However, no metabolites have been detected in faeces using spectroscopic 
or colorimetric techniques. Thus the activity measured in the faeces 
may be due to "non phenothiazine" metabolites. This would also account 
for the much larger percentages of dose detected in urine using labelling 
techniques. During the present study examination of faeces using the 
spectroscopic techniques described showed no= evidence of phenothiazine 
derivatives. Thus the low percentages of dose recovered in the urine 
do not appear to be due to predominantly biliary excretion of metabolites.
On the other hand the extensive localisation of such compounds in 
different organs and tissues previously described could account for the 
low percentages of dose recovered. Slow release from such sites of 
localisation would also account for the prolonged excretion observed^which 
has also been noted in other species (Serti and Cima, 1956; Forrest et 
al, 1959; Walkenstein and Seifter, 1959; Huang et al,, 1961; Emmerson 
and Miya, 1952),
nuc'i larger percentages of dose were excreted after oral dosing 
than after intramuscular administration in the present study, especially 
over the first 32 hours after administration (Pg,18l), Also, on the 
one occasion that promazine was administered intravenously the 
percentage of dose excreted over the first 32 hours was comparable with 
that after oral administration. Berti and Cima (1955) while studying 
the metabolism and excretion of chlorpromazine by the rabbit also noted 
that the percentage dose excreted was much greater after the oral route 
than after subcutaneous or intramuscular injection. Similar observations 
were reported by Burns et al. (1953) who studied the metabolism 
distribution and excretion of phenylbutazone in man. The latter 
workers believed the drug to be absorbed rapidly after oral administration 
but that, after the intramuscular route, precipitation or conjugation 
at the site of injection took place,
Fyodorov (1958) studied the metabolism,distribution and excretion 
of promazine, chlorpromazine and chlormepazine in rabbits, rats and 
dogs after different routes of administration. They found extensive 
localisation of the drugs at the site of injection after intramuscular, 
intraperitoneal and subcutaneous administration,whereas they were 
rapidly absorbed after the oral route. They postulated that the binding 
was due to a combination of inflammation of the tissue at the site of 
administration and alkaline hydrolysis of the salt form of the drug 
to the free base. They also reported that different drugs had different 
capacities for binding to tissues, which would explain the different 
percentages of dose obtained for the drugs studied in the present work.
It is thus postulated that phenothiazine derivatives are also 
localised in muscle tissues at the sites of injection after intra-
muscular administration to the horse, followed by slow release from 
these sites. On the other hand, after oral administration, such 
compounds are rapidly absorbed. Also the fraction of drug not bound 
at the sites of injection would not be so rapidly metabolised as after 
oral administration. The low blood-brain barrier for unchanged drug 
compared to its metabolites (Walkenstein and Seifter, 1959) would 
thus account for the similar degree of pharmacological effect noted 
after both routes of administration. However, due to the scarcity 
and value of the experimental animals employed, it was not possible to 
test this hypothesis by slaughter and subsequent analysis of tissues 
at the sites of intramuscular injection.
The conjugated fraction was assayed spectroscopically after 
enzymic hydrolysis of the conjugates. Enzymic incubation was employed 
rather than chemical hydrolysis for several reasons. Firstly the use 
of specific enzymes allowed analysis of individual conjugated fractions 
which is not possible by chemical hydrolysis. Also it has been reported 
that sulphoxide derivatives of such drugs are reduced to the corresponding 
sulphide on heating with hydrochloric acid (Schmslz and Burger, 1954),
Thus this type of hydrolysis would not give a true representation of 
the metabolites present. Strong alkali has also been reported to 
decrease the intensity of ultra violet spectra of chlorpromazine (Fels, 
Kaufman and Karczmar, 1958), which would also produce misleading 
quantitative results,
Glucuronide conjugated metabolite of promazine and chlorpromazine 
predominated which is in agreement with findings in other species,
Beckett et al, (1963), after oral administration of chlorpromazine,to
— £. t s.
man reported the ratio of glucuronide to unconjugated to sulphate 
conjugated metabolites as 12:5:4, Flanagan et al, (1359) found, after 
intraduodenal administration of chlorpromazine to dogs that the ratio 
of the "bound" (conjugated) to the "free" (unconjugated) fraction in 
the urine was approximately 3:1, Nadeau and Sobolewski (1959) reported 
that 50 " 98/0 of metabolites of leuomenromazine or chlorpromazine 
excreted after oral administration to man were glucuronide conjugates.
In the present study the ratios of glucuronide to unconjugated metabolites
t
after intramuscular administration of promazine or chlorpromazine were 
5:1 and 7:1 respectively. The corresponding ratios after oral 
administration were 6:1 and 18:1.
Sulphate conjugated metabolites were detected in only trace amourits . 
after intramuscular injection but were found in much greater quantity 
after oral administration (^ 1,3:= for each drug), Sulphate conjugated 
metabolites of chlorpromazine, accounting for approximately 1,3^ of the 
dosa were recovered from human urine by Bec'xett et al, (l963). Ethereal 
sulphates of promazine have also been reported in the urine of rabbits, 
rats and man. In man they accounted for approximately 3^ of the dose 
(Goldenberg et al. 1964), However, both groups of workers studied only 
oral administration. Posnar at al, (1963) failed to detect any sulphate 
conjugated metabolites of chlorpromazine in human urine after sulphatase 
incubation, but did not specify the route of administration. No 
reports of detection of sulphate conjugated metabolites after intramuscular 
administration of these drugs have been found.
During the present work preliminary in vitro studies using rat 
liver homogenates have shown that all three metabolic fractions examined
are formed in the liver. Since both glucuronide and sulphate 
conjugation occurs in the liver and since glucuronides are excreted in 
measurable amounts after intramuscular administration, it is postulated 
that a concentration barrier may exist for the formation of sulphate 
conjugates. If drugs were localised at the site of intramuscular 
administration this could prevent a high enough concentration being 
attained in the liver for sulphate conjugation to take place. On the 
other hand the required concentration would be reached after the oral 
route, when most of the drug absorbed passes through the portal 
ciroulation. This would explain the lack of sulphate conjugates after 
intramuscular administration.
There have been no previous reports on the metabolism of aceprornaaine 
or propionylpromazine in any species, which is surprising, especially 
in view of the widespread use of the former compound in veterinary 
medicine. The present work has shown that unlike the other compounds 
studied they are not conjugated to any great extent. It has also been 
reported that thioridazine does not undergo conjugation to any great 
extent (Eiduson and Geller, 1953) but no reasons were given* Instead 
of conjugation acepromazine and propionylpromazine undergo sulphoxidation 
and loss of the nuclear ketone grouping, A small percentage of the 
dose does retain the latter group, is hydroxylated and further conjugated 
as glucuronides or sulphates. These metabolic routes have been found 
to apply to both horses and dogs.
There is the possibility that sulphoxidation of phenothiazine 
derivatives may precede hydroxylation in the body, or that the two 
processes take place independently at different enzymic sites, Beckett 
et al, (1963) suggested that the latter mechanism operated followed by
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partial rearrangement of the sulphoxide to the 3-hydroxy derivative as 
described by Craig and Tate (1361) (figure 3), This would explain 
the presence of conjugated metabolites of promazine and chlorpromazine 
predominantly as sulphide derivatives as opposed to the sulphoxide 
forms of the unconjugated fraction. It would also explain the 
predominance of conjugated metabolites of these drugs over the unconjugated 
fraction.
In the case of acepromazine and propionylpromazine it is postulated
t
that sulphoxide formation and hydroxylation again take place independently 
but that rearrangement of the sulphoxide is largely inhibited by the 
electron withdrawing ketone group in conjugation with the benzene ring.
This would account for the much smaller proportions of conjugated 
metabolites of these drugs obtained. It is further postulated that 
the ketone grouping is subsequently cleared from the sulphoxide derivatives 
but not from the hydroxylated forms giving rise to the characteristic 
spectra and high percentages excreted in the unconjugated fraction.
The amounts and types of metabolites excreted were neither related 
to the age of the sex of the animals but, in duplicate experiments using 
the same horse metabolism and excretion were found to proceed along 
similar lines. Certain abnormalities inconsistent with the expected 
excretion patterns were found for individual animals. Horse 4 excreted 
much larger percentages of dose than other animals undergoing similar 
experiments (Pg.lS^, This was attributed to a much greater capacity 
of this horse for formation of glucuronide conjugated metabolites.
Also, although most horses excreted glucuronide conjugated metabolites 
predominantly in the sulphide form, horse 7 excreted this fraction 
almost entirely as sulphoxide derivatives on every occasion. This
seems to be a peculiarity of this horse for which there is no obvious 
explanation.
After administration of small doses of each drug sufficient to 
slow the animals in a 200 metre gallop test (Pg.224) metabolites were 
just on the limits of detection of the spectroscopic techniques employed.
In some cases only unconjugated metabolites were detected whereas in 
other cases only the conjugated fraction was noted. However, using 
thin layer chromatography, metabolites were detected even after the
r
lowest effective doses of acepromazine. Thus in cases where administration 
of phenothiazine derivatives is suspected all three metabolic fractions 
should be investigated by both techniques. The characteristic 
breakdown patterns of the phenothiazine derivatives in the mass 
spectrometer (Pg,245) may also prove invaluable in cases of suspected 
doping by these compounds.
In conclusion, the present study has borne out the complex and 
irregular metabolism and excretion of the phenothiazine tranquillisers 
experienced in other species. It has also shown the different metabolic 
routes of acepromazine and propionylpromazine compared to other members 
of the series. Since at least one of the metabolic fractions of such 
derivatives can be detected by the methods of analysis employed, these 
methods should prove of value in cases where their illegal administration 
is suspected.
The follo'îinn cour'lusinns have bean rear;'ted regarding
metabolism and excretion of phnnothlazina trannnilllsers by the horse
(1) Excretion of individual metabolit?s and rtotabolic groups 
is irregular, and rates of excretion over successive ti'ne 
intervals csn be divid'-xd into t'.jo patterns, on a attaining a 
nax.inujrTi rate almost in nod lately, and the other rising slowly 
to a maximum at a^nroxi^atoly 24 hours after administration,
(2 ) dates of Gxcrntion a re not deparr.!r?nt on urinary volume or n[-i.
(3 ) The percentages of each dose detected as urinary nstabolites 
arc low and cxcietion is crolnnscd, lasting G to 7 deys for 
p r n n a z l n e .
(4) lesLi.l ts sugars 1: a high rJnorcG of ] coalisation of tabolitas 
i n va r \ o 11 s t i s s 1.1 i-i s a n '! o S' g - - n a ,
(5 ) Unoon j unate-! me ts'x)lii:es are excrete ci rcdrr-rinant ly as 
sidpbnxldn derivatives 'jherass conjugatad metabolites are 
i?ostly in 'the sulphide form,
(6 ) Glucuronide conjugates of nro^' a z ' no and chlorpro re zinc 
prcGominato, whereas acooroa.azIne and pro'-innyIpro'iazinc are 
excreted mostly in unconjugatcd form as sulphoxide derivatives 
of promazine,
(7 ) Sulphate conjugated metabolites rr=> excreted In only trace 
amounts after ir,tra-.uscular administration bvr: a m  present in 
much greater quantity after the ^r^l routs,
(8 ) Indivie'’jc3. excretion differences rxTs ncitcs fs
(9) Metabolism is complex, a large number of biotransformations
taking place for each drug,
(10) The methods of analysis' described are sufficiently sensitive
to allow detection of doping by such derivatives.
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